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Bacterial cell division is a complex process that requires tight co-ordination and regulation of 
chromosome replication and segregation, and the synthesis and remodelling of the bacterial 
cell wall. The peptidoglycan sacculus is synthesised by peptidoglycan synthases and it is a vital 
component of the bacterial cell structure, to withstand the turgor of the cell to prevent its 
lysis FtsZ is one of the first proteins to localise at midcell during cell division where it forms a 
ring-like structure, the Z-ring, at the inner face of the cytoplasmic membrane. After Z-ring 
formation, the divisome is recruited to the division site to form the septum and the 
elongasome is positioned at the side wall for elongation. Both the elongasome and the 
divisome are dynamic macromolecular complexes composed of numerous proteins at 
unknown stoichiometries and it is thought there are proteins in both complexes that are yet 
to be discovered. Understanding bacterial cell division at the molecular and cellular level is an 
important area of research to enable the development of novel antibiotics as well as 
comprehending one of biology’s fundamental questions. 
GpsB is a conserved Gram-positive cytosolic protein that plays an important role in the 
elongation-division cycle by acting as a scaffold to control the relative spatial arrangements of 
peptidoglycan synthases (PBPs). In this thesis the molecular interactions of GpsB with 
cytoplasmic mini-domains of PBPs from two human pathogens (Listeria monocytogenes and 
Streptococcus pneumoniae) are described using structural and biochemical techniques. The 
importance of the critical interacting residues for the GpsB:PBP interaction for cell wall growth 
and viability of L. monocytogenes and S. pneumoniae were analysed in collaboration with the 
Halbedel, and Massidda and Winkler groups, respectively. A novel function of PBP binding was 
introduced into DivIVA, a cell division regulator and GpsB homolog, by protein engineering in 
an attempt to understand the functional divergence between GpsB and DivIVA. Potential 
building blocks for the development of GpsB:PBP inhibitors were identified in the form of 
small fragments by an X-ray crystallography-based fragment screening experiment at 
Diamond Light Source. 
Eukaryote-like serine/threonine protein kinases (eSTPKs) and partner phosphatases (eSTPs) 
are conserved in Gram-positive bacteria. They consist of an intracellular N-terminal kinase 
domain and an extracellular sensing region linked by a short transmembrane helix. The 
external regulatory region is comprised of three or four PASTA domains that bind to 
 
 ii 
peptidoglycans and compounds containing beta-lactams. eSTPKs are involved in the 
regulation of many cellular processes including development of regulation, control of cell 
growth, stress response, virulence and sporulation. The eSTPK/eSTP pair from L. 
monocytogenes are PrkA and PrpC. 
This thesis concerns the importance of autophosphorylation for the function of the kinase 
domain of PrkA (PrkA-KD) and that phosphorylation of serine 173 is crucial for activation, 
agreeing with the mechanism of activation of Stk1 in Staphylococcus aureus. The previously 
uncharacterised phosphoprotein Lmo1503 (renamed ReoM) is a homologue of IreB from 
Enterococcus faecalis, a negative regulator of cephalosporin resistance. It is confirmed that 
ReoM is a substrate of the PrkA/PrpC pair and the crystal structure of the full length ReoM 
protein is presented. Isothermal titration calorimetry determined the interaction of ReoM and 
PrkA-KD is within the nanomolar range and there is a ten-fold reduction in affinity with a PrkA-
KDS173A mutation. The Halbedel group have linked ReoM phosphorylation to the activation of 
ClpCP-dependent degradation of the primary UDP-GlcNAc 1-carboxyvinyltransferase in L. 
monocytogenes, MurA. We therefore propose that cell wall integrity sensing by PrkA is 
coupled to the first committed step of peptidoglycan synthesis through the intermediate 
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Bacteria are a dominant life form on the planet and, while mostly beneficial, they can also 
cause disease. It is well known that antibiotic resistance is a significant problem in the 
treatment of bacterial infections (Wright, 2005). Over time bacteria have developed 
mechanisms to counteract antibiotic action, acquiring multi-drug resistance (Medina & 
Pieper, 2016). The unsuitable consumption and overuse of antibiotics has, at least in part, 
driven this resistance making the need for novel antibiotics paramount. Penicillin was the first 
antibiotic to be discovered- by Fleming and co-workers in the 1930s- which targets bacterial 
cell wall synthesis, a vital part of cell division (Duguid, 1946). Bacterial cell division is still a 
recognised target for the development of new antibiotics. Numerous breakthroughs in the 
field have led to the development of cell division models to create a better understanding of 
the underlying mechanisms of division (Schneider & Sahl, 2010). Characterising cell division 
will enable the design and discovery of novel and potent antibiotics. 
1.2 The bacterial cell division cycle  
The bacterial cell-cycle is a highly complex and robust process than enables the production of 
an identical daughter cell, at face value a simple process that is actually so complex that after 
decades of research it is still not yet completely understood. There are a number of different 
division mechanisms that include binary fission, hyphal growth and budding (Willis & Huang, 
2017) that lead to multiple bacterial cell shapes inclusive of rods, ellipsoids, stars, spirals, 
rectangular boxes and also filamentous bacteria (Young, 2006) (Figure 1.1). The cell-cycle can 
be split into 3 periods called B, C and D. Period B is the period between division and initiation 
of DNA replication. The period necessary for replication is termed period C and period D is the 





Figure 1.1: Bacterial cell shapes and division mechanisms.  
Panel A shows a variety of cell shapes adopted by bacteria. Panel B shows a schematic 
representation of the growth and division mechanisms of rod-shaped, spherical cocci and 
ovococci cells. In rod-shaped cells division and elongation occur independently (1). Spherical 
cocci grow through division and daughter cells grow after division into spheres (2). Ovococci 
elongate by peripheral growth during cell division (3). The septum is indicated by an orange 
oval and dotted arrows show the movement of the cell wall. 
Bacterial cell division requires the tight co-ordination and regulation of chromosome 
replication and segregation with the growth and division of the bacterial cell. DNA replication 
is well characterised in the model organisms for Gram-negative and Gram-positive bacteria, 
Escherichia coli and Bacillus subtilis, respectively. Replication is initiated by the recruitment of 
replisomes to the origin of replication (oriC) which is mediated by DnaA (Figure 1.2). This 
causes origin firing, which initiates the replication of a circular chromosome. Two replication 
forks per oriC are created by the spooling of DNA bidirectionally by the replisomes until the 
forks reach the terminus region (Wang & Levin, 2009). After the generation of two complete 
copies of the DNA, the chromosomes are separated so there is one copy of each chromosome 
per daughter cell. During this process the DNA remains in the nucleoid, a highly condensed, 
ribosome-depleted region (Bakshi et al., 2012). The molecular mechanism that links bacterial 
cell growth with DNA replication initiation is not completely understood. During the cell-cycle, 
cell metabolism and growth is synchronised with DNA replication initiation and the cell 
continues to grow throughout replication and with the assembly of the division machinery 
(Murray, 2016). The elongasome is required at the side wall for the elongation phase of the 
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bacterial cell-cycle (in rod shaped bacteria), the complex is positioned by the cytoskeletal 
network, critically MreB in rod shaped bacteria (Claessen et al., 2008) (Figure 1.2). Cell division 
is initiated towards the end of chromosome segregation. Prior to the completion of DNA 
replication, the duplicated oriCs move to be evenly spaced in the cell (Lau et al., 2003). FtsZ is 
one of the first proteins to localise at mid-cell during cell division where it forms a Z-ring 
structure at the inner face of the cytoplasmic membrane, assembled between the duplicated 
oriCs. When the formation of the Z-ring is complete, a highly dynamic macromolecular 
machine composed of proteins responsible for cell division, termed the divisome is recruited 
to the division site to form the cross wall (Söderström & Daley, 2017). The final stage of the 
cell-cycle involves the closure of the septum causing cells to divide producing two identical 
daughter cells. Multiple regulatory pathways are required for co-ordinating cell growth, DNA 
replication initiation and division, with DnaA, MreB and FtsZ as prime candidates (Willis & 
Huang, 2017). 
 
Figure 1.2: Visual representation of the three periods of rod-shaped bacterial cell-cycle.  
Period B is the period between division and initiation of DNA replication where DnaA is not 
yet associated with chromosome and FtsZ is dispersed in the cell. During period C DnaA 
accumulates at the origin of replication (OriC) and initiates replication. MreB is at the lateral 
cell wall where it serves as a platform for cell elongation. In period D FtsZ localises at the mid-
cell and forms the Z-ring, the blue arrows indicate the treadmilling of the FtsZ filaments that 
leads to septum closure and two identical daughter cells are formed.  
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1.3 The bacterial cell envelope 
The bacterial cell envelope is a complex structure that consists of a number of layers that serve 
to protect the cell cytoplasm. The composition of the cell envelope differs between Gram-
negative and Gram-positive bacteria (Figure 1.3). With Gram-negatives, the complex cell 
envelope consists of a peptidoglycan cell wall located between a cytoplasmic inner membrane 
(IM) and an outer membrane (OM) (Glauert & Thornley, 1969). The exterior OM is a lipid 
bilayer that functions as a protective barrier to the environment and possess two main protein 
groups, lipoproteins and β-barrel proteins (Sankaran & Wu, 1994). Examples of β-barrel 
proteins include the porins OmpF and OmpC that allow small molecules to diffuse across the 
OM (Cowan et al., 1992). The IM consists of a phospholipid bilayer that contains proteins 
important for transport, lipid biosynthesis and protein secretion. Embedded between the two 
membranes is a single layer of peptidoglycan around 3-6 nm in thickness (Turner et al., 2014). 
Anchored to the stem peptides of the peptidoglycan are proteins of numerous functions 
(Hendrickx et al., 2011). Conversely, Gram-positive bacteria lack an OM and instead they have 
developed a thicker layer of peptidoglycan (10-40 nm) (Turner et al., 2014) around the IM to 
withstand the turgor of the cell to prevent lysis and act as a selective barrier (Claessen et al., 
2008). The peptidoglycan of Gram-positives contains teichoic acids of which there are two 
types, wall teichoic acids (WTA) and lipoteichoic acids. WTA are covalently attached to 
peptidoglycan via a phosphodiester linkage to the C6 hydroxyl of MurNAc residues (Silhavy et 
al., 2010) while lipoteichoic acids are anchored to the head groups of membrane lipids 
(Neuhaus & Baddiley, 2003). With the absence of an OM, extracellular proteins in Gram-
positives are often attached to lipid anchors, contain membrane spanning helices or are 
bound to peptidoglycan or teichoic acids (Silhavy et al., 2010). The branching of stem peptides 
in Gram-positive peptidoglycan enables the generation of attachment sites for proteins 




Figure 1.3: Comparison of the composition of the cell envelope of Gram-negative and Gram-
positive bacteria. 
Each of the cell envelope features are labelled on the diagram. 
Peptidoglycan consists of polysaccharides with alternating saccharide groups of N-
acetylglucosamine (GlcNAc) and N-acetylmuramic acid (MurNAc) linked by β-1 → 4 bonds 
(Egan et al., 2017) (Figure 1.4). The glycan strands are cross-linked by short stem peptides as 
the D-lactoyl group of each MurNAc residue is replaced by a peptide stem. In Gram-positives 
the stem peptides in the final peptidoglycan structure tend to be composed of L-Ala at position 
1 followed by D-Glu, L-Lys and D-Ala with a terminal D-Ala that is lost during crosslinking 
(Lupoli et al., 2011). Bacilli are an exception to this rule and meso-diaminopimelic acid (meso-
DAP) takes the place of L-Lys at position 3 (Vollmer et al., 2008). Crosslinking tends to occur 
between the carboxyl group of D-Ala at position 4 with amino group of the diamino acid at 
position 3- called a 3-4 cross linkage (Vollmer et al., 2008). The overall structure of 
peptidoglycan is highly conserved, and its variations include differences in the diversity of the 




Figure 1.4: Composition of the Gram-positive bacterial cell wall. 
 Alternating saccharides of N-acetylglucosamine (GlcNAc) and N-acetylmuramic acid 
(MurNAc) linked by β-1 → 4 glycosidic bonds. The most common crosslink (3-4 crosslink) is 
shown in red between D-Ala at position 4 with amino group of L-Lys/meso-DAP at position 3. 
The synthesis of new peptidoglycan is a complex process that requires approximately 20 
enzyme reactions (Figure 1.5). There are three main steps to peptidoglycan synthesis, the first 
occurs in the cytoplasm with the generation of the key intermediate lipid II. The generation of 
enolpyruvyl UDP-GlcNAc is classed as the first committed step of peptidoglycan synthesis 
(Brown et al., 1995). This reaction is catalysed by the UDP-GlcNAc 1-carboxyvinyltransferase, 
named MurA, that transfers an enolpyruvyl moiety from phospho-enolpyruvate (PEP) to 
uridine diphosphate (UDP)-N-acetylglucosamine (Lovering et al., 2012). The conversion of 
enolpyruvyl UDP-GlcNAc to UDP-MurNAc is a catalysed by MurB and a set of amino acid ligases 
encoded by murC-F catalyse the progressive addition of amino acids to produce UDP-MurNAc-
pentapeptide (Lovering et al., 2012). MraY ligates this precursor to an undecaprenyl (C55) 
carrier lipid which produces the first membrane associated intermediate termed lipid I. Lipid 
II is then generated by the ligation of a NAG residue by the enzyme MurG and lipid II is 
subsequently flipped to the outer surface of the membrane by a flippase (Scheffers & Tol, 
2015). The second stage of peptidoglycan synthesis is called the lipid II cycle in which lipid II 
provides the subunits that are polymerised into glycan strands via a transglycosylase reaction 
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performed by a peptidoglycan synthase enzyme (PBP) (Sauvage et al., 2008). A phosphate is 
then removed from the lipid carrier by a UPPase and it is then released and recycled back into 
the cytoplasm (Lovering et al., 2012). The final stage of peptidoglycan synthesis is the 
crosslinking via transpeptidase reactions and maturation of the glycan stands (Sauvage et al., 
2008). 
 
Figure 1.5: Schematic diagram displaying the main steps of peptidoglycan synthesis. 
The first step involves the generation of lipid II in the cytoplasm which is subsequently flipped 
to the outer surface of the membrane by a flippase. Lipid II then undergoes the lipid II cycle 
providing the subunits that are polymerised into the glycan stand that is then crosslinked. 
1.4 Penicillin-binding proteins 
The study of penicillin-binding proteins (PBPs) was initiated after the discovery that cell wall 
synthesis was inhibited by the antibiotic penicillin (Duguid, 1946). It later transpired that PBPs 
were required in the final stages of peptidoglycan synthesis for the polymerisation and cross-
linking of the glycan stands (Wise & Park, 1965). Treatment with penicillin inhibits the 
transpeptidation activity of PBPs and results in uncross-linked peptidoglycan (Wise & Park, 
1965; Tipper & Strominger, 1965). The first characterisations of PBPs from E. coli, PBP1A and 
PBP1B was achieved by using mutant strains overexpressing or depleting some of the PBPs 
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(Nakagawà et al., 1979; Ishino et al., 1980); these studies revealed which PBPs were required 
for both peptidoglycan formation and cross-linking. 
PBPs can be grouped into two main categories, the high molecular mass PBPs (HMM) and the 
low molecular mass PBPs (LMM). Polymerisation and the insertion of peptidoglycan into the 
pre-existing cell wall is performed by HMM PBPs which are made up of a cytoplasmic tail, 
transmembrane anchor and two domains that are joined by a β-rich linker (Goffin & Ghuysen, 
1998). LMM PBPs are often referred to as the class C PBPs, which are peptidoglycan hydrolases 
with either DD-carboxypeptidase (CPase) or endopeptidase (EPase) activity (Egan et al., 2015). 
HMM PBPs can be split into two main classes, class A penicillin-binding proteins that have 
both transglycosylase (GTase) and transpeptidase (TPase) activities and class B penicillin-
binding proteins that are monofunctional TPases (Typas et al., 2012). Bi-functional class A PBPs 
contain two active sites that belong to the two extracellular domains joined by the β-rich 
linker. The PB domain contains the active site for the transpeptidase reaction and the 
transglycosylase active site is present in the GTase domain (Sauvage et al., 2008). Class A PBPs 
have also been shown to exhibit CPase activity and it was observed that the TPase domain of 
the class A PBPs from E. coli PBP1A and PBP1B is similar to the CPase domain of LMM class C 
PBPs (Egan et al., 2015). The second extracellular domain of class B PBPs is known as the 
pedestal domain that has numerous functions such as positioning the TPase domain away 
from the cell membrane, towards the cell wall, and also interacting with a number of cell 
division proteins (Marrec-Fairley et al., 2000; Macheboeuf et al., 2006). The TPase domains of 
class A and B PBPs are similar in both sequence and structure (Goffin & Ghuysen, 1998). 
Peptidoglycan GTases are part of the glycosyltransferase family 51 (GT51) (Lovering et al., 
2007). The specific function of the GTase enzyme is to produce uncross-linked glycan stands 
from the substrate lipid II (Figure 1.6). GTases work in a progressive manner where the 
growing glycan strand stays at the active site of the enzyme until polymerisation is complete. 
The reaction is initiated by the binding of two lipid II molecules to the acceptor and donor sites 
of the GTase domain. After the first GTase reaction, the undecaprenol pyrophosphate is 
released and the resulting tetrasaccharide moves to the donor site (Sauvage et al., 2008). The 
next GTase reaction is then performed after the binding of another lipid II molecule to empty 
donor site (Fraipont et al., 2006; Perlstein et al., 2010). Different GTases can produce varying 




Figure 1.6: Penicillin binding protein glycosyltransferase mechanism.  
The growing glycan chain is present in the donor site of the PBP and a recently flipped lipid II 
molecule is in the acceptor site of the enzyme. A glutamate residue (Glu) acts as a catalytic 
base that catalyses the deprotonation of the GlcNAc 4-OH of lipid II. The nucleophile 
generated then attacks the C1 of MurNAc in the growing glycan chain.  
Peptidoglycan TPases catalyse the reactions that lead to the formation of peptide cross-links 
under the release of a D-alanine residue (Figure 1.7). The reaction is initiated when a 
pentapeptide donor loses its terminal D-alanine residue, which results in an intermediate 
tetrapeptide bound to the catalytic serine residue in the TPase domain active site (Lupoli et 
al., 2011). This is then proceeded by a nucleophilic attack of an amino group of an acceptor 
peptide that resolves the intermediate and generates the peptide bond (Sauvage et al., 2008). 
With the same mechanism, a TPase can also accept a water molecule to produce a 




Figure 1.7: Penicillin binding protein transpeptidase mechanism.  
The top strand pentapeptide loses its terminal D-alanine residue upon activation by the TPase 
(1) which initiates the formation of an intermediate tetrapeptide bound to the catalytic serine 
residue of the TPase (2). A nucleophilic attack from a bottom strand amino acid resolves the 
intermediate and forms a peptide bond (3). 
The number of PBPs differs across bacterial species and the identification of each PBP in a 
number of organisms has been made possible by genome sequencing. E. coli contains 12 PBPs 
including 3 class A PBPs (PBP1A, PBP1B and PBP1C) and 2 class B PBPs (PBP2 and PBP3) 
(Sauvage et al., 2008). PBP1A and PBP1B are the two major bi-functional PBPs, with the 
deletion of both but not one being lethal (Meberg et al., 2001). PBP2 and PBP3 have been 
shown to have important roles in cell elongation and division, respectively (Egan et al., 2015). 
B. subtilis has 4 class A PBPs (PBP1, PBP2c, PBP4 and PBP2d) and 6 class B PBPs (PBP3, SpoVD, 
PBP2b, PBP2a, PbpH and PBP4b) with PBP1 and PBP2b being a major part of the cell division 
machinery (Sauvage et al., 2008). Listeria monocytogenes and Streptococcus pneumoniae 
have fewer PBPs with 7 and 6, respectively. L. monocytogenes has 2 class A PBPs (PBP1 and 
PBP4) and 3 class B PBPs (PBP2, PBP3 and lmo0441) whereas S. pneumoniae has 3 class A PBPs 
(PBP1a, PBP2a, PBP1b) and 2 class B PBPs (PBP2x and PBP2b) (Sauvage et al., 2008). 
The crystal structures of a number of PBPs have been solved including the class A PBPs PBP1a 
and PBP1b from S. pneumoniae and PBP2 from Staphylococcus aureus (Macheboeuf et al., 
2005; Contreras-Martel et al., 2006; Lovering et al., 2007) (Figure 1.8). The general fold of bi-
functional PBPs includes an N-terminal GT domain coupled to a C-terminal PB domain with 
the interdomain linker composed of small β-sheets and one α-helix (Lovering et al., 2007). The 
PB domain contains two subdomains, an all helical domain and a five stranded β-sheet 
covered by three α-helices. The TPase active site sits between these two subdomains. The GT 
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domain contains a large and small lobe that is almost all α-helical, an extended cleft containing 
the active site separates the two lobes (Sauvage et al., 2008). 
 
Figure 1.8: The structure of PBP2 from S. aureus and its position relative to the cell 
membrane.  
Cartoon display of SaPBP2 (PDB ID: 2OLU). Each domain is shown in a different colour and 
labelled on the figure. An orange cylinder represents where the transmembrane domain 
would be and the region of the GT domain close to the membrane contains the lipid II donor 
and acceptor sites (Lovering et al., 2007). 
The cell wall must be constantly synthesised, remodelled and degraded throughout the cell-
cycle which means the regulation of PBPs is essential (Claessen et al., 2008). Peptidoglycan 
hydrolases are a key component in bacterial growth for maintaining the thickness and the 
shape of the sacculus during elongation and for remodelling the peptidoglycan at cell division 
and separation (Typas et al., 2012). An important part of PBP regulation is through protein-
protein interactions that either stimulate activity or dimerization, provide a precursor or 
substrate or control the subcellular localisation of PBPs. PBP3 from E. coli is recruited to the 
divisome via interactions with the FtsQLB complex and FtsW (Egan & Vollmer, 2013) whereas 
in B. subtilis two proteins called EzrA and GpsB control the localisation of PBP1 during the cell-




1.5 The bacterial cell wall as a target for antibiotics  
Antibiotics inhibit a number of different bacterial homeostasis processes including DNA 
replication, RNA synthesis, protein synthesis and cell wall synthesis (Wright, 2005). The 
peptidoglycan cell wall is a potent target for antibiotics. It provides mechanical strength for 
the bacteria, to withstand the turgor of the cell to prevent its lysis (Claessen et al., 2008). The 
cell wall is also a selective barrier to the environment that enables bacteria to up take only 
specific molecules (Liu & Breukink, 2016). There are two main antibiotics classes that inhibit 
cell wall synthesis, β-lactams and glycopeptides (Kohanski et al., 2010). These drugs cause a 
change in cell size and shape, induce a stress response and cause cell lysis (Tomasz, 1979). β-
lactams can be used to treat infections by both Gram-positive and Gram-negative bacteria, 
examples include penicillins, carbapenems and cephalosporins. The β-lactam is a hydrolysable 
analogue of the terminal D-alanyl-D-alanine dipeptide of peptidoglycan and it binds to the 
transpeptidase active site of PBPs (Waxman et al., 1980). This blocks the crosslinking of 
peptidoglycan and ultimately leads to cell lysis (Wise & Park, 1965) (Figure 1.9).  
Glycopeptides target Gram-positive bacteria due to their low permeability, examples include 
vancomycin and teicoplanin. The mode of action of glycopeptides is to bind directly to the 
terminal D-alanyl-D-alanine dipeptide and block the transpeptidase and transglycosylase 
activities of PBPs (Kahne et al., 2005)(Figure 1.10). Other examples of antibiotics that interfere 
with cell wall synthesis include fosfomycin that inhibits the synthesis of peptidoglycan 
subunits, bacitracin that inhibits the transport of peptidoglycan subunits and lipopeptides 
such as daptomycin, which affects the structural integrity of the cell by inserting into and 




Figure 1.9: A schematic diagram showing the action of β-lactams on Gram-positive bacteria.  
The left panel shows where the PBP TPase subunit would normally bind to peptidoglycan to 
catalyse the transpeptidation reaction forming a 3-4 crosslink (red) and the release of the 
terminal D-Ala. β-lactams such as penicillin binds to the active site of the TPase which prevents 




Figure 1.10: Schematic diagram showing the action of vancomycin on Gram-positive 
bacteria.  
The left panel shows untreated peptidoglycan compared to the right panel treated with 
vancomycin. Vancomycin binds directly to the terminal D-alanyl-D-alanine dipeptides and 
blocks PBP activity.  
1.6 Building the divisome  
The divisome has been most extensively studied in rod-shaped bacteria, specifically E. coli and 
B. subtilis (Figure 1.11 A). Approximately 20-30 divisome proteins have been discovered so far 
and it is likely there are yet more to be found. Cytokinesis is initiated by the early division 
proteins starting with the recruitment of FtsZ to the mid-cell where it polymerises in a GTP-
dependent fashion (Lutkenhaus & Addinall, 1997). Although there are differences in the 
composition of the divisome across bacteria, the accumulation of FtsZ is conserved and it is 
central to the divisome (Lutkenhaus & Addinall, 1997). FtsA, another highly conserved early 
division protein, acts as the connector between FtsZ and the cytoplasmic membrane (Loose & 
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Mitchison, 2014) and this tethering is further aided by ZipA in Gram-negative bacteria (Pazos 
et al., 2018) and potentially SepF in Gram-positives (Hamoen et al., 2006). The FtsZA filaments 
treadmill around the division septum and act as a scaffold for other divisome proteins (Bisson-
Filho et al., 2017). 
EzrA, negative regulator of Z-ring formation, also belongs to the group of early division 
proteins in Gram-positive bacteria and it is one of the first proteins to be recruited by FtsZ 
(Gamba et al., 2009). EzrA was initially discovered in B. subtilis and its deletion affected the 
localisation of FtsZ and caused the formation multiple Z-rings at the cell poles as well as mid-
cell (Levin et al., 1999; Claessen et al., 2008). EzrA directly interacts with FtsZ impeding the 
formation of FtsZ filaments (Land et al., 2014) and the crystal structure of ErzA revealed how 
this might be possible. EzrA has an N-terminal transmembrane helix and a 60 kDa cytoplasmic 
domain that forms a curved rod, resembling a semicircle (Cleverley et al., 2014). The area 
inside of the EzrA crescent is large enough to fit an FtsZ protofilament to physically prevent 
the bundling of polymerised FtsZ (Cleverley & Lewis, 2015). EzrA has also been shown to play 
a role in septum-specific peptidoglycan synthesis: in B. subtilis EzrA recruits PBP1 to the 
septum (Claessen et al., 2008) and is required for peptidoglycan synthesis in S. aureus (Steele 
et al., 2011). The prevention of abnormal Z-ring formation, and the binding of peptidoglycan 
synthases, has highlighted EzrA as a major Gram-positive divisome component.  
The progression of the Z-ring to the mature divisome is achieved by the recruitment of the 
late division proteins that are important for the remodelling of the cell wall. There are 
variations in this group of proteins across bacterial species, essentiality is not maintained and 
the exact function of certain proteins have been difficult to interpret. Five proteins that are 
widely-conserved in Gram-negatives and Gram-positives are FtsW, FtsI, FtsQ, FtsB and FtsL (E. 
coli names) (den Blaauwen et al., 2017). FtsW is an essential integral membrane protein that 
has reported lipid II flippase and transglycosylase activity and FtsI (PBP3) is a class B 
peptidoglycan synthase (Mohammadi et al., 2011; den Blaauwen et al., 2017). FtsW has been 
extensively examined, along with two other essential integral membrane proteins MurJ and 
RodA, as the prime lipid II flippase (Ruiz, 2008; Sieger et al., 2013; Sham et al., 2014). The 
discovery of FtsW and RodA as peptidoglycan polymerases (Emami et al., 2017; Taguchi et al., 
2019) and recent structures and modelling of MurJ strengthens the assignment of MurJ as the 
flippase (Kuk et al., 2017; Zheng et al., 2018a; Kuk et al., 2019). 
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FtsQ, FtsB and FtsL (DivIB, DivIC and FtsL in Gram-positives, respectively) are transmembrane 
proteins each consisting of a small N-terminal cytoplasmic domain, a single transmembrane 
helix and a large C-terminal extracellular domain (Gonzalez et al., 2010). The extracellular 
region of FtsQ/DivIB contains a PASTA domain to interact with peptidoglycan (Bottomley et 
al., 2014). The assembly of these proteins into an independent trimeric complex has been 
demonstrated in both E. coli and B. subtilis (Buddelmeijer & Beckwith, 2004; Robson & King, 
2006). For a while, it was believed that the FtsQBL (DivIB/C/FtsL) complex acted as a divisome 
scaffold, and interactions with multiple division proteins were identified including FtsW, FtsI 
(Goehring et al., 2006) and PBPs such as BsPBP2b (Angeles et al., 2019). However, a recent 
study in E. coli has shown that the complex regulates the activities of peptidoglycan synthases 
in coordination with FtsN and FtsA, thus providing a link between early division and cell wall 
remodelling (Boes et al., 2019). The FtsQBL complex inhibits the transglycosylase activity of 
PBP1b mainly though FtsB and FtsL, whereas FtsQ inhibits FtsI activity (Boes et al., 2019). GpsB 
and DivIVA are two highly-related and conserved Gram-positive divisome proteins that will be 
discussed in more depth below. 
1.7 The elongasome 
During the cell-cycle, rod-shaped bacteria elongate before dividing, which requires the growth 
and remodelling of the cell side-wall by a macromolecular complex known as the elongasome 
(or the Rod system) (Figure 1.11 B). The elongasome is composed of MreB, MreC, MreD, RodA, 
PBP2 and RodZ and both class A and B PBPs synthesise the peptidoglycan used for elongation 
(Dion et al., 2019). The mreBCD operon is conserved in rod-shaped bacteria and this operon 
encodes the three important elongation proteins, MreB MreC and MreD, and mutation in any 
of these genes causes rods to become spherical (Jones et al., 2001; Lee & Stewart, 2003; 
Leaver & Errington, 2005). Spherical bacteria do not elongate and thus the Rod system is 
absent in most cocci. 
MreB is a homologue of actin and polymerises to form cytoskeletal filaments in a helical 
structure that is found under the membrane at the cylindrical part of the cell (Jones et al., 
2001; Leaver & Errington, 2005). Fluorescent vancomycin staining (VAN-FL) showed spots of 
peptidoglycan synthesis in a similar cylindrical pattern (Leaver & Errington, 2005). It was later 
shown that filaments of MreB move around the width of rod-shaped bacteria 
circumferentially positioning the Rod complex that moves in unison (Dominguez-Escobar et 
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al., 2011; Garner et al., 2011). This motion is disturbed when either MreC, MreD, RodA or PBP2 
are lost (Dominguez-Escobar et al., 2011; Garner et al., 2011). MreB filaments were shown to 
preferentially orientate along the direction of the greatest principle membrane curvature, 
which in rod-shaped bacteria is the rod circumference (Hussain et al., 2018). The spatial 
activity of PBPs are constrained by this orientation of the MreB filaments causing the insertion 
of peptidoglycan in a circumferential direction maintaining the rod shape (Hussain et al., 
2018). MreB filaments do not define cell width, B. subtilis cells were only slightly wider when 
the mreBCD operon was replaced by the operon from Bacillus megaterium which is 1.7-fold 
wider than B. subtilis (Dion et al., 2019). However, it was shown in the same study that the 
circumferentially moving Rod system reduces the cell diameter and the non-circumferentially 
moving class A PBP (PBP1) has a widening effect on B. subtilis cells. It was further shown that 
when the activity of RodA and PBP2 is no longer orientated by MreB and when the two 
proteins are in excess they can widen cells outside of the Rod system (Dion et al., 2019). 
The proposed role of MreC in the Rod system is to act as a scaffold for other elongasome 
components. MreC has been shown to interact with MreD and MreB by BACTH (Kruse et al., 
2005) as well as multiple high molecular weight peptidoglycan synthases (Divakaruni et al., 
2005; Van Den Ent et al., 2006) and PBP2 of Caulobacter crescentus exhibits a similar helical 
localisation pattern (Figge et al., 2004). BACTH studies (Van Den Ent et al., 2006) and analysis 
of the structures of MreC (Van Den Ent et al., 2006; Lovering & Strynadka, 2007) have 
demonstrated that it has a tendency to self-associate, leading to oligomers, strengthening the 
assignment of MreC as a scaffold protein. The complex structure of rod-shape determining 
proteins, PBP2:MreC solved from Helicobacter pylori showed two distinct interaction surfaces 
of MreC. One surface bound to the N-terminal domain of PBP2 and the other was identified 
as a self-association surface for binding to a partner MreC molecule (Contreras-Martel et al., 
2017). 
RodA, a member of the SEDS family (for shape, elongation, division and sporulation) is also 
tightly associated with elongation (Meeske et al., 2016). RodA is essential for the cylindrical 
growth of both Gram-negative and Gram-positive rods and was originally suggested as the 
lipid II flippase during elongation (Begg & Donachie, 1998; Henriques et al., 1998). More 
recently, RodA has been shown to have glycosyltransferase activity and act with class B PBPs, 
polymerising the glycan strand during elongation that is then crosslinked by the PBP partner 
(Meeske et al., 2016; Cho et al., 2016). In B. subtilis the class B PBP that pairs with RodA is 
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PBP2a and/or PbpH (Jones et al., 2001). A recent study demonstrated that PBP2, along with 
MreC, stimulated the polymerisation of peptidoglycan by RodA and induced the 
polymerisation of MreB filaments (Rohs et al., 2018). The proposed activation pathway starts 
with MreC associating with PBP2 inducing a conformational change that activates RodA. This 
complex is proposed to have a higher affinity for MreB, leading to MreB polymerisation which 
orientates the synthesised peptidoglycan produced by RodA/PBP2.  
MreB, MreD and RodA have been shown by BACTH to form multiple interactions with each 
other and with the Mur/Mra enzymes important for the synthesis of peptidoglycan precursors 
(White et al., 2010). This discovery links early lipid II synthesis to the cell wall synthesis 




Figure 1.11: Schematic diagram representing the Bacillus subtilis divisome (A) and 
elongasome (B).  
Each complex is composed of a cytoskeletal network formed by the polymerisation of 
FtsZ/MreB filaments that acts as a scaffold for the recruitment and assembly of the respective 
macromolecular complex. Both the divisome and elongasome contain peptidoglycan 
synthases for cell wall synthesis at the septum and side-wall, respectively.  
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1.8 GpsB and its function in the cell-cycle 
 Discovery of GpsB 
GpsB (previously YpsB) was first identified as a potential division protein by sequence 
comparisons that showed the downstream chromosomal region of ftsZ in S. pneumoniae 
encoded an open reading frame with sequence similarity to B. subtilis DivIVA, which in turn 
had sequence similarity to GpsB of 64% over 57 amino acids (Massidda et al., 1998). Ten years 
later, the role of GpsB in growth and division was described in B. subtilis, a model for cell 
division in Gram-positive bacteria (Claessen et al., 2008; Tavares et al., 2008). Phylogenetic 
analysis and sequence comparisons of GpsB and DivIVA demonstrated that the proteins are 
paralogues (Tavares et al., 2008). At the time, DivIVA was known to be involved in cell division 
and this led to the hypothesis that GpsB may have a division function (Edwards & Errington, 
1997).The gpsB gene encodes a protein 98 amino acids in length and it is in a conserved region 
of the chromosome that also contains the gene (ponA) for PBP1 in B. subtilis (Tavares et al., 
2008) and an interaction between PBP1 and GpsB was confirmed by Claessen et al. In a 
synthetic lethal genetic screen in the absence of the cell division protein EzrA, it was found 
that cells lacking gpsB were synthetically sick (Claessen et al., 2008). In the same study, 
sequences of homologues of GpsB were observed in a number of Gram-positive bacteria such 
as L. monocytogenes and S. pneumoniae highlighting a potentially important role for GpsB in 
division (Claessen et al., 2008), which has been confirmed in the subsequent decade’s worth 
of research. 
 ΔgpsB and its effect on the cell 
The impact of gpsB deletions and depletions on cell viability, growth and morphology has been 
widely studied to gain an understanding of the function of GpsB in different species of bacteria 
(Figure 1.12). B. subtilis strains lacking gpsB had no apparent division phenotype, and the cells 
were viable and grew the same as wild-type cells under normal growth conditions (Claessen 
et al., 2008; Tavares et al., 2008). However, in high salt (0.6 M NaCl) growth media, the B. 
subtilis gpsB null mutant was prone to lysis, and the cell was notably longer compared to the 
wild-type; the mutant also formed polar bulges (when viewed by phase contrast microscopy), 
suggesting a role for GpsB under salt stress (Claessen et al., 2008). GpsB appeared neither 
essential for sporulation nor for vegetative growth (Tavares et al., 2008). A strain in which 
both ezrA and gpsB were deleted not only showed a cell division phenotype but the strain was 
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also thinner than the wild type, an indication of defective elongation (Claessen et al., 2008). 
By contrast, Tavares et al. reported that there was no synthetic phenotype in ezrA gpsB double 
mutants, but there was with ftsA gpsB double mutants (Tavares et al., 2008). The absence of 
gpsB was studied in L. monocytogenes in which a temperature sensitive phenotype was 
observed (Rismondo et al., 2016), indicating a function for GpsB at high temperatures. The 
gpsB null strain (LMJR19) grew normally at 30°C, showed a reduced growth rate at 37°C and 
there was no growth at 42°C (Rismondo et al., 2016). As in B. subtilis, gpsB deletion in L. 
monocytogenes produced elongated cells and increased lysis was observed (Rismondo et al., 
2016). In addition, although there was no change to the thickness of the cell wall, the ΔgpsB 
cells had an increased penicillin sensitivity (Rismondo et al., 2016). GpsB is essential in the 
encapsulated S. pneumoniae strain D39 (Land et al., 2013; Fleurie et al., 2014a; Rued et al., 
2017) and its depletion causes larger elongated cells with bulges, as seen in other Gram-
positive bacteria (Land et al., 2013). By comparison, the unencapsulated S. pneumoniae lab 
strains R6, R800 and Rx1 can survive gpsB deletions (Fleurie et al., 2014a; Rued et al., 2017) 
but in all cases cell are elongated, R800 cells have an irregular width (Fleurie et al., 2014a), R6 
cells are larger and Rx1 cells grow poorly (Rued et al., 2017). These results clearly indicate a 
role for GpsB in cell division, and also in some cases elongation, and that GpsB could also 




Figure 1.12: Representations of cell morphologies due to gpsB deletions and depletions in 
Gram-positive bacteria.  
Panel A shows the effect of a gpsB deletion (△gpsB)	 in B. subtilis cells (right) compared to 
wild-type (WT) (left) in high salt growth media (Claessen et al., 2008). △gpsB cells are 
elongated and form polar bulges. Panel B shows the effect of a gpsB deletion in L. 
monocytogenes (right) compared to WT (left) at 37 °C. △gpsB cells showed a reduced growth 
rate and were elongated (Rismondo et al., 2016). Panel C shows the depletion of gpsB in S. 
pneumoniae cells (right) compared to WT (left). Cells have an irregular width, are elongated 
and form multiple division septa (Land et al., 2013; Fleurie et al., 2014a; Rued et al., 2017). 
 Localisation of GpsB 
The cellular localisation of GpsB has also been explored in order to gain an understanding of 
its role in the elongation-division cycle. Fluorescence microscopy studies of GFP-tagged B. 
subtilis GpsB (both N- and C-terminal tags) have shown that it is located at both peripheral 
membranes and at mid-cell at different stages of the cell-cycle (Claessen et al., 2008; Tavares 
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et al., 2008). Claessen et al. proposed a localisation pattern for GpsB based on time-lapse 
microscopy that showed shuttling of GpsB to the septum during the cell division stage and to 
the lateral cell wall during the elongation stage (Figure 1.13). GpsB is thus involved in both 
elongation and division. The same localisation pattern has also been observed in L. 
monocytogenes in which GpsB-GFP cells were seen with either peripheral fluorescence or a 
weaker peripheral fluorescence and strong septal fluorescence (Rismondo et al., 2016). The 
shuttling model was strengthened by the similar localisation pattern of pneumococcal GpsB 
(Rued et al., 2017). GpsB fluorescence was diffuse in early cell division and localised around 
the cell equators after division, but is located at mid-cell of dividing cells and persists at 
division septa (Rued et al., 2017). B. subtilis GpsB was present in both membrane and soluble 
fractions (Tavares et al., 2008) and Western blotting showed GpsB to be enriched at the L. 
monocytogenes membrane (Rismondo et al., 2016). Consistent with the localisation data 
these observations support the idea that GpsB is a dynamic membrane associated protein. 
 
Figure 1.13: GpsB localisation pattern in B. subtilis. 
Schematic diagram representing the localisation pattern of GpsB during the cell-cycle of B. 
subtilis. Areas highlighted in green show GpsB-GFP fluorescence observed by time-lapse 
microscopy (Claessen et al., 2008). 
The subcellular localisation experiments not only yielded insights into the position of GpsB at 
different stages of the cell-cycle but also suggested potential interacting partners and their 
co-localisation relationships. The cell-cycle localisation of B. subtilis PBP1 is severely perturbed 
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when GpsB is depleted at the same time as EzrA (Claessen et al., 2008). EzrA and GpsB, which 
both interact with PBP1 (Claessen et al., 2008), therefore appear to have partially overlapping 
functions in the control of wall synthesis in B. subtilis with EzrA shuttling PBP1 and GpsB to 
the septum for division and GpsB shuttling PBP1 to the side wall for elongation (Claessen et 
al., 2008). By contrast, L. monocytogenes GpsB did not affect PBPA1 (an orthologue of PBP1) 
localisation (Rismondo et al., 2016). The relative localisation patterns of GpsB and FtsZ have 
been determined in B. subtilis and S. pneumoniae (Tavares et al., 2008; Land et al., 2013). In 
both cases GpsB and FtsZ have different localisation patterns, however, at distinct times in the 
cell-cycle the proteins co-localise indicating an overlapping disposition. GpsB and FtsZ co-
localise at midcell in pre-divisional cells and during mid-division FtsZ is present at the 
constricting septa whereas GpsB extends from the septa and along the inner hemispheres 
(Land et al., 2013). The major difference in localisation of FtsZ and GpsB is in the late stage of 
cell division where FtsZ relocates to the equators of daughter cells but GpsB remains at septal 
regions (Tavares et al., 2008; Land et al., 2013). In longer B. subtilis cells about to divide, and 
in smaller cells at the start of the cell-cycle, GpsB was located at the old division site at the 
same time that new Z-rings were forming (Tavares et al., 2008). A similar co-localisation 
pattern was seen using standard-resolution dual-protein IFM (immunofluorescence 
microscopy) (Land et al., 2013), and high-resolution 3D-SIM (three-dimensional structured 
illumination microscopy) (Land et al., 2013) IFM was used to show an overlapping localisation 
pattern of FtsZ with GpsB in S. pneumoniae (Land et al., 2013). 
The importance of specific domains and residues of GpsB to its localisation has also been 
explored by fusing truncations of GpsB to GFP, and visualising cellular localisation by 
fluorescence (Tavares et al., 2008). The coiled-coil domain, the C-terminal domain and the N-
terminal domain of GpsB were important for GpsB localisation in the wild-type strain and in a 
strain lacking endogenous GpsB, respectively (Tavares et al., 2008). The N-terminal domain 
was also shown to be crucial for membrane association in L. monocytogenes GpsB by Western 
blotting of cellular and membrane fractions (Rismondo et al., 2016).  
 Interacting partners of GpsB  
A number of different in vivo and in vitro techniques have been used to study the interactions 
between cell division and elongation proteins such as GpsB (Figure 1.14). Highlighting and 
understanding these interactions will help build a picture of the components of the cell-cycle 
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and their potential roles in space and time. Since EzrA and GpsB have important roles in 
coordinating the localisation of PBP1 within the cell-cycle, the potential for the two proteins 
to interact has been investigated. Bacterial two-hybrid (BACTH) screens have consistently 
shown an interaction between GpsB and EzrA both in B. subtilis and in S. pneumoniae 
(Claessen et al., 2008; Pompeo et al., 2015; Fleurie et al., 2014a; Rued et al., 2017). This 
interaction has also been extended to S. aureus, also identified by BACTH (Steele et al., 2011). 
A Kd of ~ 0.8 µM for the interaction of EzrA with GpsB in S. pneumoniae has been determined 
by SPR (Fleurie et al., 2014a). An interaction between EzrA and FtsZ has also been observed in 
both BACTH and by SPR (Claessen et al., 2008; Fleurie et al., 2014a; Cleverley et al., 2014), 
whereas there has been no detected interaction of GpsB with FtsZ by BACTH in S. pneumoniae 
(Fleurie et al., 2014a). The localisation and interaction relationships of ErzA, GpsB and FtsZ 
suggests EzrA acts as a connector between the Z-ring and GpsB. A recent study in S. aureus 
has indicated that GpsB interacts directly with FtsZ, increasing its GTPase activity and 
promoting the formation of FtsZ bundles (Eswara et al., 2018). At present, this function of 
GpsB is restricted to S. aureus and confirmation of the effect of GpsB on FtsZ function in 
another Gram-positive organism is currently lacking. 
Furthermore, a series of interaction studies in a range of Gram-positive bacteria has indicated 
a role for GpsB in the regulation of wall synthesis through its binding to PBPs. GpsB and the 
major bi-functional PBPs in B. subtilis and L. monocytogenes, PBP1 and PBPA1, respectively, 
have been shown to interact by BACTH (Claessen et al., 2008; Rismondo et al., 2016). GpsB 
still bound strongly to PBP1 when the just the latter's cytoplasmic tail and transmembrane 
region were present; the C-terminal domain of L. monocytogenes GpsB is completely 
dispensable for the interaction with PBPA1 (Claessen et al., 2008; Rismondo et al., 2016). 
BsGpsB and BsPBP1 interact with an SPR-measured Kd of ~0.7 µM; binding is still seen with 
just the N-terminal domain of GpsB, and the first 16 amino acids of PBP1 are crucial for this 
interaction (Rismondo et al., 2016; Cleverley et al., 2019). Fluorescence polarisation studies of 
the N-terminal domain of B. subtilis and fluorescein-labelled PBP11-32 supported the previous 
observations that the N-terminal domain of GpsB interacts with the N-terminal cytoplasmic 
domain of PBP1 (Cleverley et al., 2019). An in vitro HPLC-based fluorescent PG synthesis assay 
indicated that BsGpsB does not affect the TPase or GTase activity of PBP1, which has led to the 
idea that GpsB influences wall synthesis by acting as a scaffold to coordinate the activities of 
PBPs rather than modulating the specific enzyme activities per se (Cleverley et al., 2016). 
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Co-IP experiments have also illustrated that S. pneumoniae GpsB interacts with bPBP2b and 
aPBP2a and not with bPBP2x or aPBP1a (Rued et al., 2017)(b= class B PBP, a= class A PBP). 
Rued et al. also suggested that GpsB was required for aPBP2a activity and that GpsB was 
needed for the migration of bPBP2x to the middle of the division septa. The absence of an 
interaction of GpsB with bPBP2x by co-IP is therefore surprising, however, this could be 
explained if their interaction was weak or transient. 
The N-terminal domain of L. monocytogenes GpsB has been reported by BACTH to interact 
with the FtsZ membrane tethering protein, SepF (Cleverley et al., 2019). This imposes a new 
function for GpsB - to connect the early stages of cytokinesis with peptidoglycan remodelling. 
In the same study, LmGpsB was shown to interact with the late divisome proteins DivIB and 
DivIC by BACTH. GpsB interacted with MreC in 3 different organisms, B. subtilis, L. 
monocytogenes and S. pneumoniae, which supports the observation from localisation studies 
that GpsB plays a role in the elongation of rod-shaped bacteria and the peripheral cell wall 
remodelling of spherical bacteria (Claessen et al., 2008; Rued et al., 2017; Cleverley et al., 
2019). Other interacting partners of GpsB that have been identified include PrkC (StkP in S. 
pneumoniae) and DivIVA, interactions that will be discussed in more detail below (Claessen et 
al., 2008; Fleurie et al., 2014a; Pompeo et al., 2015; Rued et al., 2017). 
GpsB has recently been shown to play a role in the sporulation of B. subtilis (Muchová et al., 
2020), although its presence is not essential for sporulation to occur (Tavares et al., 2008). An 
initial BACTH screen and further pull-down assays revealed that GpsB interacted with the 
cytosolic region of the essential sporulation protein SpoIIE (Muchová et al., 2020). SpoIIE is a 
large membrane protein that is needed for asymmetric septum formation between the 
mother cell and the forespore during sporulation (Feucht et al., 1996). Fluorescence 
microscopy showed that GpsB and SpoIIE co-localised close to one of the cell poles in the early 
stages of sporulation (Muchová et al., 2020). As sporulation progressed, GpsB accumulated at 
the foci and either end of the septum where it could coordinate peptidoglycan synthesis. 
Conversely, SpoIIE is recaptured on the forespore face of the asymmetric septum by SpoIIQ in 
the later stages of sporulation (Muchová et al., 2020). In vegetative and polar septum 
formation the same set of division proteins are required, but the polar septum is thinner, 
probably because of the unique presence of SpoIIE (Barák & Youngman, 1996; Barák & 
Muchová, 2018; Muchová et al., 2020). The recent work by Muchovà et al. has demonstrated 
that GpsB could be the link between peptidoglycan synthesis and asymmetric division, and the 
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role of GpsB as a cell-cycle adapter protein is maintained during the formation of a vegetative 
septum and the polar septum formed during sporulation. 
 
Figure 1.14: Diagram indicating identified interacting partners of GpsB.  
GpsB has been shown to interact with EzrA (Claessen et al., 2008; Steele et al., 2011; Fleurie 
et al., 2014a; Pompeo et al., 2015; Rued et al., 2017), PBPs (Claessen et al., 2008; Rismondo 
et al., 2016; Cleverley et al., 2016; Rued et al., 2017; Cleverley et al., 2019), MreC (Claessen et 
al., 2008; Rued et al., 2017; Cleverley et al., 2019), eSTPks (Pompeo et al., 2015; Fleurie et al., 
2014a; Rued et al., 2017), DivIVA (Fleurie et al., 2014a), SepF (Cleverley et al., 2019), FtsZ 
(Eswara et al., 2018) and DivIB and DivIC (Cleverley et al., 2019). Labels at each arrow indicate 
which Gram-positive organism the interaction has been identified in. 
 Structures of GpsB 
To gain an understanding of GpsB at the molecular level, and how it interacts with PBPs, 
various crystal structures were solved (Figure 1.15) immediately before the commencement 
of my PhD studies. Obtaining good quality diffracting crystals for full length GpsB has not 
proved possible thus far, however, crystal structures of the N- and C-terminal domains have 
been determined (Rismondo et al., 2016), and how these subunits are arranged into a hexamer 
in the full-length protein has been determined by small-angle X-ray scattering (SAXS) (Cleverley 
et al., 2016). These published structures have been complemented with more recent 
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structures of the N-terminal domain of GpsB bound to a PBP-derived peptides from B. subtilis, 
L. monocytogenes and S. pneumoniae (Cleverley et al., 2019). 
Structures of the N-terminal domain of GpsB from both B. subtilis (BsGpsB1-68) and L. 
monocytogenes (LmGpsB1-73) were first solved by X-ray crystallography in the absence of 
bound peptides (Rismondo et al., 2016). The structures are essentially identical; both are 
parallel coiled-coil dimers of identical monomers. The main difference between the two 
structures is restricted to a flexible region at the very N-terminal region of the protein. A key 
feature of both structures is a negatively charged surface cavity of conserved amino acids that 
appears to be the binding site for the positively charged cytoplasmic domains of PBPs. BACTH 
and complementation assay studies confirmed an important role for Val32 and Leu36 for self-
interaction in L. monocytogenes GpsB, as implied from the crystal structure. A number of 
experiments showed that two aspartates (Asp33 and Asp37 in L. monocytogenes, and their 
equivalents in B. subtilis, Asp31 and Asp35) in the negatively-charged surface cavity of GpsB 
were crucial for binding to PBPA1/PBP1 - a complete lack of binding was observed when these 
residues were mutated to alanine (Rismondo et al., 2016). 
The co-crystallisation of BsGpsB5-64 with a PBP1 peptide containing residues 1-17 supported 
the role of the highly conserved Asp31 and Asp35 in PBP1 binding. A groove between two α-
helices was observed to be the binding site for PBP11-17 in which the side chain and peptide 
backbone amide of Arg8 interacted with Asp31 and Asp35, respectively. Arg11 of PBP11-17 was 
also involved in contacts with Leu14 and Glu17 of BsGpsB5-64. A significant reduction in binding 
affinity was established by fluorescence polarisation when either Arg8 or Arg11 were mutated 
to alanine, or when a residue such as proline was introduced to disturb the helix, as the 





Figure 1.15: Crystal structures of GpsB and DivIVA.  
(A) GpsB N-terminal domain from B. subtilis (BsGpsB1-68) (PBD ID: 4UG3) (Rismondo et al., 
2016). (B) The GpsB N-terminal domain from L. monocytogenes (LmGpsB1-73) (PDB ID: 4UGI) 
(Rismondo et al., 2016). (C) The DivIVA N-terminal domain from B. subtilis (BsDivIVA1-57) (PDB 
ID: 2WUJ) (Oliva et al., 2010). (D) The structure of N-terminal BsGpsB bound to BsPBP1 
cytoplasmic domain peptide (Cleverley et al., 2019). BsGpsB5-64 in cyan, BsPBP11-17 in green. 
(E) A representative trimer of the GpsB C-terminal domain from B. subtilis (PDB Id: 5AN5) 
(Rismondo et al., 2016). (F) Zoomed-in view of the BsPBP11-17:BsGpsB5-64 binding site. Key 
residues for binding are shown in stick form, hydrogen bonds are represented by black dashed 
lines and van der Waals’ interactions by yellow dashed lines. 
The crystal structure of the C-terminal domain of B. subtilis GpsB (BsGpsB76-98) is a trimer of a 
parallel triple-helical coiled-coil. Arg83 and Glu88 (Arg96 and Glu101 in L. monocytogenes) 
stabilise the trimer by forming a network of salt bridges that is a characteristic feature of the 
conserved RhxxhE motif of this domain. Complementation assay analysis in L. monocytogenes 
showed Arg96 and Glu101 were essential for the function of GpsB, which could mean they are 
crucial for hexamer formation. The conserved hydrophobic residues Phe78, Leu81 and Phe92 
in B. subtilis GpsB also contribute to hexamer formation as they are buried in the crystal lattice 
but in isolated trimers they are solvent exposed (Rismondo et al., 2016). 
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The low-resolution quaternary structure of L. monocytogenes GpsB was deduced by SAXS 
(Cleverley et al., 2016). The arrangement of subunits in hexameric GpsB was concluded to be 
a ‘tripod like’ arrangement consisting of three N-terminal dimers (legs) and two C-terminal 
trimers (base). The roles of Phe91 and Phe105 (equivalent of Phe78 and Phe92 B. subtilis GpsB 
as discussed above) in hexamer formation was investigated and it was found that L. 
monocytogenes cannot grow with the GpsBPhe105Ala allele (Cleverley et al., 2016). The discovery 
of a GpsB hexamer suggests that GpsB can interact and coordinate simultaneously the 
activities of multiple PBP1 molecules and/or multiple different proteins by acting as a scaffold 
(Cleverley et al., 2016) (Figure 1.16). 
 
Figure 1.16: The quaternary structure of B. subtilis GpsB.  
Arrangement of domains in the GpsB hexamer as determined by SAXS analysis of the full-
length B. subtilis GpsB protein (Cleverley et al., 2016). Figure taken from Halbedel and Lewis, 
2019. The structure of 3 N-terminal domain dimers of BsGpsB (also known as LBD: lipid binding 
domain) are shown in shades of blue. The 2 C-terminal domain (CTD) trimers of BsGpsB are 
shown in shades of red with domain stabilising salt bridges residues as sticks and hydrogen 
bonds as yellow dashed lines. The unstructured linker is represented as grey spheres.  
 GpsB and DivIVA 
As mentioned previously, DivIVA was involved in the discovery and initial identification of 
GpsB. The proteins have been studied extensively since then to determine if there is a 
relationship or shared overlapping function in cell division. Both proteins are highly conserved 
in Gram-positive bacteria. Deletion of divIVA causes filamentous growth in B. subtilis (Edwards 
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& Errington, 1997) and chaining is observed in S. pneumoniae (Fleurie et al., 2014a; Straume 
et al., 2017), suggesting that DivIVA is important in cell division and could potentially interact 
with a number of other division proteins. 
Localisation studies have revealed differences and similarities between GpsB and DivIVA. 
DivIVA localised to the poles and septal regions in S. pneumoniae (Fadda et al., 2007), and was 
targeted to negatively curved membranes in B. subtilis, where it accumulated (Lenarcic et al., 
2009). Unlike DivIVA, GpsB shuttled between the lateral cell wall and the division septum 
during the cell-cycle and did not accumulate at negatively curved membranes (Claessen et al., 
2008). GpsB and DivIVA have been shown to localise independently of each other in B. subtilis, 
and they associate simultaneously with the divisome during the later stages of the division 
cycle (Tavares et al., 2008; Gamba et al., 2009). 
The genetic relationship between GpsB and DivIVA in S. pneumoniae was explored to 
determine whether the two proteins have an epistatic relationship (Rued et al., 2017). As 
mentioned previously, a deletion of gpsB in the R6 strain caused the growth of elongated and 
larger cells. The deletion of divIVA in the same strain caused a different phenotype as the cells 
appeared shorter and rounder and chaining was observed. Fluorescent D-amino acid (FDAA) 
labelling was used in each deletion strain. The label acts as a substitute for FtsZ localisation as 
FDAA indicates TPase activity and septal and peripheral peptidoglycan synthesis are linked 
with Z-ring formation in S. pneumoniae (Kuru et al., 2012; Boersma et al., 2015). ΔgpsB cells 
had multiple FDAA rings whereas each individual bud in the ΔdivIVA chaining-phenotype strain 
contained a single FDAA ring. A double gpsB divIVA deletion produced cells that grew 
significantly slower than the single deletions and the cells contained thick FDAA rings. As with 
ΔgpsB, the double mutant cells were elongated and large, but they were also misshapen. The 
increased severity of the double mutant indicated that ΔdivIVA is not epistatic to ΔgpsB, at 
least in S. pneumoniae R6.  
DivIVA and GpsB are both comprised of two main domains (Figure 1.17). Their N-terminal 
domains are highly homologous in structure, sharing the same coiled-coil dimer arrangement 
of alpha helices (Oliva et al., 2010; Rismondo et al., 2016). The DivIVA N-terminal domain 
functions as the lipid binding domain that is required to bind to negatively curved membranes 
(Lenarcic et al., 2009), and which is mediated by hydrophobic amino acids in the loop region 
(Oliva et al., 2010). These amino acids are not maintained in GpsB orthologues but the N-
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terminal domain has been shown to be required for the recruitment to membrane fractions 
in L. monocyogenes (Rismondo et al., 2016).  
The C-terminal domains (CTD) of GpsB and DivIVA differ markedly; while the GpsB C-terminal 
domain is a parallel trimer of short helices, the equivalent domain in B. subtilis DivIVA is an 
extended coiled-coil tetramer (Oliva et al., 2010). However, the CTD of DivIVA is not well 
conserved, and pneumococcal proteins have an additional C-terminal region compared to B. 
subtilis DivIVA, which is essential for native localisation in S. pneumoniae (Straume et al., 
2017). The CTD of both GpsB and DivIVA play important roles in oligomerisation (Muchová et 
al., 2002; Rismondo et al., 2016). The DivIVA CTD interacts with various soluble cell-cycle 
proteins whereas the CTD of GpsB seemingly acts only as a multimerisation motif (Halbedel & 
Lewis, 2019). 
The precise role of DivIVA in cell division in different Gram-positive bacteria is not clear. It has 
been reported that DivIVA associates with the divisome and acts as a scaffold to localise 
division proteins (Fadda et al., 2007; Oliva et al., 2010). B. subtilis DivIVA seems to function in 
the recruitment of MinCD, an inhibitor of FtsZ assembly (Edwards & Errington, 1997; Marston 
et al., 1998). However, Gram-positive cocci, even the ovococcoid S. pneumoniae, do not 
encode a MinCD system, and DivIVA must play an important other role. In the absence of 
DivIVA, elongation of S. pneumoniae is hindered (Fleurie et al., 2014a), perhaps because 
DivIVA is part of the elongasome complex in wild type cells (Straume et al., 2017). Therefore, 
like GpsB, DivIVA appears to have important roles in elongation as well as division. In the 
genuine coccus S. aureus that lacks the min genes, DivIVA is not required for division as its 
absence caused no observable change in cell morphology (Pinho & Errington, 2004). SaDivIVA 
does however, localise at division sites (Pinho & Errington, 2004; Bottomley et al., 2017), and 
various interactions between divisome proteins and DivIVA have been determined by BACTH 
(Bottomley et al., 2017). A role for SaDivIVA in chromosome segregation has been proposed 
by Bottomley et al. who demonstrated interactions with the chromosome partitioning protein 
SMC and DnaK. DnaK is a heat stress molecular chaperone (Bukau & Horwich, 1998) and 
Bottomley et al. showed there was a higher frequency of non-viable anucleate cells with a 
ΔdivIVA dnaK::kan double mutant. The specific roles played by DivIVA and GpsB are distinct, 
and DiviVA has, seemingly, different functions in various Gram-positive species, perhaps as a 




Figure 1.17: Domains of GpsB and DivIVA from B. subtilis.  
GpsB and DivIVA are both split into two domains with a linker between the two. The 
boundaries of each domain are labelled on the figure. The suggested roles of the NTD (N-
terminal domain) and CTD (C-terminal domain) of DivIVA and GpsB are listed underneath.  
 Conclusion 
Taking into account all of the data discussed above, it appears that GpsB plays an important 
role in the elongation-division cycle by acting as a scaffolding protein that controls the relative 
spatial arrangement of PBPs and potentially other proteins during both vegetative and 
asymmetric division (during sporulation). Structural studies were vital to confirming 
predictions from localisation, deletion and interaction experiments. There are similarities and 
differences in GpsB function in a number of different Gram-positive bacteria, and hence the 
function of GpsB in cell division might differ slightly from species to species. The importance 
of GpsB in high growth temperatures in L. monocytogenes and its essentiality in S. 
pneumoniae, along with the absence of a GpsB homologue in humans, could also point to 
GpsB as a novel target for antibiotic development. 
1.9 The importance of protein kinases and cell signalling in cell division 
 Bacterial serine/threonine protein kinase family 
Around 2% of eukaryotic genes encode protein kinase domains, highlighting the importance 
of phosphorylation in living organisms, and since the 1950’s studies have shown protein 
phosphorylation to be a major regulatory mechanism (Rubin et al., 2000). Phosphorylation of 
proteins on serine, threonine and tyrosine residues was once restricted to eukaryotes but it is 
now clear that protein phosphorylation is widespread among bacteria (Gruszczyński et al., 
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2010). In prokaryotes protein phosphorylation also occurs on histidine, cysteine, aspartate 
and arginine residues. Gram-positive bacteria possess a conserved family of serine/threonine 
protein kinases (eSTPKs) that have various roles in the cell-cycle such as the development of 
regulation, control of cell growth, stress response, virulence and sporulation (Madec et al., 
2002). 
 Structure of eSTPKs 
The overall structure of eSTPKs consists of an intracellular N-terminal kinase domain and an 
extracellular sensing region linked by a short transmembrane helix (Pompeo et al., 2018). The 
kinase domain is composed of two lobes, the N-lobe which is predominantly made up of β-
sheets and one α-helix (αC) and the C-lobe which is α-helical (Huse & Kuriyan, 2002) (Figure 
1.18). ATP binds at the deep cleft between the two lobes. The N-lobe has a number of 
important functional features, the first of which is the P-loop, which is a glycine rich loop with 
the consensus sequence GXGXYGXXXV. The presence of many glycine residues makes the P-
loop flexible which acts as a clamp to cover the bound ATP molecule and stabilise it in the ATP 
binding cleft (Manuse et al., 2015). An invariant lysine residue (Lys40 of Mycobacterium 
tuberculosis PknB, MtPknB) in the N-lobe interacts with the α and β phosphates of the ATP 
molecule which helps anchor and orientate the molecule and a glutamate residue (Glu59 of 
MtPknB) stabilises the lysine by forming a hydrogen bond with it (Cox et al., 1994). The C-lobe 
of the N-terminal domain contains both the catalytic and activation loops. The catalytic 
domain contains crucial asparagine and aspartate residues (Asn143 and Asp138 of MtPknB) 
for phosphorylation. Asn143 positions Asp138 in the correct position to act as a catalytic base 
to attack the hydroxyl group of the phosphorylation substrate (Manuse et al., 2015). The 
activation loop contains a number of conserved threonine and serine residues that are 
phosphorylated for the activation of the kinase. A P+1 loop is formed by the last 4 amino acids 
of the activation loop and this is what determines the specificity of the kinase for threonine 
and serine residues (Taylor et al., 1995). Next to the kinase domain is a highly flexible 
uncharacterised juxtamembrane domain that is phosphorylated and is thought to contribute 




Figure 1.18: Structures of eSTPK domains.  
Panel A shows the structure of extracellular domain of Stk1 from S. aureus (PDB ID:3PY9) in 
cartoon form. The structure is coloured by secondary structure with β-sheets coloured in 
magenta, α-helices coloured cyan and loops in peach. Each PASTA domain is labelled. Panel B 
shows the intracellular kinase domain of PknB from M. tuberculosis bound to ATP-γ-S (PDB 
ID: 1MRU). Specific structural and functional features are coloured and labelled on the figure. 
Dotted black lines indicate salt bridges. 
The extracellular domain of eSTPKs contain a number of PASTA (PBP and serine/threonine 
kinase associated) domains with the number differing among bacterial species (Figure 1.18). 
M. tuberculosis PknB contains 4 PASTA domains whereas PrkC (B. subtilis) and Stk1 (S. aureus) 
contain 3 (Manuse et al., 2015). The first structure of a PASTA domain was from a class B PBP 
from S. pneumoniae PBP2x and this structure revealed that the domain is a globular fold 
formed by three β-strands and one α-helix (Gordon et al., 2000). PrkC and Stk1 contain an 
additional C-terminal extension of ~80 amino acids that form two β-sheets. This extension has 
potential adhesive properties and could be involved, for instance, in cell to cell interactions 
(Ruggiero et al., 2011; Squeglia et al., 2011). 
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 Localisation and essentiality of eSTPKs 
The importance of eSTPKs in a variety of Gram-positive species and their localisation during 
the cell-cycle has been studied by a number of groups. The intracellular kinase domain and 
the extracellular PASTA domains of StkP are essential for normal division in S. pneumoniae: 
phase-contrast microscopy revealed that ΔstkP cells were more spherical compared to the 
usual ovoid shape and the cells grew as chains (Fleurie et al., 2012). Conversely, the 
inactivation of B. subtilis PrkC did not affect cell growth, division or shape (Madec et al., 2002) 
and in L. monocytogenes PrkA is essential (Wamp et al., 2020). In dividing cells, BsPrkC and 
SpStkP and MtPknB are located at the septum (Mir et al., 2011; Fleurie et al., 2012; Pompeo 
et al., 2015) highlighting an important role for eSTPKs during division. The mid-cell localisation 
of SpStkP and MtPknB requires the extracellular PASTA domains of the respective kinase (Mir 
et al., 2011; Fleurie et al., 2012) but BsPrkC appears to exert this same localisation pattern 
without its PASTA domains (Pompeo et al., 2018). Furthermore, BsPrkC is dispersed all over 
the cell wall during the stationary phase of non-diving cells, suggesting a different role in non-
diving cells (Pompeo et al., 2018). The cell division regulator GpsB is required for the 
localisation of SpStk1 (Fleurie et al., 2014a) but the localisation of PrkC is not dependent on 
GpsB in B. subtilis (Pompeo et al., 2015). 
 Activity of eSTPKs 
Various reports have linked the activity of eSTPKs during the cell-cycle with its localisation 
pattern, binding muropeptides to the extracellular PASTA domains and activation of the 
kinase domain by GpsB. A number of studies have demonstrated that PASTA domains in 
MtPknB, BsPrkC, SaStk1 and SpStkP are able to bind to peptidoglycan fragments and β-lactams 
(Paracuellos et al., 2010; Maestro et al., 2011; Mir et al., 2011; Squeglia et al., 2011). An early 
model based on MtPknB that was proposed by Mir et al., states that the extracellular domains 
of eSTPKs contribute to their cellular localisation, which during cell division is at the septum. 
The increase in kinase concentration promotes homodimerisation and activation. The 
interaction of PASTA domains with cell division proteins and peptidoglycan signal information 
from the cell wall to endogenous phosphorylation targets. Since then, the hypothesis that the 
binding of muropeptides directly causes the dimerisation and activation of the extracellular 
domains of eSTPKs has been studied in a number of species. The isolated extracellular domain 
of SaStk1 was shown to be monomeric and dimerisation was not induced by muropeptides 
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(Ruggiero et al., 2011). Dynamic light scattering revealed an increased hydrodynamic diameter 
of BsPrkC with the addition of peptidoglycan fragments suggesting induced oligomerisation 
(Pompeo et al., 2018). In S. pneumoniae, muropeptides are not required for kinase activation 
but activation is dependent on its PASTA domains (Zucchini et al., 2018), whereas in B. subtilis 
the isolated catalytic domain of PrkC is active in vitro (Absalon et al., 2009). Further analysis 
of the activation of BsPrkC showed that deletion of the PASTA domains had no effect on the 
ability of the kinase to autophosphorylate in vivo during the exponential phase of growth but 
the PASTA domains were required for kinase autophosphorylation during stationary phase 
(Pompeo et al., 2018). 
In 2015 Pompeo et al. proposed a role for GpsB in the activation of PrkC in B. subtilis (Pompeo 
et al., 2015). An interaction between the catalytic domain of PrkC and GpsB was discovered 
by BACTH and no autophosphorylation of PrkC was detected in ΔgpsB cells compared to wild-
type. Substitution of the identified phosphorylation site in GpsB, Thr75, for a phospho-
mimetic glutamic/aspartic acid caused a weak signal for PrkC autophosphorylation compared 
to wild-type GpsB and a phosphoablative GpsB mutant (Thr75Ala). The activation of PrkC by 
GpsB to phosphorylate two substrates, CpgA and YvcK in vitro was also shown (Pompeo et al., 
2015). Together these data indicated that unphosphorylated GpsB activates PrkC and 
phosphorylated GpsB had lost this activating capability. In agreement with this conclusion, 
GpsB is required for StkP autophosphorylation in S. pneumoniae in multiple strains (Rued et 
al., 2017). It has not yet been shown if GpsB interacts with and is phosphorylated by PrkA in 
L. monocytogenes. 
Putting this information together it is clear that the activation mechanism of eSTPKs varies 
among Gram-positive species. A model for PrkC activation has been proposed by Pompeo et 
al. that states during the stationary phase when cells are not dividing PrkC is dispersed in the 
cell and is activated though the binding of peptidoglycan fragments in response to external 
stimuli (Pompeo et al., 2018). The model also predicts that in the exponential phase of growth, 
PrkC will be located at mid-cell during division and is activated by GpsB but not peptidoglycan 
fragments. 
 Activation mechanism of the kinase domain 
The catalytic and activation mechanism of the kinase domain of eSTPKs has been extensively 
studied in M. tuberculosis and S. aureus. The positions of the N- and C-lobes with respect to 
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each other form the inactive or active conformations and the phosphorylation of multiple 
activation loop residues dictates the catalytic state of the kinase (Cox et al., 1994). The 
activation loop is disordered in the inactive conformation and blocks the substrate binding 
site (Manuse et al., 2015). Dimerisation of the N-lobes induces allosteric activation, which 
results in kinase cis-autophosphorylation on an activating Thr/Ser residue (Thr172 in S. aureus) 
(Zheng et al., 2018b). Molecular modelling of Stk1 suggests that the autophosphorylation 
moves the activation loop from a closed conformation to an active one, revealing the 
substrate binding site and enabling ATP access to allow trans-phosphorylation of a second 
kinase (Zheng et al., 2018b) (Figure 1.19). In this conformation the conserved N-lobe Lys and 
Glu residues then form the hydrogen bond interaction that is required for phosphoyltransfer 
to take place (Manuse et al., 2015). The active kinase is then able to phosphorylate cellular 
targets until dephosphorylation inactivates the system. Complete autophosphorylation of the 
activation loop involves the phosphorylation of a number of Thr/Ser residues. It has been 
reported that there are 4 activation loop residues that are phosphorylated on PrkC in B. 
subtilis, Thr162, Thr163, Thr156 and Thr167 (Madec et al., 2003). In M. tuberculosis, PknB 
phosphorylation of Thr171 and Thr173 (equivalent to PrkC Thr156 and Thr167) is essential for 
kinase activity (Durán et al., 2005). In S. aureus Stk1 a total of 6 residues are phosphorylated 
in the activation loop Thr161, Ser162, Thr164, Th166 and Thr172 and when Thr172 is mutated 
to an alanine the kinase is rendered inactive and no activation loop residues are 





Figure 1.19: Proposed activation mechanism of Stk1.  
A schematic diagram showing the activation mechanism of Stk1 (Zheng et al., 2018b). The 
binding of an ATP molecule in the ATP binding loop of the N-lobe enables the Cis 
phosphorylation of serine 172. This induces a conformational change causing the activation 
loop to move from a closed (red) to an open (cyan) conformation. This activated kinase can 
then activate other kinase molecules by Trans phosphorylation. The N-lobe of the kinase 
domain is coloured green and the C-lobe is coloured magenta. 
 Cellular roles of eSTPKs 
The cellular roles of eSTPKs have been studied in a number of Gram-positive species. DivIVA, 
suggested to participate in the control of cell shape and localisation of PBP sites, is 
phosphorylated specifically by StkP in S. pneumoniae in vivo (Nováková et al., 2010). 
Phosphorylation occurs on Thr201 and mutation of this threonine residue to alanine causes 
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the cells to elongate and polar bulges are observed (Fleurie et al., 2012). GpsB is required for 
the StkP-dependent phosphorylation of DivIVA (Fleurie et al., 2014a). In M. tuberculosis 
Wag31, an orthologue of DivIVA, is phosphorylated by PknB to regulate cell shape (Kang et al., 
2005). Conversely, DivIVA is not phosphorylated by PrkC in B. subtilis (Madec et al., 2002). 
StkP has also been shown to phosphorylate MapZ and FtsZ: MapZ positions FtsZ at mid-cell 
and its phosphorylation on Thr67 and Thr78 regulates the closure of the Z-ring (Fleurie et al., 
2014b). 
The eSTPK in B. subtilis, PrkC, is not essential for cell division but nonetheless is an important 
regulator of sporulation and biofilm formation (Shah et al., 2008; Madec et al., 2002). Cells 
that are deficient in PrkC are unable to germinate and consequently muropeptides appear to 
act as a spore germinant (Shah et al., 2008). Several proteins have been discovered as PrkC 
targets, including CpgA, YvcK and GpsB. CpgA is a GTPase associated with the small subunit of 
the ribosome, which is essential in B. subtilis, as cell morphology defects are observed with its 
depletion (Cladière et al., 2006). CpgA is phosphorylated on Thr166, which regulates the 
GTPase activity and the ability of CpgA to bind to the 30S ribosome (Pompeo et al., 2012). This 
discovery links CpgA to peptidoglycan synthesis and cell growth through the regulation of 
protein synthesis. YvcK is a protein essential for cell growth and maintenance on 
gluconeogenic sources (Görke et al., 2005). It is phosphorylated on Thr304, and it has been 
suggested that it could have a valuable role in glucogenesis for the synthesis of cell wall 
precursors (Foulquier et al., 2014). 
In vitro phosphorylation assays and mass spectrometry revealed Thr75 to be the single 
phosphorylation site in B. subtilis GpsB by PrkC (Pompeo et al., 2015). As discussed above, 
Pompeo et al. demonstrated that for the autophosphorylation of PrkC, GpsB is required and 
this autophosphorylation is inhibited by phosphorylated GpsB, implying a negative feedback 
relationship. Phosphorylation of GpsB by PrkA in L. monocytogenes has yet to be shown, 
although the equivalent residue to BsGpsBThr75 is Thr88 and the phosphomimetic mutant 
Thr88Asp was inactive in L. monocytogenes even though the hexameric structure of this GpsB 
variant was maintained in vitro (Cleverley et al., 2016). GpsB is important for division site 
localisation and activation of StkP in S. pneumoniae, though without a requirement to be 
phosphorylated (Fleurie et al., 2014a). Therefore, the role of phosphorylation with regards to 
GpsB still needs clarification. 
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1.10 Aims of this study  
This thesis details the functions of two important cell division proteins found in Gram-positive 
bacteria, GpsB and ReoM. GpsB has been previously shown to interact with a number of cell 
division proteins and its main role is to co-ordinate the activities of PBPs via a direct interaction 
with the PBP cytoplasmic mini-domain (Cleverley et al., 2016). The critical structural features 
of the GpsB interaction with the major class A PBP (PBP1) in B. subtilis have been determined 
(Cleverley et al., 2019). These features will be examined in two pathogenic organisms, L. 
monocytogenes and S. pneumoniae, to gain a wider understanding of the interaction across 
Gram-positive bacteria (Chapter 3). The N-terminal domain of BsGpsB is highly homologous in 
structure to the N-terminal domain of BsDivIVA and when the crystal structures are overlaid 
they show only slight differences. BsDivIVA, however, does not bind to PBP1, therefore, 
mutants of BsDivIVA will be made by comparison to BsGpsB in an attempt to engineer PBP1 
binding to DivIVA and, combined with mutagenesis that abrogates binding of GpsB to PBP, will 
yield an understanding of what is crucial for the binding of PBPs to this critical cell division 
regulator (Chapter 4). A fragment-based X-ray screening experiment was performed on GpsB 
to try and identify a lead fragment for the development of a potential drug to block the crucial 
GpsB:PBP binding in S. pneumoniae (Chapter 5). In L. monocytogenes, a gpsB suppressor 
mutation was mapped to the lmo1503 gene encoding a protein of unknown function (Wamp 
et al., 2020). The protein encoded by lmo1503 is a homologue of Enterococcus faecalis IreB, 
which has been implicated as a negative regulator of cephalosporin resistance (Hall et al., 
2013). The structure and function of this previously uncharacterised protein Lmo1503 (herein 
named ReoM) in cell division was explored and its relationship with a major protein kinase 
PrkA was determined (Chapter 6). 
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Chapter 2: Methods 
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2.1 Molecular biology 
 Chemical suppliers 
Unless otherwise stated, all chemicals were purchased from Fisher Scientific, Formedium or 
Sigma Aldrich. Molecular biology reagents and kits were purchased from Thermo Scientific. 
 General buffers and solutions 
Tris and HEPES buffers were made by dissolving Tris/HEPES base powder in MilliQ water and 
were adjusted to the desired pH using hydrochloric acid.  
Below is a list of general buffers and solutions: 
• 1x TAE: 0.4 M Tris-acetate pH 8.0, 0.1 M EDTA. 
• 5x DNA loading dye: 40 mM Tris.HCl pH 6.8, 10 % (w/v) glycerol, 0.1 % bromophenol blue, 
3 % SDS.  
• 1x SDS running buffer: 25 mM Tris.HCl pH 8.5, 250 mM glycine, 0.1 % (w/v) SDS. 
• 6x SDS loading dye: 50 mM Tris.HCl pH 6.8, 10 % (w/v) SDS, 0.1 % (w/v) bromophenol blue, 
10 % (w/v) glycerol, 1 mM DTT. 
• 1x native-PAGE running buffer: 0.192 M glycine, 250 mM Tris.HCl. 
• 6x native load dye: 50 mM Tris.HCl pH 8.5, 0.1 % (w/v) bromophenol blue, 10 % (w/v) 
glycerol.  
• 10x Tris-tricine anode buffer: 1 M Tris.HCl pH 8.9. 
• 10x Tris-tricine cathode buffer: 1 M Tris, 1 M tricine, 1 % SDS. 
• Coomassie blue stain: 40 % ethanol, 10 % acetic acid, 0.25 % Coomassie blue R-250. 
• Destain: 20 % ethanol, 10 % acetic acid. 
 Growth medium  
20 g/L of LB-Broth Lennox from Formedium was used as growth medium and 1.5 % (w/v) agar 
(Formedium) was added to LB prior to autoclaving for LB agar plates. 
 Plasmids  
The plasmids used in this study are listed in Table 2.1. Kanamycin at 50 μg/mL or ampicillin at 
100 μg/mL were added to the growth medium for the selection of transformed bacteria. 
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Plasmid Antibiotic resistance Description 
pETM11 Kanamycin  Plasmid with a T7 promoter. Contains a 
multiple cloning site which allows the fusion 
of a His6-tag to the N-terminus of the 
expressed protein that is cleavable with TEV 
protease.  
pMAT11 Ampicillin  Plasmid with a high copy number and a T7 
promoter. Thrombin and TEV cleavable N-
terminal His6-tag-MBP fusions. No NcoI site 
within the MBP coding region.  
pET28a Kanamycin Plasmid with a T7 promoter. Contains a 
multiple cloning site with His6-tag 
incorporation at either the N- or C-terminus. 
N-terminal His6-tag is cleavable with 
thrombin protease.   
Table 2.1: A list of the plasmids used in this study  
 
 Bacterial strains  
The bacterial strains used in this study are summarised in Table 2.2.  
E. coli strain Genotype Description 
BL21 (DE3) F– ompT hsdSB (rB–, mB–) gal 
dcm (DE3) 
 
Expression strain with high efficiency. 
The most widely used host for protein 
expression using E. coli and T7 
expression system 
XL1-blue recA1 endA1 gyrA96 thi-1 
hsdR17 supE44 relA1 lac [F´ 
proAB lacIq Z∆M15 Tn10 
(Tetr )].  
 
Strain allows blue-white colour 
screening for recombinant plasmids and 
host strain for routine cloning 
applications.  
T7 Express fhuA2 lacZ::T7 gene1 [lon] 






High-efficiency chemically competent 
cells suitable for T7 protein expression.  
Table 2.2: A list of bacterial strains used in this study 
 
 Preparation of competent cells 
10 mL of LB medium was inoculated with a single colony from an LB agar plate and the culture 
was incubated at 37 °C for 15-18 hours. 5 mL of the saturated starter culture was used to 
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inoculate a 100 mL culture that was grown at 37 °C to an absorbance at 600 nm of 0.5. The 
culture was cooled on ice for 15 minutes before being split into two 50 mL falcon tubes and 
centrifuged at 4500 rpm for 10 minutes. The supernatant was discarded and the pellets were 
resuspended in 6 mL total of TfbI (see below) and cooled on ice for 15 minutes. A second 
centrifugation step at 4000 rpm was followed by resuspension of the pellet in 1.2 mL TfbII (See 
below). The cells were then aliquoted in 50 μL volumes, flash frozen in liquid nitrogen and 
stored at -80 °C.  
• TfbI: 100 mM rubidium chloride, 50 mM manganese chloride, 30 mM potassium acetate 
pH 5.8 (with acetic acid), 10 mM calcium chloride, 15 % (v/v) glycerol. 
• TfbII: 10 mM MOPS pH 6.8 (with NaOH), 10 mM rubidium chloride, 75 mM calcium 
chloride, 15 % (v/v) glycerol. 
 Transformation of competent cells 
A 50 μL aliquot was defrosted on ice and ~100 ng of plasmid or 4 μL of mutagenesis reaction 
was added. The cells were incubated on ice for 30 minutes and then heat shocked at 42 °C for 
45 seconds. The cells were cooled for 2 minutes on ice and 1 mL of LB medium was added 
before a one hour recovery at 37 °C. Transformed cells were plated onto LB agar with the 
appropriate antibiotic and incubated at 37 °C overnight or 20 °C for 48 hours.  
 Quikchange mutagenesis  
The list of primers used for Quikchange mutagenesis can be found in Table Apx B.1. All primers 
were manufactured by Eurofins Genomics.  
In the 50 μL reaction 50 ng of plasmid template was used with 100 ng of both the forward and 
reverse primers. dNTPs were added to a final concentration of 0.25 mM along with 1 x Pfu 
reaction buffer and 2.5 U of Pfu polymerase. The cycling parameters can be found in Table 2.3 
below. All reactions were carried out in a T100™ Thermal Cycler (Bio-Rad).  
Table 2.3: Cycling parameter for Quikchange mutagenesis 
 
Segment Cycles  Temperature Time 
1 1 95 °C 1 minute 
2 15 95 °C 30 seconds 
  55 °C 1 minute 
  68 °C 8.5 minutes 
 
 47 
In the event of unsuccessful mutagenesis using the above method, a second longer 
Quikchange method was used were a single-primer extension reaction was carried out before 
the standard Quikchange reaction. (Wang & Malcolm, 1999). For this experiment there were 
two reaction mixes with the same reagents used in the first method, however each reaction 
contained one primer. Both reactions underwent the cycling parameters in Table 2.4 before 
25 μL of each reaction with a single primer were added together along with 2.5 U of Pfu 
polymerase and undergoing the cycling parameters in Table 2.5. 
Parental DNA was digested with 16 U of DpnI and the reaction was incubated for 2 hours at 
37 °C.  
Segment Cycles  Temperature Time 
1 1 95 °C 1 minute 
2 9 95 °C 30 seconds 
  55 °C 1 minute 
  68 °C 8 minutes 
3 1 68 °C 10 minutes  
Table 2.4: Cycling parameters for step one of longer Quikchange method  
Segment Cycles  Temperature Time 
1 1 95 °C 1 minute 
2 15 95 °C 30 seconds 
  55 °C 1 minute 
  68 °C 8 minutes 
3 1 68 °C 10 minutes  
Table 2.5: Cycling parameters for step two of longer Quikchange method 
 
 PCR amplification of target genes from genomic DNA 
The primers used in PCR amplification can be found in Table Apx B.2.  
Genomic DNA from Listeria monocytogenes EGD-e was supplied by Dr. S. Halbedel (Division 
of Enteropathogenic bacteria and Legionella, Robert Koch Institute, Germany). Streptococcus 
pneumoniae R6 genomic DNA was supplied by Prof. W. Vollmer (Newcastle University). PCR 
reaction mixes consisted of 50 ng of template, 50 pmol of forward and reverse primer, 0.2 
mM dNTPs, 1x Phusion buffer and 1 U of Phusion polymerase. The cycling parameters for the 





Segment Cycles  Temperature Time 
1 1 98 °C 30 seconds 
2 34 98 °C 10 seconds 
  55 °C 20 seconds 
  72 °C 40 seconds 
3 1 72 °C 5 minutes  
Table 2.6: Cycling parameters for amplification of target genes 
 
 Agarose gel electrophoresis, visualisation of PCR products and purification of DNA 
Mutagenesis products were analysed on 1 % (w/v) agarose gels and PCR amplification 
products were analysed on 2 % (w/v) agarose gels, and both were stained with 0.5 μg/mL of 
GelRed (Sigma-Aldrich). 6 x loading dye was added to the samples and 0.5 ng of 1 kb or 1 kb 
Plus DNA ladder was used as a marker (Thermo Fisher). Gels were run at 100 V for 45 minutes 
and were imaged using a Gel Doc XR+ (Bio-Rad) (Figure 2.1). PCR amplification gels were 
visualised using a UV transilluminator and PCR products of the appropriate sizes were excised 
and purified using a GeneJET PCR purification kit (Fisher).  
 
Figure 2.1: Representative agarose gels.  
A representative PCR amplification gel is shown in panel A and a representative mutagenesis 
gel in panel B.  
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 Restriction digests of DNA and plasmids  
The purified PCR fragment was digested with 30 units of each restriction enzyme (NcoI and 
XhoI) (Thermo Fisher Scientific) in 1 x Tango buffer with a total reaction volume of 200 μL for 
2 hours at 37 °C. 3-4 μg of plasmid was digested in the same way. Both the plasmid and the 
DNA insert were purified using the GeneJET PCR purification kit (Fisher).  
 Ligation of DNA into plasmids 
10 μL ligation reactions were carried out at 16 °C for 2 hours. Reactions contained 1 x T4 ligase 
buffer, 37.5 ng of vector, DNA insert at 1:5 molar ratio (vector to insert) and 1 U of T4 ligase 
(NEB). A control reaction without the DNA insert was used.  
 Small-scale cultures and isolation of plasmids  
Successful Quikchange and ligation reactions (determined by the presence of a band of the 
correct length on an agarose gel) were transformed into XL1-blue cells, which were then 
plated onto LB agar plates. 10 mL LB cultures with the appropriate antibiotic were inoculated 
with a single colony from an LB agar plate and grown overnight at 37 °C. The cells were 
pelleted by centrifugation at 4000 xg for 10 minutes and the supernatant was discarded. The 
plasmid was extracted and purified from the cells using a GeneJET plasmid miniprep kit 
(Fisher) per the manufacturer’s instructions.  
 DNA sequencing  
All DNA sequencing was carried out by Eurofins Genomics (formerly GATC biotech) using 
universal T7 primers (T7 and pET-RP).  
 Analysis of proteins by SDS-PAGE and Native-PAGE electrophoresis  
All gels were constructed using a Mini-PROTEAN® tetra handcast system (Bio-Rad). 12 % Tris-
glycine gels and 17 % Tris-tricine gels were used. The components of each gel are listed in 
Table 2.7. 1- 10 μL of sample was mixed with 6x SDS loading dye and heated at 100 °C for 1 
minute before being loaded on the gel. 3 μL of prestained protein ladder (Geneflow Ltd) was 
also loaded. Tris-glycine gels were run at 200 V for 45 minutes and Tris-tricine gels were run 
at 150 V for 1 hour and 15 minutes. 20 % native gels (see below) were used; 10 μL of sample 
with 6x native load dye were loaded and the gels were run at 200 V on ice for 1-2 hours. Gels 
 
 50 
were stained using for 20 minutes and de-stained for 10 minutes before being transferred to 
water and heated for 1 minute in a microwave set to ‘high’. A representative SDS-PAGE gel is 
shown in Figure 2.2. 
Gel Number of gels Stacking gel Resolving gel 
12 % Tris-glycine 4 dH2O- 5.84 mL 
Acrylamide (40 %)- 1 
mL 
1 M Tris pH 6.8- 3.3 mL 
10 % SDS- 80 μL 
10 % APS- 80 μL 
TEMED- 8 μL 
dH2O- 8.6 mL 
Acrylamide (40 %)- 6 
mL 
1.5 M Tris pH 8.8- 5 
mL 
10 % SDS- 200 μL 
APS- 200 μL 
TEMED- 10 μL 
17 % Tris-tricine  2 dH2O- 5.34 mL 
Acrylamide (40 %)- 1.25 
mL 
3 M Tris, 0.3 % SDS pH 
8.5- 3.3 mL 
10 % APS- 100 μL 
TEMED- 8 μL 
Glycerol- 1 g 
dH2O- 2.25 mL 
Acrylamide (40 %)- 
4.25 mL 
3 M Tris, 0.3 % SDS 
pH 8.5- 3.3 mL 
10 % APS- 200 μL 
TEMED- 16 μL 
20 % Native 2 N/A dH2O- 3.59 mL 
Acrylamide (40 %)- 
7.5 mL 
1.5M Tris pH 8.8- 
3.75 mL 
10 % APS- 150 μL 
TEMED- 10 μL 
Table 2.7: PAGE gel components 
 
Figure 2.2: Representative SDS-PAGE gel.  
A 17 % Tris-tricine gel of the Ni-NTA purification of His6-tagged ReoM.  
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2.2 Recombinant protein overexpression and purification  
 Large-scale cultures for the overexpression of target proteins 
N-terminally His6-tagged GpsB proteins, N-terminally tagged DivIVA, ReoM, PrkA and PrpC 
were expressed in E. coli BL21 (DE3) cells. Cell cultures were grown in LB liquid medium at 37 
°C with 50 µg/mL kanamycin to an OD600 0.6-0.8. Expression of the target protein was induced 
with 0.4 mM IPTG and the cultures were incubated at 20 °C for 18 hours. The cells from 2 L of 
cell culture were harvested by centrifugation (3500 x g) for 30 minutes.   
MBP-PBP peptide fusion proteins were expressed in E. coli BL21 (DE3) and E. coli T7 Express 
cells. E. coli cells were grown in 1 L cultures in LB liquid medium containing 100 µg/mL 
ampicillin at 37 °C until they reached an OD600 of 0.6-0.8 (BL21) or 0.3-0.5 (T7 express). MBP-
PBP expression was induced with 0.2 mM IPTG and overnight incubation at 20 °C before the 
cells were harvested by centrifugation (3500 x g).  
 Purification of target proteins by metal affinity chromatography (Ni-NTA) 
Cell pellets from 2 L of cultures were resuspended in 70 mL of buffer (50 mM Tris.HCl, pH 8, 
300 mM NaCl, 10 mM imidazole) with 500 Kunitz units of DNase I and 1 mL Roche complete 
protease inhibitor cocktail at 25x working concentration. MBP-PBP peptide fusion lysis buffer 
also contained 1 mM DTT. The 70 mL of resuspended cells were lysed for 5 minutes on ice by 
sonication (Sonopuls HD2070- Bandelin) at 100 % power, 50 % cycle and clarified at 19000 x g 
for 20 minutes. The supernatant was filtered using a 0.45 µm filter and the cell lysate was 
loaded onto a 5 mL Ni-NTA column (Qiagen) at 1.5 mL/min that had been equilibrated in 50 
mM Tris.HCl, pH 8, 300 mM NaCl, 10 mM imidazole. The column was subsequently washed at 
5 mL/min with 80 mL of the same buffer and proteins were eluted with 50 mM Tris.HCl, pH 8, 
300 mM NaCl, 250 mM imidazole. MBP-peptide fusions were eluted in 50 mM Tris.HCl, pH 7, 
300 mM NaCl, 250 mM imidazole. Peptide fusions were labelled straight after elution and a 
drop to pH 7 increased the efficiency of labelling of the cysteine residue in the peptide with 
either fluorescein-maleimide (Vector laboratories) or TAMRA-maleimide (Santa Cruz 




Figure 2.3: Representative chromatogram of His6-ReoM purification from cell lysate using a 
Ni-NTA column. 
 Peak A is the flow-through of the cell lysate and peak B is the elution of His6-ReoM with an 
increase on imidazole concentration to 250 mM at 250 mL indicated by the red arrow. 
 Removal of His6-tag/His6-tagged MBP by TEV/ thrombin cleavage 
The N-terminal His6 tag was cleaved with thrombin (1 unit for 0.25 mg of protein) or TEV 
protease (1mg TEV for 20 mg of protein). TEV cleavage was carried out during dialysis against 
1 L of 50 mM Tris.HCl pH 8, 300 mM NaCl and 1 mM DTT at 4 °C (ReoM at 20 °C). The His6-tag 
was not cleaved from PrpC to allow separation after incubation with PrkA (section 2.5.3). MBP-
peptide fusions were cleaved after labelling with fluorescein or TAMRA maleimide and is 
described in 2.2.6.  
 Separation of His6-tag, uncleaved protein and histidine rich proteins from cleaved 
target by metal affinity chromatography (Ni-NTA) 
Proteins cleaved by TEV protease were passed over a 5 mL Ni-NTA column (Qiagen) for a 
second time to remove the His6-tagged TEV protease, histidine-rich contaminants and any 
uncleaved protein. Imidazole was added to the cleaved protein mix to 10 mM to prevent non-
specific binding to the column before filtering with a 0.45 µm filter. The column was 
equilibrated with 50 mM Tris.HCl, pH 8, 300 mM NaCl and 10 mM imidazole and the protein 
was passed over the column at 5 mL/min and the flow though containing cleaved protein was 
collected. Contaminants and remaining His-tagged proteins were then eluted from the column 
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with 50 mM Tris.HCl, pH 8, 300 mM NaCl, 250 mM imidazole. A representative chromatogram 
is shown in Figure 2.4. 
 
 
Figure 2.4: Representative chromatogram of TEV cleaved His6-ReoM using a Ni-NTA column.  
Peak A is the flow-through of the TEV cleavage reaction which contains ReoM without a His6 
tag. Peak B is the elution of the TEV cleavage reaction with an increase on imidazole 
concentration to 250 mM at 155 mL (red arrow) which contains TEV protease, uncleaved His6-
ReoM and histidine rich contaminants. 
 Fluorescent labelling of PBP peptides  
MBP-peptide fusions purified by metal affinity chromatography at 5 mg/mL were labelled with 
either TAMRA-maleimide (Santa Cruz Biotechnology) or fluorescein maleimide (Vector 
laboratories), by conjugation of the labelling agent to the cysteine residue introduced at the 
C-terminus of the peptide. The final concentration of the labelling agent was 625 µM and 1 
mM, respectively and stocks were made by dissolving the power in 100% DMSO to a final 
concentration of 20 mM and 40 mM, respectively. Labelling was carried out at 4 °C overnight 
and the following day a PD 10 desalting column was used to remove excess labelling agent 
and to buffer exchange the MBP-peptide into 10 mM Tris.HCl pH8 and 250 mM NaCl. 
Complete buffer exchange was achieved by dialysis in 1 L of the same buffer at 4 °C for 4 hours. 
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 Separation of MBP from PBP peptides  
1 mg of TEV protease for 50 mg of protein was used to cleave the His6-MBP protein from the 
PBP peptide at 4 °C overnight. The TEV protease, uncleaved MBP-peptide and His6-MBP were 
separated from the peptide by concentrating through a 30 kDa molecular mass cutoff (MWCO) 
centrifugal ultrafiltration device, allowing only the peptide to pass through. Peptides were 
further concentrated in a 3 kDa (MWCO) centrifugal ultrafiltration device to 30-100 µM and 
stored at -20 °C. 
 Purification of proteins by size-exclusion chromatography (Superdex 75 and 200) 
The proteins were concentrated in a 3-30 kDa (MWCO) concentrator depending on MW to 5 
mL and loaded onto either a Superdex 75 XK16/60 or Superdex 200 XK16/60 column (GE 
Healthcare) equilibrated with 10 mM Tris.HCL, pH 8, 250 mM NaCl for proteins to be used in 
FP experiments, or 10 mM HEPES.HCl pH 8 and 100 mM NaCl for proteins used in ITC and 
crystallisation, with a flow rate of 1 mL/min. A representative chromatogram is shown in 
Figure 2.5. The fractions from gel filtration were analysed on SDS-PAGE, concentrated to 20-
40 mg/mL and aliquots were snap frozen in liquid nitrogen and stored at -80 °C. 
 
Figure 2.5: Representative chromatogram. 
ReoM elution from a Superdex S75 HiLoad 16/60 size exclusion column.  
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 Analytical size-exclusion chromatography 
1 mM of ReoM and 250 µM of PrkA-KD diluted in 10 mM HEPES.HCl pH 8.0 and 100 mM NaCl 
to a total volume of 100 µL was initially incubated at 37 °C for 20 minutes (same conditions as 
phosphorylation reactions, section 2.5.1). The protein complex was then loaded into a 
Superdex 200 Increase 10/300 GL column at 0.75 mL/min equilibrated in 10 mM HEPES.HCl 
pH 8.0 and 100 mM NaCl. The individual proteins at the same concentrations were run in the 
same way as controls as well as ReoM and P-ReoM at 1 mM. 
2.3 Biophysical and biochemical characterisation of proteins  
 Determination of protein/peptide concentration 
Protein concentration was routinely determined using a NanoDrop lite spectrophotometer 
(Thermo Fisher) that measured the absorbance at 280 nm. The concentration in mg/mL and 
M was calculated from the absorbance value using the extinction coefficient and absorbance 
0.1 % (=1 g/l) of the protein calculated from the protein sequence by ProtParam. 
Fluorescent peptide concentrations were determined using a NanoDrop 1000 (Labtech) 
measuring at 555 nm for TAMRA and 495 nm for fluorescein and using the extinction 
coefficient (TAMRA maleimide = 65,000 cm-1M-1, fluorescein maleimide = 75,000 cm-1M-1) of 
the respective labelling agent to determine the molar concentration.  
 Circular Dichroism  
CD was performed to monitor the secondary structure content of all purified proteins. CD 
scans were performed at a wavelength range of 190 nm - 260 nm at 20 °C, using a Jasco J-180 
spectropolarimeter equipped with a Jasco 4235 Peltier cooler. The band width was 2 nm with 
a four second response time and 10 nm/min scan speed. CD measurements were performed 
with samples of proteins at 2.5-10 µM diluted in dH2O using a 0.1cm path length quartz 
cuvette. Scans were repeated nine times. All CD data were buffer subtracted using buffer runs 
done prior to each protein run. The data from these runs were analysed using beStSel 
(Micsonai et al., 2018). CD thermal melt scans were also performed in a temperature range of 
20 °C to 90 °C, at a fixed wavelength of 222 nm, 2 nm bandwidth, eight second response time 
with no time delay.  
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For CD spectra of peptides, full wavelength scans were done with a scan speed of 10 nm/min 
and a response time of 4 seconds was used. The final spectra were the average of at least four 
measurements.  CD spectra were recorded at 40 μM in 20mM sodium phosphate buffer, pH 
7.8. 
 Detection of protein:protein interactions and phosphorylation by native-PAGE 
electrophoresis  
The effect of phosphorylation and dephosphorylation on ReoM and PrkA-KD proteins was 
analysed by 20% non-denaturing PAGE. Phosphorylation reactions consisted of 18.5 µM 
ReoM, 3.7 µM PrkA-KD, 5 mM ATP and 5 mM MgCl2, diluted in 10 mM HEPES.HCl pH 8.0 and 
100 mM NaCl. Dephosphorylation reactions consisted of 37 µM P-ReoM, 3.7 µM PrkA-KD, 18.5 
µM PrpC and 1 mM MnCl2, diluted in 10 mM HEPES.HCl pH 8.0 and 100 mM NaCl. In each case 
individual proteins were loaded at the same concentrations. The reactions were incubated at 
37 °C for 20 minutes prior to electrophoresis at 200 V for 2.5 hours on ice. 
 Isothermal titration calorimetry 
ITC was used to determine the thermodynamic parameters of the ReoM:PrkA interaction. 
These measurements were made using a Malvern MicroCal PeaQ-ITC microcalorimeter. All 
proteins were diluted to the desired concentrations with 10 mM HEPES.HCl pH 8.0 and 100 
mM NaCl. Twenty 0.5 µL injections, all with a four second duration and a jacket temperature 
of 20 °C, were made in each ITC titration. The reference power was 6 µcal/s and the spin speed 
was 750 rpm. Control buffer runs were performed to determine any thermodynamic effect of 
diluting each protein. Data were analysed using the MicroCal PEAQ-ITC analysis software with 
the single set of identical sites model.  
 Fluorescence polarisation (FP) assays  
FP experiments were done in a buffer of 10mM Tris.HCl pH 8.0, 250mM NaCl, 0.1% reduced 
Triton X-100. A PHERAstar FS (BMG Labtech) microplate reader was used to record 
fluorescence polarisation with 384-well plates. The excitation wavelength for fluorescein was 
485 nm and for TAMRA 540 nm, with the fluorescence emission recorded above 520 nm for 
fluorescein and above 590 nm for TAMRA. The N-terminal domains of GpsB proteins were 
used in all experiments in preference to the full-length GpsB proteins due to the high solubility 
of the former, which facilitated achieving the high protein concentrations necessary to 
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saturate peptide binding. A target polarisation of 35 mP in wells with free labelled peptide 
was used to adjust the focus and gain. A 20 µL sample of GpsB (0-4 mM) with 40 nM labelled 
peptide corresponds to each data set. Kd values ± the standard error, generated after 
simultaneously fitting all the binding data to a 1:1 interaction model, were reported and there 
were three separate measurements at each data point in a titration. 
 MicroScale Thermophoresis 
MicroScale Thermophoresis (MST) experiments were carried out using a Monolith NT.115 
(NanoTemper). A medium MST-power of 40 % and an excitation power of 20 % were used 
with the excitation type as blue. MST experiments were done in a buffer of 10mM Tris.HCl pH 
8.0, 250mM NaCl, 0.1% reduced Triton X-100. Each capillary contained 40 nM of fluorescein 
labelled LmPBPA11-20 and were titrated in 12 steps against a 2-fold decrease of BsGpsB1-
68
Lys32Glu from 1500 µM to 0.366 µM. Three measurements were taken for each data point and 
the data were analysed using the MO.Affinity Analysis v2.2.4 software.  
 Size exclusion chromatography with multi-angle light scattering 
Experiments were performed and processed by Dr Owen Davies at Newcastle University 
Biosciences Institute. Protein samples at 10 mg/mL were loaded onto a Superdex 200 increase 
10/300 GL size exclusion chromatography column (GE Healthcare) in 20 mM Tris pH 8.0, 250 
mM KCl, 2 mM DTT, at 0.5 mL/min. The column outlet was fed into a DAWN HELEOS II MALS 
detector (Wyatt Technology), followed by an Optilab T-rEX differential refractometer (Wyatt 
Technology). Light scattering and differential refractive index data were collected and 
analysed using ASTRA 6 software (Wyatt Technology). Molecular weights and estimated errors 
were calculated across eluted peaks by extrapolation from Zimm plots using a dn/dc value of 
0.1850 mL/g.  
 Small-angle X-ray scattering 
Data were collected and processed by Dr Owen Davies. 
 Mass spectrometry  
Mass spectrometry experiments were carried out by Dr Claire Jennings. All liquid 
chromatography-mass spectrometry (LC-MS) analyses were performed using an Agilent 6530 
Q-TOF instrument with electrospray ionisation (ESI) in positive ion mode, coupled to an 
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Agilent 1260 Infinity II LC system, utilising a mobile phase of 0.1% (v/v) formic acid in LC-MS 
grade water (A) and acetonitrile (B). Prior to peptide mapping, 10 μL of purified proteins (~1 
mg/mL) were digested using Smart Digest Soluble Trypsin Kit (Thermo Fisher Scientific) 
according to the manufacturer’s guidelines. Tryptic peptides and intact protein samples were 
extracted using HyperSep Spin Tip SPE C18 and C8 tips, respectively (ThermoFisher Scientific) 
before analysis. For phosphor-site analysis, 10 μL of digest was injected onto an Acclaim RSLC 
120 C18 column (Thermo Fisher Scientific, 2.1 x 100mm, 2.2 µm, 120 Å) for reverse phase 
separation at 60 °C and 0.4 mL/min, over a linear gradient of 5-40% B over 25 min, 40-90% B 
over 8 min followed by equilibration at 5% B for 7 min. ESI source conditions were nebuliser 
pressure of 35 psig, drying gas flow of 13 L/min and gas temperature of 290 °C. Sheath gas 
temperature of 275 °C and gas flow of 12 L/min, capillary voltage of 4000V and nozzle voltage 
of 300V were also applied. Mass spectra were acquired using MassHunter Acquisition 
software (version B.08.00) over the 100-3000 m/z range, at a rate of 5 spectra/s and 200 
ms/spectrum, using standard mass range mode (3200 m/z) with extended dynamic range (2 
GHz) and collection of both centroid and profile data. MS/MS fragmentation spectra were 
acquired over the 100-3000 m/z range, at a rate of 3 spectra/s and 333.3 ms/spectrum. For 
intact protein analysis,10 μL of desalted protein (~1 mg/mL) was injected onto a Zorbax 300Å 
Stable Bond C8 column (Agilent Technologies, 4.6 x 50 mm, 3.5 μM) for reversed phase 
separation at 60 °C and 0.4 mL/min, over a linear gradient of 15-75% B over 14 min, 75-100% 
B over 11 min followed by post-run equilibration at 15% B for 10 min. ESI source conditions 
were nebuliser pressure of 45 psig, drying gas flow of 5 L/min and source gas temperature of 
325 °C were applied. Sheath gas temperature of 400 °C and gas flow of 11 L/min, capillary 
voltage of 3500V and nozzle voltage of 2000V were also used. Mass spectra were acquired 
using MassHunter Acquisition software (version B.08.00) over a mass range of 100-3000 m/z, 
at a rate of 1 spectra/s and 1000 ms/spectrum in extended mass range (20000 m/z) at 1 GHz. 
Acquired MS and MS/MS spectra were analysed using Agilent MassHunter BioConfirm 
software (version B.10.00) for identification of phosphorylated residues and subsequent 




2.4 X-ray crystallography and structure determination  
 Crystallisation trials 
20 mg/mL of SpGpsB4-63 and 23 mg/mL of ReoM in 10 mM Na-HEPES pH 8, 100 mM NaCl were 
subjected to crystallisation by sparse matrix screening using commercial screens PACT, JCSG+, 
Morpheus, Index and Structure (Molecular Dimensions). For co-crystallisation of BsGpsB5-
64
Lys32Glu:LmPBPA11-15, SpGpsB4-63:SpPBP2a27-40 and SpGpsB4-63:SpPBP2x13-28 20 mg/mL of the 
N-terminal domain of GpsB was mixed with PBP peptide at 25 mg/mL, corresponding to a 1:5 
molar ratio of protein:peptide, in 10 mM Na-HEPES pH 8, 100 mM NaCl and crystallised in 
sparse matrix screens. 100 nL drops of apo GpsB or GpsB:PBP complex and 200 nL of screen 
solution were dispensed into 96 well MRC 2-well crystallisation plates (Molecular Dimensions) 
by a Mosquito (TTP Labtech) liquid handling robot and left to incubate for 1-2 weeks at 20 °C. 
 Screening of crystals for diffraction  
Crystals of SpGpsB4-63 were transferred to a cryoprotectant consisting of the well solution 
supplemented with 20% v/v PEG 400. After 5 seconds the crystals were mounted onto rayon 
loops and cyro-cooled by plunging in liquid nitrogen. Crystals of SpGpsB4-63:SpPBP2a27-40 and 
SpGpsB4-63:SpPBP2x13-28 were transferred to a drop of the well solution containing 2.5 mg/mL 
of the respective peptide and after 30 seconds the crystals were mounted in rayon loops and 
frozen in liquid nitrogen. Crystals of BsGpsB5-64Lys32Glu:LmPBPA11-15 were transferred to a 
cryoprotectant comprising the well solution supplemented with 20% v/v PEG 300 and 2.5 
mg/mL of the LmPBPA11-15 peptide; after 30 seconds the crystals were mounted in rayon loops 
and frozen in liquid nitrogen.  ReoM crystals were mounted onto rayon loops (Hampton 
Research) directly from the crystallization drops and cryo-cooled by plunging in liquid 
nitrogen. 
Crystals were mounted onto an in-house Bruker gallium Metaljet and two images per crystal 
were collected at relative phi angles of 0° and 90°. Crystals were then ranked on diffraction 
pattern and resolution and full data sets were either collected in house or at the Diamond 
Light Source (Didcot, UK). 
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 Data collection 
SpGpsB4-63 crystals from JCSG + condition D6 (0.2 M magnesium chloride, 0.1 M Tris pH 8.5 
and 20 % w/v PEG 8000) gave the best dataset. Diffraction data were collected in house using 
a Bruker gallium Metaljet, (wavelength 1.35 Å). The best diffracting crystals of BsGpsB5-
64
Lys32Glu:LmPBPA11-15 were obtained from JCSG+ condition E6 (0.2 M zinc acetate, 0.1 M 
imidazole pH 8, 20% PEG3K) (Page et al., 2003). Diffraction data were collected at the Diamond 
light source (DLS) synchrotron at the I04 beamline. Crystals of SpGpsB4-63:SpPBP2a27-40 from 
JCSG+ condition D7 (0.2 M lithium sulphate, 0.1 M Tris pH 8.5, 40 % w/v PEG 400) were 
obtained. Diffraction data were collected at the DLS synchrotron at the I03 beamline. Crystals 
of SpGpsB4-63:SpPBP2x13-28 were obtained from JCSG+ D7 and  data were collected at I24 at 
the DLS. The ReoM crystals that were subsequently used for diffraction experiments were 
obtained in 0.1 M phosphate/citrate pH 4.2, 0.2 M lithium sulfate, 20 % w/v PEG 1000 from 
the JCSG+ screen. Diffraction data were collected on beamline I03 at the Diamond Light Source 
(DLS) synchrotron. 
 Data processing, model building and refinement  
For SpGpsB4-63 diffraction images were indexed, integrated, scaled and merged with 
PROTEUM3 (Bruker). PHASER (McCoy et al., 2007) was used to generate the initial model using 
chain A of PDB entry 4UG1 to solve the structure by molecular replacement. BUCCANEER 
(Cowtan, 2012) was used to build the SpGpsB sequence into the model which was built in 
COOT (Emsley et al., 2010) and refined in REFMAC (Murshudov et al., 1997) and 
PHENIX.REFINE (Afonine et al., 2010). 
Diffraction images of BsGpsB5-64Lys32Glu:LmPBPA11-15 crystals were integrated in XDS (Kabsch, 
2010) and scaled and merged with AIMLESS (Evans & Murshudov, 2013). The initial model was 
generated by molecular replacement in PHASER (McCoy et al., 2007) using residues 5-64 of 
BsGpsB from the BsPBP11-17:BsGpsB5-64 structure as the search model. The model was built in 
COOT (Emsley et al., 2010) and refined with PHENIX.REFINE (Afonine et al., 2010). 
For SpGpsB4-63:SpPBP2a27-40 images were indexed and integrated with XDS, scaled in XSCALE 
(Diederichs et al., 2003) and merged with AIMLESS (Evans & Murshudov, 2013). The initial 
model was produced in PHASER (McCoy et al., 2007) by molecular replacement using the apo 
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SpGpsB4-63 structure as a model. The final model was built in COOT (Emsley et al., 2010) and 
refined with REFMAC (Murshudov et al., 1997) and PHENIX.REFINE (Afonine et al., 2010). 
With SpGpsB4-63:SpPBP2x13-28,  diffraction images were indexed and integrated in MOSFLM 
(Battye et al., 2011) and scaled and merged in AIMLESS (Evans & Murshudov, 2013). PHASER 
was used to solve the phases by molecular replacement with the apo SpGpsB4-63 structure. 
The final model was built in COOT (Emsley et al., 2010) and refined with REFMAC (Murshudov 
et al., 1997). 
Images of ReoM were integrated in MOSFLM (Battye et al., 2011) and scaled and merged with 
AIMLESS (Evans & Murshudov, 2013). The initial model was generated by molecular 
replacement in PHASER (McCoy et al., 2007) using the dimeric, 20-conformer ensemble model 
(PDB ID 5US5) of IreB solved by nuclear magnetic resonance (Hall et al., 2017) as a search 
model. The final model was produced by iterative cycles of model building COOT (Emsley et 
al., 2010) with refinement in REFMAC (Murshudov et al., 1997) until convergence. 
 Model validation  
MolProbity (Chen et al., 2010) was used to validate all the structures. The statistics for data 
collection and refinement are listed in Table 3.1, Table 3.2 , Table 5.1, Table 5.2 and Table 6.1. 
2.5 Protein phosphorylation and dephosphorylation 
 Phosphorylation assays 
Upscaled phosphorylation reactions consisted of 37 µM ReoM, 3.7 µM PrkA-KD, 5 mM ATP 
and 5 mM MgCl2, diluted in 10 mM HEPES.HCl pH 8.0 and 100 mM NaCl, to a total volume of 
5 mL. Reactions were carried out at 37 °C for 20 minutes.  
 Isolation of phosphorylated ReoM 
The protein mix was loaded onto a PD-10 desalting column to remove excess ATP and protein 
fractions were loaded onto a MonoQ 5/50 GL anion exchange column (GE Healthcare). Buffer 
A consisted of 10 mM HEPES.HCl pH 8.0 and 100 mM NaCl and buffer B was 10 mM HEPES.HCl 




 Isolation of dephosphorylated PrkA  
Upscaled dephosphorylation reaction consisted of 12 µM PrkA, 60 µM PrpC and 2 mM MnCl2 
in 10 mM HEPES.HCl pH 8 and 100 nM NaCl. The reaction was incubated at 37 °C for 1 hour 
and the solution was passed over a 5 mL Ni-NTA column equilibrated with 50 mM HEPES.HCl 
pH8, 300 mM NaCl and 10 mM imidazole. Dephosphorylated PrkA was collected in the flow 
through and column-bound His6-tagged PrpC was eluted with 50 mM HEPES.HCl pH8, 300 mM 
NaCl and 250 mM imidazole. The proteins were dialysed back into 10 mM HEPES.HCl pH 8 and 
100 nM NaCl. 
2.6 Fragment Screening-XChem 
 Production of reproducible crystals 
Crystallisation conditions for N-SpGpsB had already been established prior to the allocation of 
XChem beamline as stated in 2.4. To ensure a ready supply of crystals, a microseed stock was 
prepared by crushing ~20 crystals, each no bigger than 200 µm, in 50 µL of 0.1 M Tris.HCl pH 
8.5, 0.2 M MgCl2, 24 % PEG 8000. 600 nL sitting drop crystallisation experiments of N-SpGpsB 
were set up in SwissCi 3-drop plates (Molecular Dimensions), using a Mosquito (TTP Lab Tec) 
pipetting workstation, by mixing 300 nL of N-SpGpsB at 20 mg/mL (in a buffer of 10 mM 
HEPES.HCl pH 8 and 100 mM NaCl), with 100 nL seed stock and 200 nL of reservoir solution, 
(0.1 M Tris.HCl pH 8.5, 0.2 M MgCl2, 16 % PEG 8000). 
 Experimental procedure 
Images of the crystal drops were recorded and TeXRank (Tsing Ng et al., 2014) was used to 
select the drops containing crystals to be soaked. 40 of these crystals were used for DMSO- 
and cryo-testing. DMSO was tested from 0 to 30 % and soaking was done for 1-3 hours with 
and without a cryoprotectant of 20 % PEG 200 added before harvesting. It was determined 
from the diffraction patterns that the N-SpGpsB crystals could withstand 20 % DMSO for 3 
hours and that no cryoprotectant was required. Subsequently, 547 crystals were soaked with 
fragments from the DSi-Poised Library (Enamine) using the XChem ECHO acoustic liquid 
handler (Labcyte). A crystallisation plate containing 100-150 chosen drops was soaked for an 
hour and then the crystals were harvested manually with the aid of a Shifter, a microscope x-
y stage that also handles unsealing and resealing as well as automatically tracking samples 
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(Oxford Lab Technologies). It took approximately 1-1.5 hours to harvest the crystals from a 
single tray. The same process was repeated 4 times to harvest all of the chosen crystals.  
 Data collection 
Diffraction data were collected on i04-1 (DLS) in an automated, unattended mode using loop 
centring as the crystals were larger than the loops (> 200 µm). All crystals diffracted to 
between 1.2 and 1.8 Å. 
 Data processing and structure solution  
From the 547 crystals that were soaked, a total of 536 useful diffraction datasets were 
collected and used for subsequent structural analysis. For the remaining 11 samples, data 
collection failed due to empty or broken loops. Data were processed using the auto-processing 
pipeline (https://www.diamond.ac.uk/industry/Industry-News/Latest-News/Synchrotron-
Industry-News---MXnews4/Auto-processing-Pipeline.html) at the Diamond Lightsource 
Synchrotron. Each data set was solved using Dimple (http://ccp4.github.io/dimple/) with the 
structure of N-SpGpsB as a molecular replacement model. 
 Model building 
PANDDA.analyse (Pearce et al., 2017a) was used to find residual difference density and 
PANDDA.inspect (Pearce et al., 2017b) was used to view these sites and model the ligands. 
REFMAC (Murshudov et al., 1997) was used to refine the final structures. 
 Competition assay (FP) 
The compounds of 12 individual ‘hits’ were synthesised by Enamine and the ability of the 
ligands to bind to N-SpGpsB was tested using ITC. The same equipment and experimental 
parameters were used as explained in 2.3.5 but with 30 µM of N-SpGpsB in the cell and a 
syringe with 20 mM of each compound. 
The ability of the compounds to compete with the binding of SpPBP2a was tested using FP. 
The same equipment was used as explained in 2.3.6. In each well there was 40 nM of TAMRA-
conjugated SpPBP2a23-45 and 100 µM of N-SpGpsB with increasing concentrations of the 
individual compound from 15-2000 µM with triplicates of each data point being recorded. A 
target polarisation of 35 mP in wells with free labelled peptide was used to adjust the focus 
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and gain and the polarisation of each well was recorded. The FP was plotted against 
compound concentration. The ability of unlabelled SpPBP2a27-40 to complete with the bound 
labelled peptide was also tested with the same parameters.
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Chapter 3: The Cell-Cycle Regulator GpsB Functions as a Cytosolic Adaptor for 
Multiple Cell Wall Enzymes 
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3.1 Introduction  
It has become evident that GpsB is a major regulator of peptidoglycan synthesis, ensuring the 
correct subcellular localisation of penicillin binding proteins (PBPs) by binding to their 
cytoplasmic mini-domains (Cleverley et al., 2016). GpsB and the major bi-functional PBPs in B. 
subtilis and L. monocytogenes, PBP1 and PBPA1, respectively, have been shown to interact by 
bacterial two-hybrid screens (Claessen et al., 2008). More specifically, SPR and fluorescence 
polarisation have demonstrated that the N-terminal domain of B. subtilis GpsB interacts with 
the N-terminal cytoplasmic mini-domain of PBP1 (Cleverley et al., 2016, 2019). Co-IP 
experiments have illustrated that S. pneumoniae GpsB interacts with bPBP2b and aPBP2a and 
not with bPBP2x or aPBP1a (Rued et al., 2017) (b= class B PBP, a= class A PBP). 
Crystal structures of the N- and C-terminal domains of GpsB have been determined to gain an 
understanding of how GpsB interacts with PBPs at the molecular level (Rismondo et al., 2016). 
How these subunits are arranged into a hexamer has been shown by the use of small-angle X-
ray scattering (SAXS) (Cleverley et al., 2016). The structure of BsGpsB5-64 bound to BsPBP11-17 
confirmed the role of a negatively charged groove between helix 1 and 2 for binding, 
specifically the highly conserved aspartate pair Asp31 and Asp35 (Cleverley et al., 2019). The 
structure also revealed that BsPBP1 binding was centred on two of its arginine residues, Arg8 
and Arg11, which are part of a conserved SRxxR(R/K) motif across Bacilaceae PBP1 (Cleverley 
et al., 2019). 
This chapter will focus on determining the molecular interactions of GpsB with PBPs from two 
human pathogens, L. monocytogenes and S. pneumoniae. Since GpsB is important for 
virulence in L. monocytogenes (Rismondo et al., 2016) and essential in S. pneumoniae (Land 
et al., 2013), determining how GpsB interacts with PBPs is important as GpsB could be a 
potential target for new antibiotics in the treatment of disease. 
3.2 Binding of the L. monocytogenes PBPA1 cytoplasmic domain to the N-terminal domain 
of LmGpsB 
 Generation of a cytoplasmic domain peptide of LmPBPA1 
In order to establish whether GpsB from L. monocytogenes interacts with the class A PG 
synthase PBPA1, like its homologue in B. subtilis, a cytoplasmic domain peptide of PBPA1 was 
generated. The first 29 amino acids of PBPA1 form the cytoplasmic mini-domain, and in this 
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region, there are numerous positively-charged residues. The first 20 residues were chosen in 
the creation of the peptide as this encompassed the conserved sequence TRxxYR that is the 
closest equivalent to the SRxxR(R/K) motif of Bacillaceae PBP1 (Figure 3.1). A sequence 
alignment of the first 17 residues of LmPBPA1 and BsPBP1 is shown in Figure 3.2.  
 
Figure 3.1: Analysis of the N-terminal domain of L. monocytogenes PBPA1.  
Protein topology prediction (TOPCONS) (Tsirigos et al., 2015) and secondary structure 
prediction (Jpred4) (Drozdetskiy et al., 2015) analysis of the first 60 residues of LmPBPA1. The 
key explains the figure’s main features. The sequence of the cytoplasmic mini-domain selected 
for peptide generation is shown by the blue brace. 
 
Figure 3.2: A sequence alignment of the first 17 residues of LmPBPA1 and BsPBP1.  
Fully conserved residues are indicated by an asterisk, sites with strong similarity are indicated 
by a colon and sites with weak similarity are indicated by a period. 
The sequence encoding these first 20 residues was cloned into a pMAT11 vector for TEV-
cleavable conjugation to MBP to enhance the expression of the peptide in E. coli. To create a 
fluorescent peptide, serine 19 was mutated to a cysteine to enable labelling with fluorescein 




Figure 3.3: Generation of a fluorescently-labelled cytoplasmic domain peptide of LmPBPA1. 
Steps taken in the generation of a fluorescein maleimide-conjugated LmPBPA11-20 peptide. 
Step 1 shows the purified expression product from the pMAT11 vector. The first 20 residues 
of LmPBPA1, highlighted in grey, are linked to maltose binding protein (MBP) by a linker 
sequence containing a TEV cleavage site. The mutated serine 19 to cysteine residue in 
LmPBPA1 is highlighted in yellow with the thiol group annotated. Step 2 is the result of the 
incubation of the expression product with fluorescein maleimide which is linked to the protein 
by a reaction with the thiol group of the cysteine residue. Step 3 is TEV cleavage, in which the 
result is a fluorescently-labelled LmPBPA1 cytoplasmic domain peptide. The two residues not 
highlighted in grey are two remaining residues from the linker sequence after TEV cleavage. 
 Quantifying the interaction by fluorescence polarisation 
A Kd of 200 ± 20 µM was determined for the affinity of LmGpsB1-73 for LmPBPA11-20 by 
fluorescence polarisation (FP) (Figure 3.4). This binding affinity is comparable to that 





Figure 3.4: Interaction of the cytoplasmic domain peptide of LmPBPA1 with the N-terminal 
domain of GpsB. 
Interaction of fluorescein-labelled LmPBPA11-20 peptides with wild-type N-terminal domains 
of GpsB from L. monocytogenes (LmGpsB1-73), B. subtilis (BsGpsB1-68), a variant of B. subtilis 
GpsB mutated to mimic L. monocytogenes GpsB (BsGpsB1-68Lys32Glu) and BsGpsB1-68Asp35Ala, as 
monitored by fluorescence polarisation. Binding data and the fit of the data to a 1:1 binding 
model in Sigma plot for each of the data sets are plotted in the graph. The average of three 
measurements and the standard error for each data point is shown. The key shows which data 
set is represented by colouring and the respective Kd that was determined in Sigma plot. 
Co-crystallisation attempts of LmGpsB constructs in complex with LmPBPA11-15 failed; there 
was very little precipitation observed in a number of crystal screens and no crystals were 
obtained. The N-terminal domain of B. subtilis GpsB appeared to be more ‘crystallisable’ than 
LmGpsB. In the structure of BsGpsB5-64 bound to BsPBP11-17, the only residue that differs 
between LmGpsB and BsGpsB within 8 Å of the binding interface is BsGpsB Lys32, which is a 
glutamate in LmGpsB; otherwise all of the residues that contact the peptide are conserved, as 
well as residues that indirectly help shape the binding site. Fluorescence polarisation data 
showed that LmPBPA11-20 bound to BsGpsB1-68Lys32Glu with a Kd of 190 ± 35 μM and to BsGpsB1-
68 with a Kd of 430 ± 50 μM (Figure 3.4). This demonstrates that LmPBPA11-20 binding is 2-fold 
stronger when the binding site of BsGpsB is ‘LmGpsB like’. In a control experiment carried out 
to test the binding of LmPBPA11-20 to BsGpsB1-68Asp35Ala, the Kd was shown to be greater than 
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4 mM. Asp35 is an important residue for BsGpsB to bind to BsPBP1 and mutating it to alanine 
abolished binding (Rismondo et al., 2016; Cleverley et al., 2019). Therefore LmPBPA11-20 binds 
to BsGpsB1-68Lys32Glu as though the proteins are derived from the same biological source, and 
that binding is strong enough to attempt co-crystallisation. 
3.3 Co-crystallisation of the N-terminal domain of BsGpsB with LmPBPA1 cytoplasmic 
peptide 
 Crystallisation trials of BsGpsBLys32Glu:LmPBPA11-15 
Crystals of BsGpsB5-64Lys32Glu:LmPBPA11-15 grew in two conditions from the JCSG+ sparse matrix 
screen, E6 (0.2 M Zinc acetate dihydrate, 0.1 M imidazole pH 8, and 20 % w/v PEG 3000) and 
C7 (0.2 M Zinc acetate dihydrate, 0.1 M sodium acetate pH 4.5 and 10 % w/v PEG 3000) (Figure 
3.5). The crystals were rod shaped and often grew in clusters with just the odd single crystal. 
Crystals from each condition were harvested in rayon loops and transferred to a drop of well 
solution supplemented with 20 % v/v PEG 400 as a cryoprotectant. The crystals were then 
transferred back into the rayon loops and cryo-cooled in liquid nitrogen. Diffraction data were 
collected at Diamond Light Source on beamline I04. 
 
Figure 3.5: Crystals of BsGpsB5-64Lys32Glu:LmPBPA11-15. 
 Panel A is a drop from JCSG+ E6 and panel B is a drop from JCSG+ C7. The scale bars above 
each image provide a visual indication of the size of each crystal. 
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 Data processing, molecular replacement and model building  
Diffraction data collected from crystals obtained from JCSG+ E6 were processed as described 
in 2.4.4. The structure of BsGpsB5-64Lys32Glu:LmPBPA11-15 was solved using data to 1.6 Å by 
molecular replacement (PHASER) (McCoy et al., 2007) with GpsB residues 5-64 of the BsGpsB5-
64:BsPBP11-17 structure as the search model. The final atomic model was built in COOT (Emsley 
et al., 2010) and refined in REFMAC (Murshudov et al., 1997). The full list of data collection 
and refinement statistics can be found in Table 3.1. 
 Analysis of the BsGpsBLys32Glu:LmPBPA11-15 structure 
The crystal structure showed that the N-terminal domain of BsGpsB was almost identical to 
previously-determined structures; the main difference is restricted to the presence of 
glutamate at position 32 instead of lysine (Figure 3.6 A). Only one of the monomers in the 
dimer is bound to peptide, as observed in the structure of BsGpsB5-64:BsPBP11-17, because the 
second peptide binding site is blocked by residues from a neighbouring GpsB molecule in the 
crystal lattice. LmPBPA11-15 appeared to bind in the same binding site as BsPBP11-17. However, 
most of the LmPBPA11-15 peptide is disordered: arginine 8 is the only residue of the peptide 
that is sufficiently ordered to be built and refined satisfactorily in the electron density (Figure 
3.6 B and C). Consequently, most of the specific contacts of the peptide to GpsB could not be 
determined, and the only interactions that could be described were from Arg8. The side chain 
of Arg8 penetrates into the groove of BsGpsB as has been seen by Cleverley et al. with the 
corresponding Arg8 in BsPBP11-17 forming the same set of interactions (Cleverley et al., 2019) 
(Figure 3.6 D). Since Arg8 is the only visible residue in the complex, the secondary structure of 
the peptide cannot be built either, but it is notable that the backbone torsion angles of Arg8 




Figure 3.6: Structure of the N-terminal domain of BsGpsBLys32Glu bound to LmPBPA11-15. 
The two subunits of the GpsB N-terminal dimer are coloured cyan in cartoon form and the 
peptide is coloured green. Arg8 is completely visible and Thr7 and Ser9 are only partially visible 
in the structure of the peptide which is bound in a groove between helix 1 (α1) and helix 2 
(α2) of one subunit (chain B). (A) The structure in cartoon form highlighting the N and C-
terminus and α1 and α2 of each subunit of the GpsB dimer. (B) Zoomed-in view of the binding 
site with the peptide in stick form. The side chain of Arg8 penetrates into the groove between 
the two helices. The position of Arg8 of BsPBP1 from the superimposition of BsGpsBLys32Glu5-
64:LmPBPA11-15 with BsGpsB5-64:BsPBP11-17 is shown in grey sticks. (C) Zoomed-in view of the 
binding site looking down at helix 1 and 2 from chain B. LmPBPA1 shown in stick form and the 
electron density map is represented by a grey mesh. The map shown is the final Refmac-
weighted 2mFobs-DFcalc map contoured at 0.14 electrons per Å3 with a PyMol “carve” value of 
1.6. (D) Residues important in binding are shown in stick form coloured by atom. Salt bridges 
and hydrogen bonds are represented by dashed black lines and van der Waals’ contacts by 
dashed yellow lines. 
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3.4 Important features of LmPBPA1 cytoplasmic domain peptide for BsGpsB N-terminal 
binding 
The small part of the LmPBPA11-15 peptide that was visible in the crystal structure meant that 
essential residues, contacts from these residues and the importance of secondary structure 
for binding to GpsB could not be determined. To gain an understanding of the features of the 
LmPBPA1 cytoplasmic peptide that are vital for binding, a number of mutants of LmPBPA11-20 
were produced and the binding to BsGpsB1-68Lys32Glu was analysed by fluorescence polarisation 
(Figure 3.7).  
 
Figure 3.7: Interaction of LmPBPA11-20 mutants with BsGpsBLys32Glu. 
The binding of wild type LmPBPA11-20 and mutant peptides to BsGpsB1-68Lys32Glu, as monitored 
by fluorescence polarisation. Raw data and the fit of the data to a 1:1 binding model in Sigma 
plot for each of the data sets are plotted. The average of three measurements and the 
standard error bars for each data point is shown. The key shows which data set is represented 
by colouring and the respective Kd that was determined in Sigma plot. 
First, a mutant was produced in which Arg8 was mutated to alanine to verify the importance 
of this arginine for binding (LmPBPA11-20Arg8Ala). At 3 mM, the Kd was 15-fold higher than that 
of the wild-type (WT), with a Kd of 190 ± 35 μM, therefore Arg8 was crucial for binding. To 
check that this was a specific interaction and that BsGpsB does not simply have a tendency to 
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bind to arginine per se, another arginine residue was introduced into the LmPBPA11-20Arg8Ala 
peptide at position 16 (Ser16Arg). This position is outside the proposed binding motif and is 
in a region of lower alpha helix-forming propensity, as determined by secondary structure 
predictions (Figure 3.1). The binding of LmPBPA11-20Arg8AlaSer16Arg to BsGpsB was determined to 
have a Kd of 2 mM, which indicates that the interaction between Arg8 of LmPBPA1 with 
BsGpsB was indeed specific, and that the critical arginine of PBPA1 needs to be in an alpha 
helical conformation to interact with GpsB. A third mutant was made that had a proline 
residue introduced to the alpha helical region of the binding motif (LmPBPA11-20Gln10Pro). 
Proline has the lowest alpha helical propensity of all amino acids and it is the least likely amino 
acid to be present in an alpha helix (Pace & Scholtz, 1998). LmPBPA11-20Gln10Pro had a Kd of 1.5 
mM, which compared to WT peptide is a 10-fold weaker binding. This result suggested that 
the introduction of proline disrupted the formation of the alpha helix and although Arg8 was 
present in the peptide, there was a significant reduction in affinity for BsGpsB as it was not in 
the correct alpha helical form. 
The structure of the BsGpsB5-64:BsPBP11-17 complex showed that two arginine residues in the 
PBP (Arg8 and Arg11) were involved in key salt bridges and hydrogen bonds to GpsB (Figure 
1.15 F). In LmPBPA1 the equivalent residue at position 11 is a tyrosine with an arginine at 
position 12. Tyr11Ala and Arg12Ala mutants (LmPBPA11-20Tyr11Ala and LmPBPA11-20Arg12Ala) 
reduced the binding affinity by 2- and 4-fold, respectively, indicating that Arg12 contributed 
to the binding capability of LmPBPA1 but the interaction is highly dependent on Arg8 (Figure 
3.7). 
A second technique, microscale thermophoresis (MST) was used to confirm the interaction 
between BsGpsB1-68Lys32Glu and LmPBPA11-20 and to compare the binding affinities of two 
techniques. A Kd of 70 ± 2.5 µM was determined by MST, which is in the same range as the 
affinity determined by FP (200 ± 20 µM). The experiment was repeated with the LmPBPA11-
20
Arg8Ala mutant, with which no observable Kd was detected (Figure 3.8).  However, it was 
concluded that MST was not the best method for determining the µM interaction between 
GpsB and PBP peptides as the high concentration of protein required to saturate the 
interaction caused the solution in the capillary to become viscous hampering free diffusion of 




Figure 3.8: Confirmation of the affinity of LmPBPA1 for BsGpsBLys32Glu. 
The affinity of LmPBPA11-20 for BsGpsB1-68Lys32Glu compared to the non-binding mutant 
LmPBPA11-20Arg8Ala, as monitored by MST. The average of three measurements and the 
standard error bars for each data point is shown. The key shows which data set is represented 
by colouring and the respective Kd that was determined by the MO.Affinity Analysis v2.2.4 
software. 
Bacterial-two-hybrid experiments carried out by the Halbedel lab supported the assignment 
of the crucial GpsB binding residues in PBPA1 (Cleverley et al., 2019). LmPBPA11-20Arg8Ala and 
LmPBPA11-20Arg12Ala mutants had a significant negative impact on the LmGpsB:LmPBPA1 
interaction. The mutation of Tyr11 to alanine had a milder impact on the binding capacity 
consistent with FP data. As expected, alanine substitutions of positively charged residues 
downstream of residue 14 had no impact on binding. 
The effects of these identified GpsB binding residues (Section 3.4) in PBPA1 were tested in 
Listeria using fosfomycin as a reporter, because ΔgpsB mutants are more susceptible to this 
antibiotic at 37 °C (Rismondo et al., 2017). Mutants carrying the pbpA1Arg8AlaArg12Ala and 
pbpA1Gln10Pro alleles had an increased sensitivity to fosfomycin but only when the paralogue 
of LmPBPA1, LmPBPA2 was also absent (Halbedel lab, personal communication). This 
highlights the importance of these residues for the function of PBPA1 in vivo but these 
residues are not essential for the bacteria as LmPBPA2 can carry out the same role when 
LmPBPA1 is mutated. 
 
 76 
3.5 Crystallisation of the N-terminal domain of GpsB from S. pneumoniae 
 Crystallisation trials of SpGpsB 
The recombinantly-expressed and purified N-terminal domain of GpsB from S. pneumoniae 
SpGpsB1-63 at 20 mg/mL was subjected to crystallisation in a number of sparse matrix 
crystallisation screens. The low frequency of high-quality crystals prompted the design of a 
new construct, SpGpsB4-63, in which the flexible N-terminal residues were deleted in order to 
produce a more crystallisable protein. Crystals of SpGpsB4-63 grew in 5 different conditions 
from 3 different crystallisation screens (Figure 3.9). Crystals from JCSG+ D6 (0.2 M magnesium 
chloride hexahydrate, 0.1 M Tris pH 8.5 and 20 % w/v PEG 8000) were parallelepipedal in 
shape in comparison to crystals from C11 (0.1 M sodium acetate pH 4.6 and 2 M ammonium 
sulphate) that grew as plates. Two conditions E7 (0.12 M ethylene glycols, 0.1 M buffer system 
2 pH 7.5 and 30 %GOL_P4K) and F9 (0.12 M monosaccharides, 0.1 M buffer system 3 pH 8.5 
and 30% P550MME_P20K) from the Morpheus screen yielded crystals. Crystals from E7 where 
long needles and crystals in F9 grew as thin plates. A single large crystal 200 µM x 100 µM x 
100 µM in size formed in the PACT screen condition D11 (0.2 M calcium chloride, 0.1 M Tris 
pH 8 and 20 % w/v PEG 6000).  
 Data processing, molecular replacement and model building  
For the crystal harvested from JCSG+ D6, diffraction data were collected and processed in 
house as described in 2.4.4. The diffraction data for the other 4 conditions were collected at 
Diamond Light Source on beamline I24. Images were indexed and integrated in DIALS 
(Beilsten-Edmands et al., 2020) and scaled and merged with AIMLESS (Evans & Murshudov, 
2013). In each case the initial model was produced in PHASER (McCoy et al., 2007) by 
molecular replacement using chain A of the N-terminal domain of LmGpsB (PDB ID:4UG1) as 
a model. BUCCANEER (Cowtan, 2012) was used to build the SpGpsB sequence into each model 
that was rebuilt in COOT (Emsley et al., 2010) and refined in REFMAC (Murshudov et al., 1997). 
The models from crystals grown in JCSG+ C11, Morpheus E7 and F9 and PACT D11 underwent 
a few refinement cycles and were analysed as potential candidates for peptide soaking. The 
model from JCSG+ D6 was fully refined for deposition. The data collection and refinement 




Figure 3.9: Crystals of SpGpsB4-63. 
Panel A is a drop from JCSG+ D6, panel B is a drop from Morpheus E7, panel C is a drop from 
Morpheus F9, panel D is a drop from PACT D11 and panel E is a drop from JCSG+ C11 in which 
crystals of SpGpsB4-63 grew. The scale bar above each image provides an indication of the size 
of each crystal.  
 Analysis of the SpGpsB structure  
The structure of SpGpsB4-63 was solved to 1.9 Å and is formed of two identical subunits forming 
a dimer with each monomer composed of 2 alpha-helices as seen for the structures of 
LmGpsB1-73 and BsGpsB1-68 (Figure 3.10 A) (Rismondo et al., 2016). In the structure there are 
4 molecules in the crystallographic asymmetric unit with monomer:monomer rmsds of 0.51 ± 
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0.07 Å which is comparable with the monomer:monomer rmsds of BsGpsB1-68 (Rismondo et 
al., 2016). The structure of SpGpsB4-63 was solved a total of 5 times to try and obtain a 
candidate for PBP peptide soaking. In all cases the binding site was involved in crystal lattice 
contacts to neighbouring GpsB molecules so that the solvent channels were not large enough 
to allow for soaking with a ~20 residue peptide (Figure 3.10 B and C). It was therefore 
concluded that co-crystallisation would be the most realistic route to obtain SpGpsB:SpPBP 
complexes, described in sections 3.7.1 and 3.10.1. 
 
Figure 3.10: Analysis of the SpGpsB4-63 structure. 
The analysis of the structure of SpGpsB4-63 solved from a crystal grown in JCSG+ D6. Panel A 
shows the SpGpsB4-63 dimer in cartoon form. Panel B shows the arrangement of the SpGpsB4-
63 dimer in the crystal lattice, highlighting small solvent channels between each molecule. 
Panel C is a zoomed-in view of panel B in which the structure of BsGpsB5-64:BsPBP11-17 has 
been superimposed onto SpGpsB4-63. BsGpsB5-63 is coloured orange and BsPBP11-17 is coloured 
magenta. Residues from BsPBP11-17 clash with SpGpsB4-63 which indicated that this crystal 
form was probably not suitable for peptide soaking.  
3.6 Interaction of SpPBP2a with the SpGpsB N-terminal domain  
 Generation of a cytoplasmic domain peptide of SpPBP2a 
The essentiality of GpsB in S. pneumoniae presumably reflects its importance as a protein 
interaction scaffold, especially for PBPs (Land et al., 2013). It had been suggested that GpsB is 
required for PBP2a activity in S. pneumoniae and shown that PBP2a and GpsB were pulled-
down by co-IP (Rued et al., 2017). Synthetic lethality studies with ΔgpsB suppressor mutants 
revealed that pbp1a became essential in the absence of gpsB, which indicated that SpPBP2a 
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is the class A PBP regulated by SpGpsB (Rued et al., 2017). The cytoplasmic domain of SpPBP2a 
contains an RRSRSDR (residues 30-36) sequence that contributes to an (S/R)RS(R/G)(K/S)xR 
conserved motif across Streptococcaceae PBP2a proteins (Figure 3.11) (Cleverley et al., 2019), 
and SRSDRK (residues 32-37) is a perfect match to the consensus SRxxR(R/K) motif of 
Bacillaceae PBP1. To probe the interaction of SpPBP2a with SpGpsB, a cytoplasmic domain 
peptide was produced as for LmPBPA11-20, encompassing residues 23-45 (SpPBP2a23-45) in 
which glycine 43 was mutated to a cysteine for TAMRA maleimide labelling (Figure 3.12). 
 
Figure 3.11: Analysis of the N-terminal domain of S. pneumoniae PBP2a. 
Protein topology prediction (TOPCONS) (Tsirigos et al., 2015) and secondary structure 
prediction (Jpred4) (Drozdetskiy et al., 2015) analysis of the first 80 residues of SpPBP2a. The 
key explains the figure’s main features. The sequence of the cytoplasmic mini-domain selected 





Figure 3.12: Generation of a fluorescently-labelled cytoplasmic domain peptide of SpPBP2a. 
The steps taken in the generation of a TAMRA maleimide-conjugated SpPBP2a23-45 peptide. 
Step 1 shows the purified expression product from the pMAT11 vector. Residues 23-45 of 
SpPBP2a, highlighted in grey, are linked to maltose binding protein (MBP) by a linker sequence 
containing a TEV cleavage site. The mutated glycine 43 to cysteine residue in SpPBP2a is 
highlighted in yellow with the thiol group annotated. Step 2 is the result of the incubation of 
the expression product with TAMRA maleimide which is linked to the protein by a reaction 
with the thiol group of the cysteine residue. Step 3 is TEV cleavage, from which the result is a 
fluorescently-labelled SpPBP2a cytoplasmic domain peptide. The two residues not highlighted 
in grey are two residual residues from the linker sequence after TEV cleavage. 
 Analysis by fluorescence polarisation  
SpPBP2a23-45 bound to SpGpsB1-63 with a Kd of 74 ± 14 µM, similar to the affinity of BsGpsB 
and LmGpsB for their respective PBP1 and PBPA1 peptide binding partners. As a control, a 
mutant of SpGpsB1-63Asp33Ala was produced, which is the equivalent of BsGpsB1-68Asp35Ala that 
does not bind to BsPBP1. A Kd of > 3mM was recorded for this interaction, which highlights 
the importance of this conserved aspartate residue for binding of partner proteins to GpsB, 




Figure 3.13: Interaction of the cytoplasmic domain peptide of SpPBP2a with the N-terminal 
domain of GpsB. 
The interaction of TAMRA-labelled SpPBP2a23-45 peptides with the wild-type N-terminal 
domain of GpsB from S. pneumoniae (SpGpsB1-63) and the mutant SpGpsB1-63Asp35Ala, as 
monitored by fluorescence polarisation. Binding data and the fit of the data to a 1:1 binding 
model in Sigma plot for each of the data sets are plotted. The average of three measurements 
and the standard error bars for each data point is shown. The key shows which data set is 
represented by colouring and the respective Kd that was determined in Sigma plot. 
 Determining the thermodynamic parameters of the interaction using isothermal 
titration calorimetry 
The interaction of SpGpsB1-63 with unlabelled SpPBP2a27-40 was analysed by ITC, revealing a Kd 
of 7.33 ± 0.52 µM (Figure 3.14). The 10-fold increase in affinity measured by ITC could be 
explained by the bulky fluorophore, which could inhibit the binding of the PBP peptide to 
GpsB. FP was favoured to ITC for GpsB:PBP interactions studies because the technique 
requires considerably less protein and experiments take seconds to run as opposed to an hour 
for an individual ITC run. The binding enthalpy (ΔH) of the interaction was -2.81 kcal/mol, 
which indicates a favourable interaction that is comprised of hydrogen bonding and salt 
bridges. The entropy factor (-TΔS) was also favourable at -4.09 kcal/mol, which highlights that 
no conformational changes were required for binding. This is consistent with the absence of 
conformational changes in structures of GpsB N-terminal domains, from all species, in the 
presence/absence of bound peptide. The expected stoichiometry of the interaction was 1 as 
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there are two peptide binding sites for every GpsB dimer. However, the N-value determined 
for the interaction was 1.6. The N-value only equals the stoichiometry if the concentrations 
used for fitting are 100 % correct and active, suggesting that one or both of the 
protein/peptide concentrations are not accurate.  
 
Figure 3.14: Determining the thermodynamic parameters of the SpGpsB1-63:SpPBP2a27-40 
interaction. 
Panel A shows the ITC raw heat plot of 25 µM SpGpsB1-63 in the cell with 20 syringe injections 
of SpPBP2a27-40 at 1 mM. Panel B shows the corresponding binding isotherm, also known as a 
Wiseman plot, from which a number of thermodynamic parameters (N, Kd, DH, DG and -TDS) 
can be determined. 
3.7 Co-crystallisation of the SpGpsB N-terminal domain in complex with SpPBP2a 
cytoplasmic domain peptide 
 Crystallisation trials of SpGpsB4-63:SpPBP2a27-40 
Co-crystallisation attempts of the N-terminal domain of SpGpsB with a SpPBP2a peptide was 
carried out by combining SpGpsB4-63 (at a final concentration of 20 mg/mL) with SpPBP2a27-40 
(25 mg/mL final; 1:5 molar ratio of protein:peptide) and subjecting the mix to sparse matrix 
crystallisation screening. Crystals grew in two conditions, JCSG+ D7 (0.2 M lithium sulphate, 
0.1 M Tris pH 8.5 and 40 % v/v PEG 400) and PACT D12 (0.002 M zinc chloride, 0.1 M tris pH 
8, 20 % w/v PEG 6000). Crystals from JCSG+ D6 were cuboidal and those from PACT D12 were 
needle-like (Figure 3.15). Crystals were transferred to a drop of the well solution containing 
2.5 mg/mL of SpPBP2a27-40 peptide, supplemented with 20 % PEG 400 for PACT D12. After 30 




Figure 3.15: Crystals of SpGpsB4-63:SpPBP2a27-40. 
Panel A and B are drops from JCSG+ D7 and panel C is a drop from PACT D12 in which crystals 
grew from SpGpsB4-63:SpPBP2a27-40. The scale bar above each image provides a visual 
indication of the size of each crystal. 
 Data processing, molecular replacement and model building 
Data were collected a Diamond light source I03; crystals from JCSG+ D7 diffracted to 1.8 Å 
whereas crystals from PACT D12 did not diffract. Diffraction data were processed and the 
structure of SpGpsB4-63:SpPBP2a27-40 was solved by molecular replacement following the same 
procedures as described in 2.4.4. Each PBP2a molecule was manually built into the electron 
density using COOT (Emsley et al., 2010) and refined until convergence. 
 Analysis of the SpGpsB4-63:SpPBP2a27-40 structure  
There were two molecules of SpGpsB4-63:SpPBP2a27-40 in the asymmetric unit, which 
comprised a single SpGpsB dimer and peptide was present in the binding site of each SpGpsB 
monomer (Figure 3.16 A). The whole peptide was built into both binding sites with the 
exception of threonine 27 in binding site 1 as there was insufficient electron density to 
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confidently build this residue; the majority of each peptide was in an extended conformation 
(Figure 3.17 A and C). The binding of SpPBP2a in both sites was heavily centred on two arginine 
residues as seen in BsPBP1, but the peptide is bound in different conformations in each 
binding site. In binding site 1, Arg33 and Arg36 penetrate into the space between helix 1 and 
2 of the SpGpsB monomer with the residues being positioned at the start and end of a single 
turn alpha helix. Conversely, arginine residues Arg31 and Arg36 occupy the same sites in the 
second site and they are in a type I beta turn. Arg31/33 bind in the same position as Arg8 in 
BsGpsB5-64:BsPBP11-17 and Arg36 in both sites is the same as Arg11 (Figure 3.16 B).  
 
Figure 3.16: Structure of the N-terminal domain of SpGpsB bound to residues 27-40 of 
SpPBP2a. 
The two subunits of the GpsB N-terminal dimer are coloured cyan and are shown as cartoons, 
and the peptide is coloured in green. (A) highlight of each of the SpPBP2a peptides and α1 and 
α2 of each subunit of the SpGpsB dimer. (B) Zoomed-in view of the binding site. The side 
chains of Arg33 and Arg36 in binding site 1 and Arg31 and Arg36 in binding site 2 penetrate 
into the groove between the two helices and are shown in sticks. The positions of Arg8 and 
Arg11 of BsPBP1 from the superimposition of SpGpsB4-63:SpPBP2a27-40 with BsGpsB5-




Figure 3.17: Structure of the N-terminal domain of SpGpsB bound to residues 27-40 of 
SpPBP2a. 
Zoomed-in view of binding site 1 (A) and binding site 2 (C) looking down at helix 1 and 2. 
SpPBP2a peptides shown as sticks and the electron density map is represented by a grey mesh. 
The map shown is the final Refmac-weighted 2mFobs-DFcalc map contoured at 0.5 electrons per 
Å3 with a PyMol ‘carve’ value of 1.6. (B and D) Residues important in binding are shown as 
sticks and coloured by atom, binding site 1 (B) and binding site 2 (D). Salt bridges and hydrogen 
bonds are represented by dashed black lines and van der Waals’ interactions by dashed yellow 
lines. 
The arginine pairs form a similar set of interactions with SpGpsB as seen in the BsGpsB5-
64:BsPBP11-17 structure. In binding site 1 there are hydrogen bonds between the SpGpsB 
carbonyl oxygens of Phe12 and Glu13 with SpPBP2a Arg36 and the carbonyl oxygens of Ile11 
and Gln14 with SpPBP2a Arg33. SpPBP2a Arg31, 33 and 36 form salt bridges with the 
carboxylic acids of SpGpsB Glu40, Asp29 and Glu15, respectively. There are also van der Waals’ 
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interactions between SpGpsB Leu32 and SpPBP2a Arg33 and the peptide backbone amide of 
Arg33 interacts with SpGpsB Asp33 (Figure 3.17 B). 
In binding site 2, there are hydrogen bonds between SpGpsB carbonyl oxygens of Phe12 and 
Gln14 with SpPBP2a Arg36 and carbonyl oxygens of Ile11 and Gln14 with Arg31. Asp29 from 
SpGpsB in this site forms a salt bridge with Arg31 and Leu32 forms van der Waals’ contacts 
with the same residue. The peptide backbone amides of SpPBP2a Arg31 and Ser32 and the 
backbone carbonyl of Ser32 interact with SpGpsB Asp33 (Figure 3.17 D). 
3.8 Important features of SpPBP2a cytoplasmic domain peptide for SpGpsB N-terminal 
domain binding.  
The crystal structure of SpGpsB:SpPBP2a demonstrates that binding is centred on 3 arginine 
residues compared to 2 arginines with BsPBP1 and LmPBPA1, and the binding capacity was 
highly reliant on a single arginine residue at the start of a binding motif. To confirm the 
importance of Arg31, Arg33 and Arg36, each residue was mutated separately to an alanine to 
establish if any of these mutants compared to the reduction in binding seen by the Arg8Ala 
mutant of both BsPBP1 and LmPBPA1 (Figure 3.18). SpPBP2a23-45Arg31Ala, SpPBP2a23-45Arg33Ala 
and SpPBP2a23-45Arg36Ala had a reduced affinity for SpGpsB1-63 by 3-, 7- and 3.5-fold, 
respectively, which suggested that SpPBP2a was not dependent on a single arginine residue 
for SpGpsB binding, as seen previously with the 15-fold reduction in affinity of Arg8Ala 




Figure 3.18: Interaction of SpPBP2a23-45 mutants with SpGpsB1-63.  
The binding of wild-type SpPBP2a23-45 and Arg to Ala mutant peptides with SpGpsB1-63, as 
monitored by fluorescence polarisation. Data and the fit of the data to a 1:1 binding model in 
Sigma plot for each of the data sets are shown. The average of three measurements and the 
standard error bars for each data point are shown. The key shows which data set is 
represented by colouring and states the respective Kd that was determined in Sigma plot. 
The structure indicated that an alpha helical conformation was not essential for the binding 
of SpPBP2a to SpGpsB, as was seen with BsPBP1 and implicit in the complex with LmPBPA1. 
To confirm this by FP, two potential alpha helix-disrupting mutant were made that were 
chosen according to the disruption of model helical proteins (Doig & Baldwin, 1995; Iqbalsyah, 
2004). SpPBP2a23-45Ser32Ala reduced the binding affinity by 3.5-fold and SpPBP2a23-45Asp35Pro by 
only 2-fold. The equivalent proline introduction in BsPBP1 and LmPBPA1 affected binding 
capacity by ~10-fold, which showed SpPBP2a does not have the same secondary structure 
requirements for binding to GpsB (Figure 3.19). Another explanation for the reduction in 
binding with the introduction of a proline residue is the loss of hydrogen bonding as proline 
does not contain a hydrogen on its backbone amide. Leu29 of SpPBP2a is a conserved 
hydrophobic residue across Streptococci PBP2a proteins and along with Ile28, contacts to a 
hydrophobic pocket in SpGpsB could contribute to binding. In binding site 2 of the SpGpsB4-
63:SpPBP2a27-40 structure, SpPBP2aLeu29 makes van der Waals’ contacts with SpGpsBIle36. 
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However, there was less than a 2-fold reduction in affinity with a SpPBP2aIle28AlaLeu29Ala mutant, 
suggesting these residues were not crucial for binding (Figure 3.19).  
 
Figure 3.19: Interaction of SpPBP2a23-45 mutants with SpGpsB1-63. 
The binding of wild-type SpPBP2a23-45 and mutants with SpGpsB1-63, monitored by 
fluorescence polarisation. Data and the fit of the data to a 1:1 binding model in Sigma plot for 
each of the data sets are shown. The average of three measurements and the standard error 
bars for each data point are shown. The key shows which data set is represented by colouring 
and states the respective Kd that was determined in Sigma plot. 
Arginine to lysine mutations were made to evaluate the impact of reducing the hydrogen 
bonding capacity without changing the overall charge of the peptide (Figure 3.20). The 
affinities of SpPBP2a23-45Arg31Lys and SpPBP2a23-45Arg36Lys were comparable to the equivalent 
alanine substitutions while SpPBP2a23-45Arg33Lys reduced the affinity by 5-fold. The crystal 
structure showed that Arg31 and Arg33 of SpPBP2a can occupy the same position as the 
crucial binding residue, Arg8, in BsPBP1 and LmPBPA1. A double mutant in which both Arg31 
and 33 were mutated to lysine (SpPBP2a23-45Arg31LysArg33Lys) reduced the binding affinity to GpsB 
by 27-fold. SpPBP2a can thus bind to SpGpsB in two different conformations and when one of 
these is prevented, either by crystal contacts or by mutation, the peptide can compensate by 




Figure 3.20: Interaction of SpPBP2a23-45 mutants with SpGpsB1-63. 
The binding of wild-type SpPBP2a23-45 and Arg to Lys mutants with SpGpsB1-63, monitored by 
fluorescence polarisation. Data and the fit of the data to a 1:1 binding model in Sigma plot for 
each of the data sets are shown. The average of three measurements and the standard error 
bars for each data point are shown. The key shows which data set is represented by colouring 
and states the respective Kd that was determined in Sigma plot. 
The binding of SpPBP2a to SpGpsB was confirmed by BACTH by the Massidda group and 
important residues for the interaction were confirmed (Cleverley et al., 2019). The binding 
was lost completely with SpGpsBTyr23Ala, SpGpsBVal28Ala, SpGpsBAsp29Ala, SpGpsBLeu32Ala and 
SpGpsBAsp33Ala variants, and with SpGpsBIle36Ala the interaction was reduced, though it was not 
possible to quantify the reduction in interaction using this method. The Winkler group also 
showed there were severe growth and morphological defects of S. pneumoniae strains 
harbouring the 5 different alleles that caused complete loss of binding in BACTH (Cleverley et 
al., 2019). The same growth defects were not observed with S. pneumoniae Δpbp1a strains 
carrying SpPBP2aArg31Ala, SpPBP2aArg33Ala or SpPBP2aArg31AlaSer32Ala alleles. SpPBP2a mutants with 
longer stretches of amino acids deleted such as residues 32-37 or 27-38 or 26-45 in a Δpbp1a 
strain showed progressively reduced growth rates. In each case pbp1a was deleted to 
separate the mutational effects of SpPBP2a from SpPBP1a activity. This data suggests that 
SpPBP2a binding is just one function of SpGpsB as a more severe phenotype is observed when 
the interacting residues of SpGpsB are mutated compared to SpPBP2a.  
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3.9 Interaction of SpPBP2x with the SpGpsB N-terminal domain  
 Generation of a cytoplasmic domain peptide of SpPBP2x  
S. pneumoniae PBP2x contains a conserved NR pair (residues 21 and 22) in its cytoplasmic 
domain that is essential for its function (Berg et al., 2014). The rest of the cytoplasmic domain 
of SpPBP2x has an abundance of arginine residues and the NR pair is part of a consensus 
NRx(R)VG motif. The NR pair could be the functional equivalent of the SR (residues 7 and 8) at 
the start of the SRxxR(R/K) motif in Bacillaceae PBP1 that is essential for binding to BsGpsB 
(Figure 3.21). However, co-IP experiments have not supported the idea that SpPBP2x and 
SpGpsB interact through this motif (Rued et al., 2017).  
 
Figure 3.21: Analysis of the N-terminal domain of S. pneumoniae PBP2x. 
Protein topology prediction (TOPCONS) (Tsirigos et al., 2015) and secondary structure 
prediction (Jpred4) (Drozdetskiy et al., 2015) analysis of the first 50 residues of SpPBP2x. The 
key explains the figure’s main features. The sequences of the cytoplasmic mini-domain 
selected for the generation of the peptides are shown by a light blue and dark blue brace.  
In order to test the binding of the cytoplasmic domain of SpPBP2x to the N-terminal domain 
of SpGpsB by fluorescence polarisation, two peptides were created that contained residues 1-
31 and 12-31 (SpPBP2x1-31 and SpPBP2x12-31) (Figure 3.22). SpPBP2x12-31 was created as initial 
attempts to purify the full cytoplasmic domain were challenging, possibly because of an 
amphipathic helix between residues 5-11 interacting non-specifically with the MBP fusion 
partner used to generate the peptide (Figure 3.23). Fluorescently labelled PBP peptides were 
separated from the MBP fusion protein by concentrating through a 30 kDa molecular mass 
cutoff (MWCO) centrifugal ultrafiltration device, allowing only the peptide to pass through. 
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With SpPBP2x1-31, the peptide remained in the concentrator with the cleaved MBP fusion 
partner, whereas SpPBP2x12-31 passed through.  
 
Figure 3.22: Generation of a fluorescently-labelled cytoplasmic domain peptide of SpPBP2x. 
Panel A shows the steps taken in the generation of a TAMRA maleimide conjugated SpPBP2x1-
31 peptide and panel B shows the same process but with residues 12-31 of SpPBP2x. Step 1 
shows the purified expression product from the pMAT11 vector. Residues 1-31/12-31 of 
SpPBP2x, highlighted in grey, are linked to maltose binding protein (MBP) by a linker sequence 
containing a TEV cleavage site. The mutated serine 30 to cysteine residue in SpPBP2x is 
highlighted in yellow with the thiol group highlighted. Leucine 31 was mutated to a serine to 
keep the peptide hydrophobicity down and to have a less bulky residue near the cysteine to 
facilitate labelling. Step 2 is the result of the incubation of the expression product with TAMRA 
maleimide which is linked to the protein by a reaction with the thiol group of the cysteine 
residue. Step 3 is TEV cleavage, in which the result is a fluorescently-labelled SpPBP2x 
cytoplasmic domain peptide. The two residues not highlighted in grey are residual residues 




Figure 3.23: SpPBP2x cytoplasmic domain peptide amphipathic helix. 
A helical wheel projection of the secondary structure predicted alpha-helix KRVIRYA (residues 
5-11) of SpPBP2x1-31. Hydrophilic residues are circles, hydrophobic residues are diamonds and 
positively charged residues are pentagons. The most hydrophobic residue is green, and the 
amount of green is decreases proportionally to the hydrophobicity, with zero hydrophobicity 
coded as yellow. Hydrophilic residues are coded red, and the amount of red decreases 
proportionally to the hydrophilicity. Positively charged residues are coloured blue.  
 Analysis by fluorescence polarisation 
SpGpsB1-63 bound to SpPBPx1-31 and SpPBP2x12-31 with modest affinities, Kd of 370 ± 60 µM 
and 620 ± 80 µM, respectively. SpPBP2x12-31 appeared to bind to the same site on GpsB as 
BsPBP1, LmPBPA1 and SpPBP2a as there was a 5-fold decrease in affinity of SpPBP2x12-31 for 
SpGpsB1-63Asp33Ala (Figure 3.24). It was unwise to conclude that these affinities were accurate 





Figure 3.24: Interaction of the cytoplasmic domain peptide of SpPBP2x with the N-terminal 
domain of GpsB. 
The interaction of TAMRA-labelled SpPBP2x1-31 and SpPBP2x12-31 peptides with wild-type N-
terminal domain of GpsB from S. pneumoniae (SpGpsB1-63) and the mutant SpGpsB1-63Asp33Ala, 
monitored by fluorescence polarisation. Data and the fit of the data to a 1:1 binding model in 
Sigma plot for each of the data sets are shown. The average of three measurements and the 
standard error bars for each data point are shown. The key shows which data set is 
represented by colouring and states the respective Kd that was determined in Sigma plot. 
3.10 Co-crystallisation of the SpGpsB N-terminal domain with a SpPBP2x cytoplasmic 
domain peptide 
 Crystallisation trials of SpGpsB4-63:SpPBP2x13-28 
Co-crystallisation attempts of SpGpsB with SpPBP2x were carried out by combining SpGpsB4-
63 (at a final concentration of 20 mg/mL) with SpPBP2x13-28 (25 mg/mL final; 1:5 molar ratio of 
protein:peptide) and subjecting the mix to sparse matrix crystallisation screening. Crystals 
grew in two conditions, JCSG+ D7 (0.2 M lithium sulphate, 0.1 M Tris pH 8.5 and 40 % v/v PEG 
400) and JCSG+ C11 (0.1 M sodium acetate pH 4.6 and 2 M ammonium sulphate). Crystals 
from JCSG+ D7 were parallelepipedal and crystals from C11 grew as plates (Figure 3.25). 
Crystals were transferred to a drop of the well solution containing 2.5 mg/mL of SpPBP2x13-28 
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peptide and 20 % PEG 400 for JCSG+ C11. After 30 seconds the crystals were mounted in rayon 
loops and cryo-cooled in liquid nitrogen. 
 
Figure 3.25: Crystals of SpGpsB4-63:SpPBP2x13-28. 
Panel A is a drop from JCSG+ D7 and panel B is a drop from JCSG+ C11 in which crystals grew 
from SpGpsB4-63:SpPBP2x13-28. The scale bar above each image provide a visual indication of 
the size of each crystal. 
 Data processing, molecular replacement and model building 
Data were collected at Diamond Light Source I24. Crystals from JCSG+ D7 diffracted to 1.8 Å 
and crystals from JCSG+ C11 diffracted to 4 Å. Diffraction data were processed, and the 
structure of SpGpsB4-63:SpPBP2x13-28 was solved by molecular replacement, as described in 
Chapter 2, using the dataset collected from the crystal grown in JCSG+ D7 and the co-ordinates 
of SpGpsB4-63 as the search model. Each SpPBP2x molecule was manually built into the 
electron density using COOT (Emsley et al., 2010), and the structure was refined until 
convergence. 
 Analysis of the SpGpsB4-63:SpPBP2x13-28 structure  
The SpGpsB4-63:SpPBP2x13-28 structure contained two molecules in the asymmetric unit and 
there was visible electron density in both of the SpPBP2x binding sites in SpGpsB (Figure 3.26 
A). This electron density was sufficient to build an 8-residue peptide (spanning residues 20-




Figure 3.26: Structure of the N-terminal domain of SpGpsB bound to residues 13-28 of 
SpPBP2x. 
(A and C) Zoomed-in view of binding site 1 (A) and binding site 2 (C) looking down at helix 1 
and 2. SpPBP2x peptides are shown as sticks and the electron density map is represented by 
a grey mesh. The map shown is the final Refmac-weighted 2mFobs-DFcalc map contoured at 0.22 
electrons per Å3 with a PyMol ‘carve’ of 1.6. (B and D) Residues important in binding are shown 
as sticks coloured by atom, for binding site 1 (B) and binding site 2 (D). Salt bridges and 
hydrogen bonds are represented by dashed black lines, van der Waals’ interactions by dashed 
yellow lines and intra-molecular interactions by a dashed red line. 
Residues 24-27 of SpPBP2x in binding site 1 form a type II beta turn stabilised by an interaction 
between the carbonyl oxygen of Arg24 and the backbone amide of Lys27 (Figure 3.27 B). In 
binding site 1, Arg24 of SpPBP2x was bound in the same site as Arg8 in BsGpsB5-64:BsPBP11-17 
and BsGpsB5-64
Lys32Glu
:LmPBPA11-15 and Arg31/33 in SpGpsB4-63:SpPBP2a27-40 (Figure 3.26 B), 
forming a similar set of interactions with GpsB (Figure 3.27 B). The identity of the coordinated 
arginine residue in binding site 2 could not be determined due to the lack of peptide that could 
be confidently built into the electron density. This arginine is bound in the same site as the 
central arginine residues in the other GpsB:PBP structures (Figure 3.26 B), coordinated in a 
similar fashion by GpsB (Figure 3.27 D). In binding site 1 with an 8 residue peptide built, there 
was not a second arginine residue binding near the carbonyl oxygens of SpGpsB residues 11-
14 like seen with BsGpsB5-64:BsPBP11-17 (Figure 1.15 F) and SpGpsB4-63:SpPBP2a27-40 (Figure 
3.17). SpPBP2x has a lower hydrogen binding capacity at this site and this supported the 
observation from FP that SpPBP2x had a weaker affinity for GpsB than the other PBP peptides 
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studied. A second arginine residue of SpPBP2x, Arg22, forms a salt bridge with SpGpsB Glu40 
(Figure 3.27 B) which is comparable to the interaction seen between SpGpsB Glu40 and 
SpPBP2a Arg31 in binding site 1 of SpGpsB4-63:SpPBP2a27-40 (Figure 3.17 B). SpPBP2xAsn21 is 
pointed away from the binding interface and does not make any direct contacts with SpGpsB 
(Figure 3.27 B). 
 
Figure 3.27: Structure of the N-terminal domain of SpGpsB bound to residues 13-28 of 
SpPBP2x. 
(A and C) Zoomed-in view of binding site 1 (A) and binding site 2 (C) looking down at helix 1 
and 2. SpPBP2x peptides are shown as sticks and the electron density map is represented by 
a grey mesh. The map shown is the final Refmac-weighted 2mFobs-DFcalc map contoured at 0.22 
electrons per Å3 with a PyMol ‘carve’ of 1.6. (B and D) Residues important in binding are shown 
as sticks coloured by atom, for binding site 1 (B) and binding site 2 (D). Salt bridges and 
hydrogen bonds are represented by dashed black lines, van der Waals’ interactions by dashed 
yellow lines and intra-molecular interactions by a dashed red line.  
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3.11 Important features of the SpPBP2x cytoplasmic domain peptide for binding the 
SpGpsB N-terminal domain 
The effect of arginine to lysine mutations, alongside an Asn21Ala mutation of SpPBP2x, in 
binding to SpGpsB was probed using fluorescence polarisation, since it had been reported 
previously that Asn21 and Arg22 are required for function (Berg et al., 2014) (Figure 3.28). 
SpPBP2x12-31Asn21Ala and SpPBP2x12-31Asn21AlaArg22Lys decreased the affinity for SpGpsB1-63 less 
than 2-fold compared to the WT peptide, whereas SpPBP2x12-31Asn21AlaArg24Lys and SpPBP2x12-
31
Asn21AlaArg22LysArg23LysArg24Lys each had more than 4-fold decreases in affinity. This supported the 
interaction observed by crystallography that Arg24 is the central arginine residue in the 
binding of SpPBP2x to SpGpsB. However, whilst Asn21 might be important in the function of 
SpPBP2x in vivo it is not essential for the binding of SpPBP2x12-31 to SpGpsB4-63 in vitro. 
 
Figure 3.28: Interaction of SpPBP2x12-31 mutants with SpGpsB1-63. 
The binding of wild-type SpPBP2x12-31 and binding mutants with SpGpsB1-63, monitored by 
fluorescence polarisation. Data and the fit of the data to a 1:1 binding model in Sigma plot for 
each of the data sets are shown. The average of three measurements and the standard error 
bars for each data point are shown. The key shows which data set is represented by colouring 
and states the respective Kd that was determined in Sigma plot. 
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3.12 Secondary structure analysis of cytoplasmic domain peptides by circular dichroism 
The secondary structures of LmPBPA11-15, SpPBP2a27-40 and SpPBP2x13-28 were determined 
using CD (Figure 3.29 A). Each of the cytoplasmic mini-domains contained secondary structure 
as the traces did not resemble disordered peptides. The predicted secondary structure 
composition of each of the peptides was determined using beStsel (Micsonai et al., 2018) 
(Figure 3.29 B). For each peptide around 50 % of the peptide fell under the category ‘Others’ 
which is composed of: 3,10-helix, π-helix, β-bridge, bend, loop and invisible regions in the 
three-dimensional structure. The second highest structural element for each peptide was 
antiparallel which ranged from 32-38 %. Putting together this data with the structural and 
functional data it is apparent that secondary structural elements are important in PBPs for 
binding to GpsB. The backbone torsion angles of LmPBPA1Arg8 in the BsGpsB5-
64
lys32Glu:LmPBPA11-15 structure were consistent with a residue in an alpha-helix and disruption 
of this helix negatively impacted the binding. An alpha-helical conformational was not 
required for SpPBP2a and SpPBP2x to bind to SpGpsB, but the key arginine residues formed 
either a single turn alpha-helix (SpPBP2a), a type I beta turn (SpPBP2a) or a type II beta turn 
(SpPBP2x). These secondary structural elements are key to positioning the binding PBP 




Figure 3.29: Secondary structure determination of cytoplasmic domain PBP peptides. 
A. Circular dichroism spectra of the cytoplasmic domain peptides of LmPBPA1, SpPBP2a and 
SpPBP2x. These data were analysed using BeStsel (Micsonai et al., 2018) and CD spectra were 
converted from millidegrees to mean residue ellipticity. Shown here are the experimental data 
and the key indicates which data set is represented on the graph. B. Secondary structure 
prediction of each of the peptides determined by BeStsel (Micsonai et al., 2018) from the CD 




Recent work on B. subtilis GpsB and its interaction with the class A PBP1, including the 
structure of BsGpsB5-64:BsPBP11-17, has supported the hypothesis that GpsB regulates cell 
division though interactions with the positively charged cytoplasmic domain motifs in PBPs 
(Cleverley et al., 2019). In this study, the crystal structures of GpsB in complex with PBPs were 
solved from 2 pathogenic organisms, L. monocytogenes in which GpsB is important during 
stress (Rismondo et al., 2016), and S. pneumoniae where GpsB is essential (Land et al., 2013).  
In each case, as with BsGpsB5-64:BsPBP11-17, no more than 3 residues from the PBP are required 
for binding to GpsB. Of these residues, a single positively charged arginine residue pokes into 
a negatively charged groove between the two alpha-helices of a GpsB monomer. In each 
structure this arginine residue is fixed in the same orientation and forms a similar set of 
interactions with GpsB (Figure 3.6, Figure 3.17 and Figure 3.27). It was observed by 
fluorescence polarisation that mutating this arginine residue in LmPBPA1 (LmPBPA1Arg8Ala) 
significantly reduced the affinity of the peptide for LmGpsB (Figure 3.7). Two binding modes 
of SpPBP2a were observed in which either Arg31 or Arg33 can act as the central arginine 
residue. The double mutation of both of these arginine residues, SpPBP2aArg31LysArg33Lys, gave a 
comparable reduction in affinity to GpsB as LmPBPA1Arg8Ala (Figure 3.20). The multiple binding 
modes of SpPBP2a may suggest why it has a stronger affinity for GpsB than the other 3 
peptides. 
GpsB binding to PBP peptides is favoured by secondary structural environments that 
simultaneously stabilise the torsion angles at an arginine residue and yet ensure nearby main 
chain amide protons are accessible for forming intermolecular hydrogen bonds with GpsB. In 
BsPBP1, LmPBPA1 and in one binding mode of SpPBP2a, the arginine residue is required to be 
in an alpha-helical conformation. In the second binding mode of SpPBP2a and in SpPBP2x the 
arginine residue is in a beta turn. The binding of BsPBP1 and SpPBP2a involves a second 
arginine residue making key contacts in the binding groove, BsPBP1Arg11 and SpPBP2aArg33/Arg36 
(Figure 1.15 F and Figure 3.17). The reduction in affinity seen with LmPBPA11-20
Arg12Ala (Figure 
3.7) could suggest that this is the second arginine residue to bind alongside Arg8, however, 
this could not be confirmed due to the lack of ordered peptide in the crystal structure.  
This work represents the first demonstration of a specific interaction between the cytoplasmic 
domain of S. pneumoniae PBP2x and GpsB (Figure 3.24). Although further work will be 
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required to clarify how prominent this is in vivo, even a transient interaction between these 
two proteins could explain the previous observation that depletion of GpsB impacts the 
localisation of PBP2x during cell division (Rued et al., 2017).  
There are a conserved set of GpsB residues required for PBP binding: Tyr25, Asp31 and Asp35 
in B. subtilis (Tyr27/Asp33/Asp37 in L. monocytogenes and Tyr23/Asp29/Asp33 in S. 
pneumoniae) (Figure 1.15 F and Figure 3.17) (Cleverley et al., 2019). L. monocytogenes cells 
with mutations in these residues show growth defects and in S. pneumoniae these mutations 
are lethal (Cleverley et al., 2019). So far LmGpsBAsp37 and SpGpsBAsp33 have been shown to be 
important, specifically in the binding of PBPs were they form interactions with the mainchain 
amide of the central arginine residue and its downstream residue. LmGpsBAsp33 and 
SpGpsBAsp29 are important for both PBP binding and also other proteins, such as MreC. BACTH 
screens showed reduced binding of LmGpsBAsp33 and SpGpsBAsp29 mutants with MreC, 
however LmGpsBAsp37 and SpGpsBAsp33 mutants bound to MreC like WT (Cleverley et al., 2019). 
This data suggests that different surfaces are used by GpsB to bind to PBPs and MreC.  
L. monocytogenes has increased sensitivity to fosfomycin in vivo with LmPBPA1
Arg8AlaArg12Ala 
and LmPBPA1
Glu10Pro mutants when LmPBP2A is also absent (Cleverley et al., 2019). In S. 
pneumoniae there was no observed defect when arginine residues alone were mutated even 
though there was a large reduction in affinity to GpsB in vitro. Reduced growth rates were, 
however, seen in Δpbp1a strains with SpPBP2a lacking residues 32-37, 27-38 or 26-45 
(Cleverley et al., 2019). An explanation for this could be that without the critical arginine 
residues there are other, less-well conserved positively-charged residues around the binding 
core, including the PBP juxtamembrane region. These residues could contribute to affinity, 
meaning that larger stretches of amino acids need to be deleted to inhibit the interaction with 
GpsB. The mutation of the cytoplasmic domain of PBP2a does not resemble the phenotype of 
a GpsB depletion in S. pneumoniae, however, and nor does a pbpA1 deletion phenocopy a 
gpsB deletion in L. monocytogenes (Cleverley et al., 2019). This indicates that there must be 
another GpsB-dependent interaction occurring that leads to the more severe phenotype with 
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DivIVA and GpsB are both important cytosolic proteins involved in regulating the cell division 
of Gram-positive bacteria. It was initially demonstrated that GpsB is required for the cellular 
localisation of PBP1 in B. subtilis, coordinating the activity of this PG synthase (Claessen et al., 
2008). DivIVA is thought to play a similar role as GpsB in division, associating with the divisome 
to act as a scaffold for the localisation of division proteins (Fadda et al., 2007; Oliva et al., 
2010). Both proteins have been linked to the elongation stage of the cell-cycle; GpsB has been 
shown to interact with the elongation factor MreC in a range of Gram-positives by BACTH and 
co-immunoprecipitation (Claessen et al., 2008; Rued et al., 2017; Cleverley et al., 2019) and 
elongation is hindered in S. pneumoniae lacking DivIVA (Fleurie et al., 2014a). GpsB was 
discovered by sequence comparisons and phylogenetic analysis with DivIVA (Tavares et al., 
2008). Since then, the two proteins have been studied extensively to determine if there is a 
relationship or overlapping function in cell division (Halbedel & Lewis, 2019; Hammond et al., 
2019). Both proteins are highly conserved in Gram-positive bacteria and localisation studies 
have revealed some similarities and differences between GpsB and DivIVA: the latter localised 
to the poles and septal regions in S. pneumoniae (Fadda et al., 2007), and was shown to be 
targeted to negatively curved membranes in B. subtilis, where it accumulated (Lenarcic et al., 
2009). Unlike DivIVA, GpsB shuttled between the lateral cell wall and the division septum 
during the cell-cycle and did not accumulate at negatively curved membranes (Claessen et al., 
2008). GpsB and DivIVA have been shown to localise independently of each other in B. subtilis, 
and they associate simultaneously with the divisome at the later stages of the division cycle 
(Tavares et al., 2008; Gamba et al., 2009).  
Both DivIVA and GpsB are composed of two main domains with varying levels of sequence 
conservation (Figure 4.1). Their N-terminal domains are highly homologous in structure, 
sharing the same coiled-coil dimer arrangement of alpha helices (Oliva et al., 2010; Rismondo 
et al., 2016). The DivIVA N-terminal domain functions as the lipid binding domain to bind to 
negatively curved membranes (Lenarcic et al., 2009), which is mediated by hydrophobic amino 
acids in the loop region (Oliva et al., 2010). The N-terminal domain of GpsB is important for 
membrane association and binding to the cytoplasmic mini-domains of peptidoglycan 
synthases (Rismondo et al., 2016; Cleverley et al., 2019). A number of residues are conserved 
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in the N-terminal domains of GpsB and DivIVA proteins (Figure 4.1 A). They both possess a 
conserved hydrophobic-arginine pair in their N-terminal domains required for membrane 
association as well as numerous conserved amino acids in the hydrophobic face of the coiled-
coil dimer (Oliva et al., 2010; Rismondo et al., 2016; Halbedel & Lewis, 2019). Val25, Phe28 
and Leu36 of BsDivIVA are the most well conserved hydrophobic residues in the core of the 
helical bundle across GpsB and DivIVA proteins. The essential PBP binding residues of BsGpsB 
Try25, Asp31, Asp35 and Ile38 are highly conserved across GpsB proteins compared to DivIVA 
in the Firmicute phylum.  The C-terminal domains of GpsB and DivIVA differ markedly; while 
the GpsB C-terminal domain is a parallel trimer of short helices (Rismondo et al., 2016), the 
equivalent domain in B. subtilis DivIVA is an extended coiled-coil tetramer (Oliva et al., 2010). 
However, the C-terminal domain of DivIVA is not well conserved, and pneumococcal proteins 
have an additional C-terminal region compared to B. subtilis DivIVA, which is essential for 
native localisation in S. pneumoniae (Straume et al., 2017). Figure 4.1 B shows very little 
sequence conservation between GpsB and DivIVA C-terminal domains. The conserved salt 
bridge residues required for the formation of a GpsB C-terminal domain trimer (Rismondo et 
al., 2016) are not conserved in DivIVA. 
GpsB and DivIVA appear to have important roles in overlapping areas of the Gram-positive 
cell-cycle, however, their specific roles are distinct and DivIVA has, seemingly, different 
functions in various Gram-positive species. This chapter explores the structure/function 
relationship of B. subtilis GpsB and DivIVA, specifically seeking greater understanding at the 
molecular level why the N-terminal domain of BsGpsB can bind to BsPBP1 but BsDivIVA 
cannot. Pioneering work was performed by engineering a novel PBP binding function into 





Figure 4.1: A multiple sequence alignment of GpsB and DivIVA proteins. 
Panel A shows the sequence alignment of the N-terminal domains and panel B is the alignment 
of the overlapping C-terminal domain regions of GpsB proteins from Firmicutes (indicated by 
a red box) and DivIVA proteins from Firmicutes (blue box) and Actinobacteria (purple box). 
Important conserved residues are coloured and labelled. Amino acids that are conserved 
within a subgroup are shaded black and amino acids that are conserved across subgroups are 
shaded grey. In panel B, an asterisk indicates the start of the C-terminal domain (CTD) of each 
sub group. Abbreviations: Sa, Staphylococcus aureus; Se, Staphylococcus epidermidis; Sp, 
Streptococcus pneumoniae; Sm, Streptococcus mitis; Lp, Lactobacillus plantarum; Lm, Listeria 
monocytogenes; Bs, Bacillus subtilis; Bc, Bacillus cereus; Ba, Bacillus anthracis; Bt, Bacillus 




4.2 Comparison of the N-terminal domains of GpsB and DivIVA from B. subtilis  
One of the major differences between the cell division proteins BsDivIVA and BsGpsB in terms 
of function is that BsGpsB can bind to PBPs and BsDivIVA cannot, even though their N-terminal 
domains are structural homologues that are almost indistinguishable (r.m.s.d of 0.69 Å). This 
near indistinguishable structural homology raises the question of how does BsPBP1 thus 
discriminate between BsGpsB and BsDivIVA? Fluorescence polarisation assays were used to 
investigate the binding of BsDivIVA and BsGpsB to BsPBP1. These data revealed that the N-
terminal domain of GpsB (BsGpsB1-68) interacted with the cytoplasmic domain of PBP1 
(BsPBP11-32) with a Kd of 150 ± 20 µM. However, the same PBP peptide did not interact with 
the N-terminal domain of DivIVA (BsDivIVA1-62) at all, with no evidence of saturation of binding 
and a ~linear increase of polarisation with protein concentration resulting in a fitted Kd > 4 
mM, suggesting only non-specific binding occurred between the BsPBP1 peptide and 
BsDivIVA1-62 (Figure 4.2). 
 
Figure 4.2: Interaction of a cytoplasmic domain peptide of BsPBP1 with the N-terminal 
domains of BsGpsB and BsDivIVA.  
The interaction of fluorescein-labelled BsPBP11-32 with wild-type BsGpsB1-68 and BsDivIVA1-62, 
as monitored by fluorescence polarisation. Binding data and the fit of the data to a 1:1 binding 
model in Sigma plot for each of the data sets are plotted on the graph. The average of three 
technical replicates and the standard error for each data point is shown. The key shows which 




The N-terminal domains of BsGpsB and BsDivIVA share a sequence similarity of 32.1 %. GpsB 
proteins have a conserved pair of aspartate residues that are essential for binding to PBPs 
(Figure 4.1 A) (Cleverley et al., 2019); in B. subtilis, these residues are Asp31 and Asp35. The 
crystal structure of BsGpsB5-64:BsPBP11-17 showed Asp35 formed an interaction with the 
backbone amides of Arg8 and Glu9 of PBP1 and Arg8 also formed a salt bridge with Asp31 
(Cleverley et al., 2019) (Figure 4.3). 
 
Figure 4.3: The BsGpsB:BsPBP1 interaction requires conserved arginines in the cytoplasmic 
mini-domain of BsPBP1.  
The formation of the BsGpsB5-64:BsPBP11-17 complex (PDB ID: 6GP7) is dependent upon a 
conserved SRxxR(R/K) motif in BsPBP1 (Cleverley et al., 2019). Key interfacial residues in the 
complex are shown in sticks and coloured and are labelled. BsGpsB5-64 is coloured in cyan and 
BsPBP11-17 is coloured in green. The carbonyl oxygens of BsGpsB5-64Ile13, BsGpsB5-64Leu14 and 
BsGpsB5-64Lys16 are labelled with their respective red numerals. Hydrogen bonds are shown as 
black dashed lines and van der Waals’ interactions are shown as yellow dashed lines. 
These conserved aspartate residues in GpsB are not maintained in DivIVA proteins (Figure 4.1 
A) and the equivalent residues in BsDivIVA are Asn26 and Ala30 (highlighted by red arrows in 
Figure 4.4). The first step in an attempt to introduce BsPBP1 binding-function in BsDivIVA was 
to introduce these key BsGpsB aspartate residues at the equivalent positions in BsDivIVA. 
Therefore, Asn26 and Ala30 of BsDivIVA were both mutated to aspartic acid and the ability of 
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this double mutant to bind to BsPBP11-32 was assessed by fluorescence polarisation. However, 
the BsDivIVA1-62Asn26AspAla30Asp change had no effect on the affinity measured to BsPBP11-32 (Kd 
> 5mM; Figure 4.6), suggesting that the lack of binding of BsDivIVA to BsPBP1 was not solely 
due to the absence of the twin aspartates. 
 
Figure 4.4: Comparison of BsGpsB and BsDivIVA sequences for construction of DivIVA 
binding mutants. 
A sequence alignment of the N-terminal domains of GpsB and DivIVA from B. subtilis. The 
triangles indicate the residues in BsDivIVA that were mutated to the equivalent BsGpsB 
residue in an attempt to confer binding to BsPBP1. The red triangles highlight the conserved 
aspartate residues in BsGpsB, Asp31 and Asp35 that are essential for the binding of BsPBP1. 
The equivalent residues in BsDivIVA are Asn26 and Ala30. The N-terminal domains of BsGpsB 
and BsDivIVA contain two a-helices, the positions of these helices are shown above each 
sequence by a cartoon helix. 
4.3 Structural differences in the N-terminal domains of GpsB and DivIVA from B. subtilis 
Close inspection of the superimposition of the crystal structures of N-BsGpsB and N-BsDivIVA 
provides a potential explanation as to why BsDivIVA cannot bind to BsPBP1 (Figure 4.5). In 
BsDivIVA the C-terminal end of helix 1 stops two amino acids before the equivalent helix in 
BsGpsB and a loop between helix 1 and 2 protrudes somewhat into the binding site of BsPBP1, 
where the side chain of BsPBP1 Arg8 would penetrate into the groove between the two helices 
(Figure 4.5). There is no such blockage in BsGpsB, the molecular basis of which could be 
explained by the conserved salt bridge between Lys11 and Glu15 that stabilises helix 1 (Figure 
4.1 A). This Lys/Glu salt bridge is not conserved in DivIVA proteins; the equivalent residues in 
BsDivIVA are Asn6 and Asn10. Another trait of BsGpsB that could contribute to the binding 
site is the presence of the bulky amino acid Ile38 in helix 2 that packs against helix 1, 
constraining its position and steering the path of the main chain downstream of the helix away 
from the PBP binding site. In BsDivIVA, the corresponding residue is Arg33, which does not 
have the ability to constrain helix 1. A conserved glutamate at position 17 in BsGpsB is also 
required to form a salt bridge with Arg11 of BsPBP1 as shown in the structure of the GpsB/PBP 
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complex (Figure 4.3). Again, this residue is not conserved in DivIVA sequences and in BsDivIVA 
it is a threonine.  
 
Figure 4.5: Structural differences between BsGpsB and BsDivIVA. 
The structure of BsGpsB5-64:BsPBP11-17 (PDB ID: 6GP7) superimposed onto BsDivIVA1-57 (PDB 
ID: 2WUJ). GpsB is coloured cyan, the bound BsPBP1 peptide is coloured green and BsDivIVA 
is in grey. The six BsDivIVA residues and equivalent BsGpsB residues to which their sequences 
were mutated are labelled and shown in stick form. The colouring of the labels corresponds 
to the structure. Arg8 and Arg11 of BsPBP1 are shown in stick form to demonstrate how the 
loop between α1 and α2 (indicated by the red arrow) blocks the peptide binding site in 
BsDivIVA but not in BsGpsB. The black dotted lines represent the salt bridge between Lys11 
and Glu15 of BsGpsB. 
4.4 Binding of BsDivIVA mutants to BsPBP1 
Further mutations were made to the BsDivIVA1-62Asn26AspAla30Asp variant based on the structural 
analysis described in Section 3.3 in an attempt to ‘open up’ the engineered PBP binding site 
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between helix 1 and 2 of BsDivIVA to enable the necessary contacts between the key aspartate 
residues and BsPBP1. The ability of these mutants to bind to BsPBP1 were also tested by 
fluorescence polarisation (Figure 4.6). The selected mutation sites, based on structural 
analysis, are highlighted in Figure 4.4 with black triangles indicating the introduced 
substitutions. Introducing the potential salt bridge residues, Lys and Glu to replace Asn6 and 
Asn10, respectively, to the BsDivIVA1-62Asn26AspAla30Asp mutant did not contribute substantially 
to the binding affinity of BsDivIVA for BsPBP1. The new quadruple mutant, BsDivIVA1-
62
Asn6LysAsn10Glu26AspAla30Asp, had a Kd of >2 mM for BsPBP11-32. By contrast, mutating Arg33 to Ile, 
to produce the triple mutant BsDivIVA1-62Asn26AspAla30AspArg33Ile, had a bigger impact on the 
affinity for BsPBP11-32, a Kd of 980 ± 20 µM was measured and the binding curve began to 
adopt a hyperbolic, saturable curve, consistent with a specific binding event. Incorporating 
both of these features enhanced the binding of the BsDivIVA penta-mutant (BsDivIVA1-
62
Asn6LysAsn10GluAsn26AspAla30AspArg33Ile) to BsPBP11-32 leading to a measured Kd of 670 ± 20 µM. This 
interaction was considerably stronger than for the WT BsDivIVA (Kd > 4mM) but was still 4-
fold weaker than the binding of the BsPBP1 peptide to WT BsGpsB. Finally, a 6-residue mutant 
was constructed that introduced a glutamate at position 12 (BsDivIVA1-62 
Asn6LysAsn10GluThr12GluAsn26AspAla30AspArg33Ile), in an attempt to replicate the salt bridge formed 
between BsGpsBGlu17 and BsPBP1Arg11, and potentially introducing additional BsDivIVA:BsPBP1 
contacts to strengthen the binding. This BsDivIVA mutant had an almost GpsB-like affinity for 
BsPBP1, being just ~2-fold weaker, with a measured Kd of 390 ± 40 µM in comparison to 150 
± 20 µM for BsGpsB1-68 vs BsPBP11-32. The BsDivIVA mutants that bound to BsPBP1 with a sub 
mM Kd had a higher maximal binding to BsPBP1 (maximum mP of ~200) compared to BsGpsB 
(maximum mP of ~ 160). The higher polarisation value for the BsDivIVA:BsPBP1 interaction 
suggests there was less free fluorescent BsPBP11-32 peptide in solution as an increase in 
polarisation was observed when the tumbling fluorescent peptide bound to the protein, 
slowing the tumbling and thus causing a polarised emission. An explanation for this 
observation could be the introduced mutations enabled two BsPBP1 peptides to bind more 
easily to BsDivIVA1-62 than with WT BsGpsB1-68. If time had not been constrained, the 




Figure 4.6: Interaction of a cytoplasmic domain peptide of BsPBP1 with the N-terminal 
domain of BsDivIVA mutants. 
The interaction of fluorescein-labelled BsPBP11-32 with wild-type BsGpsB1-68, BsDivIVA1-62 and 
engineered BsDivIVA1-62 variants, as monitored by fluorescence polarisation. Binding data and 
the fit of the data to a 1:1 binding model in Sigma plot for each of the data sets are plotted on 
the graph. The average of three technical replicates and the standard error for each data point 
is shown. The key shows which data set is represented by colouring and the respective Kd 
estimate that was determined in Sigma plot. 
Since BsDivIVA1-62 could be mutated to bind to BsPBP11-32 in vitro, the ability of a PBP-binding 
DivIVA mutant to supress a △gpsB phenotype was tested. The Halbedel group constructed 
LmdivIVA with Leu6Lys, Asn10Glu and Asn26Asp exchanges in an attempt to introduce 
LmPBPA1 binding. It was concluded from complementation experiments that this was not 
sufficient to turn divIVA into gpsB. To test if different C-terminal domains of GpsB and DivIVA 
were the reason complementation was not seen, the C-terminal domains were exchanged to 
produce the N-terminal domain of LmDivIVA encoded by the LmdivIVALeu6LysAsn10GluAsn26Asp 
triple mutant fused to the C-terminal domain of gpsB. Again, this did not achieve the desired 
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effect and as the genetics did not provide a clear-cut phenotype it was decided to call a halt 
to this avenue of research. 
4.5 Secondary structure of BsDivIVA mutants confirmed by Circular Dichroism. 
Circular dichroism of the BsDivIVA1-62 mutants confirmed that the mutants were correctly 
folded and the CD spectra did not differ significantly compared to WT. (Figure 4.7 A). The 
secondary structure prediction of each of the mutants (Figure 4.7 B) revealed each variant was 
predominantly alpha-helical (42-53 %) which is consistent with the secondary structure 
observed in the BsDivIVA1-57 structure, which contains 69 % alpha-helical (residues 3-52) (Oliva 
et al., 2010). Therefore, there was negligible disruption to the secondary structure of BsDivIVA 
when these mutations were introduced, just slight deviations in the overall structure, to open 
up the BsPBP1 binding site and consistent with the design principles from the outset that 




Figure 4.7: Secondary structure determination of wild type and mutants of N-BsDivIVA.  
A. Circular dichroism spectra of WT and engineered BsDivIVA variants. These data were 
analysed using Bestsel (Micsonai et al., 2018) and CD spectra were converted from 
millidegrees to delta epsilon. Shown here is the experimental data and the key indicates which 
data set is represented on the graph. B. Secondary structure prediction of each of the BsDivIVA 
mutants determined by BeStsel (Micsonai et al., 2018) from the CD spectra. The percentage 
of each element is displayed in a pie chart. 
4.6 Summary  
The aim of this chapter was to try and understand exactly what enables BsGpsB to bind to 
PBPs and what the differences are that means BsDivIVA is unable to so, despite the structures 
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sharing essential indistinguishable features. Close comparison of the structures of the N-
terminal domains of BsGpsB and BsDivIVA showed there were subtle differences that may 
provide a rationale for the binding of the former only to BsPBP1: BsDivIVA is incapable of 
binding to BsPBP1 because the BsPBP1 binding site in BsGpsB between helix 1 and 2 is blocked 
by a loop between the equivalent two helices in BsDivIVA. This feature has been reversed by 
protein engineering by opening up the PBP-binding site in BsDivIVA. The introduction of a 
lysine/glutamate pair at positions 6 and 10, together with the addition of a bulky isoleucine 
residue at position 33, glutamate at position 12 and the aspartate pair, essential for BsPBP1-
binding in BsGpsB, the interaction of BsDivIVA with BsPBP1 approached levels close to that of 
the native BsGpsB:BsPBP1 interaction.  
The question still remains, why is there such high structural homology between the N-terminal 
domains of DivIVA and GpsB? It is probable that GpsB arose from an initial gene duplication 
of divIVA, which is why they share a unique fold in their N-terminal domains. Their C-terminal 
domains have diverged quite significantly in structure and function, yet the N-terminal 
domains have not.  
The C-terminal domain of DivIVA is considerably longer than the C-terminal domain of GpsB 
and while both are important in oligomerisation, the overall tertiary structure of the two 
proteins differ significantly. The BsDivIVA C-terminal domain is a single helix that dimerises to 
form a parallel coiled coil dimer. Residues at the C-terminal ends of two dimers associate to 
form an elongated tetramer with N-terminal domain dimers at the respective ends (Oliva et 
al., 2010). The long C-terminal domain results in a distance between the N-terminal lipid 
binding domains which aids DivIVA in sensing membrane curvature with the C-terminal 
domain acting as a bridge from one part of the membrane to another (Halbedel & Lewis, 
2019). The shorter BsGpsB C-terminal domain forms a trimer of 3 parallel coiled coils that 
oligomerises into a hexamer (Rismondo et al., 2016). The overall tertiary structure of LmGpsB, 
determined by SAXS, positions 3 N-terminal domain dimers as arms and two C-terminal 
trimers at the base of a tripod-like hexamer (Cleverley et al., 2016). This oligomerisation of 
GpsB increases its binding capacity to coordinate PBPs and potentially other proteins. The C-
terminal domain of DivIVA has been shown to interact with a number of soluble proteins 
including the important sporulation protein RacA (Lenarcic et al., 2009; Schumacher et al., 
2016) and chromosome segregation proteins ParA and ParB/Spo0J (Perry & Edwards, 2004; 
Donovan et al., 2012; Ginda et al., 2013). DivIVA seems to have varying functions and 
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interacting partners across Gram-positive bacteria (Halbedel & Lewis, 2019), which could 
explain why sequence conservation of the C-terminal domain is lacking. GpsB only seems to 
interact with membrane or membrane associated proteins through its N-terminal domain 
with the short C-terminal domain serving solely for oligomerisation. 
ConSurf analysis (Landau et al., 2005) of the N-terminal domains of GpsB and DivIVA 
demonstrated a higher level of conservation at helix 1 and the adjacent region of helix 2, and 
the C-terminus of helix 2 was more variable (Figure 4.8). This suggested the conserved area is 
important for protein binding, although the conservation level in GpsB proteins is higher than 
in DivIVA. The essential PBP binding residues of BsGpsB include Tyr25, Asp31, Asp35 and Ile38, 
and these are in areas of high conservation. By comparison, the equivalent residues in 
BsDivIVA, Tyr20, Asn26, Ala30 and Arg33, are less well conserved and only Tyr20 maintains 
the same level of conservation, suggesting that DivIVA interactions with other proteins takes 
place at different sites. The loop region of BsDivIVA including Asn10, that blocks the PBP 
binding site, is also well conserved in DivIVA proteins.  
It has been shown by BACTH and co-immunoprecipitation that Wag31 (the DivIVA homologue 
in M. tuberculosis) interacted with the septum-specific peptidoglycan synthase PBP3 (FtsI) 
(Mukherjee et al., 2009; Plocinska et al., 2014). Under oxidative stress, Wag31 protected PBP3 
from proteolysis (Mukherjee et al., 2009). PBP3 contains a cytoplasmic N-terminal domain 
located in close proximity to the cytoplasmic membrane (Lu et al., 2020) which would suggest 
the interaction takes place with the lipid binding N-terminal domain of Wag31. Wag31 
contains a pair of aspartates at the same positions as the conserved aspartates in GpsB, 
essential for PBP binding. However, there is no lysine/arginine pair in helix one and the 
equivalent of BsGpsBIle38 is a glutamate, suggesting that Wag31 must interact with PBP3 via a 
different mechanism. DivIVA is required for the recruitment the division inhibitor MinCD to 
the cell poles, an interaction that is bridged by MinJ (Bramkamp et al., 2008). Domain swap 
experiments have located the MinJ binding site to the N-terminal domain of BsDivIVA, 




Figure 4.8: An estimation of the evolutionary conservation of the amino acids in the N-
terminal regions of GpsB and DivIVA.  
The structures of BsGpsB1-68 (PDB ID: 4UG3) and BsDivIVA1-57 (PDB ID: 2WUJ) were input to 
the ConSurf sever (Landau et al., 2005) which produced the resulting conservation models 
applied to chain A of each structure. The model of BsGpsB1-68 is shown in panels A and B and 
the model of BsDivIVA1-57 is shown in panels C and D in cartoon form. Panels B and D show a 
zoomed-in view of the PBP binding site with important binding residues labelled and shown 
as sticks. The conserved membrane association residues, Val22/Arg23 of BsGpsB and 
Phe17/Arg18 of BsDivIVA are also labelled and shown as sticks. The level of conservation is 
represented by colour which in indicated by the key. 
An explanation for the homologous N-terminal structures could be that sufficient time has not 
elapsed since gene duplication for the structures to diverge but the sequences have, 
explaining why the N-terminal domains of GpsB and DivIVA have apparently different 
functions. The structural homology enables both DivIVA and GpsB to associate with the 
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membrane and act as scaffold proteins for different protein targets: DivIVA with proteins 
involved in various roles including division site selection (Kaval et al., 2014), sporulation 
(Lenarcic et al., 2009; Schumacher et al., 2016) and chromosome segregation (Perry & 
Edwards, 2006; Donovan et al., 2012; Ginda et al., 2013) and GpsB with peptidoglycan 
synthesis, cell elongation factors (Cleverley et al., 2019) and sporulation regulator SpoIIE 
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5.1 Introduction  
GpsB is a cell-cycle regulator that controls the switch between bacterial growth and division, 
and one of its key roles is to ensure the proper cellular localisation of the major peptidoglycan 
synthase in those bacteria that encode GpsB. GpsB in several Gram-positive bacteria interact 
with an array of binding partners, including major penicillin binding proteins, and mutations 
in GpsB in the interaction interface are lethal (Rismondo et al., 2016; Cleverley et al., 2016, 
2019). The development of chemical probes that block these essential protein:protein 
interactions could help discriminate between essential and non-essential pairs of amino acids, 
that could be developed long-term into lead compounds for antibiotic drug discovery to 
address specifically infections caused by the Gram-positive pathogens streptococci, 
staphylococci and enterococci. Well-diffracting crystals of the N-terminal domain of GpsB 
from Streptococcus pneumoniae were already available that diffracted to a resolution of 1.9 
Å (Section 3.5.1), as were well-characterised biochemical and genetic systems to investigate 
GpsB interactions in several bacteria (Cleverley et al., 2019). This chapter explores the X-ray 
crystallography-based fragment screening experiment of N-SpGpsB, performed at the 
fragment screening XChem facility at Diamond Light Source. 
5.2 Development of reproduceable crystals 
In order to complete an XChem experiment the production of large, uniform and reproducible 
crystals needed to be established. The solvent channels in the original structure of SpGpsB 
were inspected and it was determined that the binding site would be accessible for small 
ligands (Figure 5.1). The crystallisation condition was therefore developed from the already 
established conditions that SpGpsB was crystallised in prior to XChem beamtime allocation 




Figure 5.1: The arrangement of molecules in this SpGpsB4-63 structure makes it a suitable 
candidate for fragment soaking. 
Panel A shows a single dimer of SpGpsB4-63 in cartoon and panel B is the arrangement of these 
dimers in the crystal. Solvent channels between each dimer at the target binding site are 
highlighted by red arrows.  
Screening was carried out in MRC 2 well plates with 20 mg/mL of N-SpGpsB (100 and 200 nL) 
and 0.1 M Tris pH 8.5, 0.2 M MgCl2, with precipitant concentrations between 15-30 % PEG 
8000 (100 nL). This method was not sufficient to obtain reproducible crystals and seeding was 
explored. Approximately 20 crystals no bigger than 200 µm in the largest dimension were 
crushed in a buffer of 50 uL of 0.1 M Tris.HCl pH 8.5, 0.2 M MgCl2, 24 % PEG 8000 to create a 
microseed stock. Screening was carried out in SwissCi 3-drop plates with a Mosquito (TTP Lab 
Tec) pipetting workstation mixing 300 nL of N-SpGpsB at 20 mg/mL, 100 nL of microseed stock 
and 200 nL of reservoir (0.1 M Tris pH 8.5, 0.2 M MgCl2, 15-20% PEG 8000). Crystals from 16 
% PEG 8000 diffracted to the highest resolution (1.6 Å) tested on an in-house Bruker gallium 
Metaljet. To obtain the adequate number of crystals required for an XChem experiment, 




Figure 5.2: A crystal drop from the final seeding conditions of SpGpsB4-63.  
The scale bar gives an indication of the size of the crystals in the drop and the red arrow points 
to a uniform crystal ~ 200 x 200 x 200 µm that was chosen for fragment soaking. 
5.3 Experimental procedure at Diamond Light Source 
Images of the crystal drops were recorded and TeXRank (Tsing Ng et al., 2014) was used to 
select the drops containing crystals to be soaked. The crystals were selected based on size and 
shape, and clusters or multiple crystals were automatically disregarded. 40 of these crystals 
were used for DMSO- and cryo-testing. It was determined from the diffraction patterns that 
the N-SpGpsB crystals could withstand 20 % DMSO for up to 3 hours and that no additional 
cryoprotection was required. Each crystal was soaked with a fragment for 1 hour before 
harvesting began; in no instance did the soak time exceed 3 hours. 
Subsequently, 547 crystals were soaked with fragments from the DSi-Poised Library (Enamine) 
using the XChem ECHO acoustic liquid handler (Labcyte). The final concentration of the 
fragment in each drop was 100 mM. The crystals in drops from a crystallisation plate 
containing 100-150 chosen drops was soaked for an hour and then the crystals were harvested 
manually with the aid of a Shifter (Oxford Lab Technologies) and cryo-cooled in liquid nitrogen 
directly into pucks. It took approximately 1-1.5 hours to harvest the crystals from a single tray. 
This same process was then repeated 4 times in order to sample a larger range of the chemical 
library. For each drop selected using TeXRank where harvesting was attempted, a note was 
made with regards to the condition of the drop. Examples of notes included, precipitation of 
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fragment, cracked crystal and dissolved crystal. It was then recorded if a crystal was 
successfully harvested from the given drop. In total, 540 crystals were harvested. Diffraction 
data were collected on the I04-1 beamline in automated, unattended mode using loop 
centring as the crystals were larger than the loops (> 200 µm). All crystals diffracted to 
between 1.2 and 1.8 Å. 
5.4 Data processing and structure determination 
A total of 536 useful diffraction datasets were collected and used for subsequent structural 
analysis. For the remaining 4 samples, data collection failed due to empty or broken loops. 
The data were processed using Diamond’s automated processing pipeline 
(https://www.diamond.ac.uk/industry/Industry-News/Latest-News/Synchrotron-Industry-
News---MXnews4/Auto-processing-Pipeline.html). The space group and unit cell parameters 
for each data set were unsurprisingly consistent with the structure of SpGpsB4-63 (Table 3.2). 
The data were then loaded onto XChemExplorer (XCE) (Krojer et al., 2017) which is a graphical 
workflow tool for large-scale protein-ligand structure determination. XCE automatically 
selected the best data for each dataset from the automated pipeline. Dimple 
(http://ccp4.github.io/dimple/), a programme used for batch molecular replacement, was 
used to solve the 536 datasets using the structure of SpGpsB4-63 as a reference ‘ground-state’ 
model. 
5.5 Determining potential ligand binding sites by differential electron density 
For each solved structure the ligand restraints corresponding to each fragment were 
generated using AceDRG (Long et al., 2017). A programme called PANDDA.analyse (Pan-
dataset density analysis) (Pearce et al., 2017a) was used to find potential ligand binding sites. 
PANDDA.analyse compared all of the structures by aligning them to the SpGpsB4-63 reference 
structure and identified residual difference density that might correlate to the binding of a 
potential ligand. In total 122 datasets were identified by PANDDA.analyse as containing 
residual difference density. 
5.6 Modelling small ligands into identified sites 
PANDDA.inspect (Pearce et al., 2017b) was used to visually inspect the 122 datasets, make 
annotations and manually model the fragment within the coot interface. There were 77 
datasets were a fragment was modelled satisfactorily (a 14 % ‘hit’ rate). For the remaining 45 
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datasets, the electron density identified by PANDDA.analyse was either not strong enough to 
confidently model the ligand or corresponded to unmodelled electron density at the N- or C-
terminus of GpsB. An example of a modelled ligand and electron density that did not represent 
a ligand are shown in Figure 5.3. Conformations and rotamers of protein residues surrounding 
the fragment binding site that had changed due to binding were corrected during inspection. 
Water molecules surrounding the fragment binding site were also added at this stage. The 
resulting structures from PANDDA.inspect were not fully built, ‘final’ crystallographic models 
refined to convergence but bound-state models at the specific binding site. In total, there 
were 14 different ‘hot-spots’ in the crystal where ligands were bound (Figure 5.4). Of these 
14, 10 sites were at or immediately adjacent to crystal packing interfaces, and are presumably 
of secondary importance to the goal of identifying functionally important binding sites. The 
remaining 4 ‘hot-spots’ were either close to or at the target binding site, as defined as the 
interaction site for PBP peptides in GpsB, mutation of which is lethal (Cleverley et al., 2019).  
The 77 datasets with bound ligands underwent a few rounds of refinement using REFMAC 
(Murshudov et al., 1997), including the addition of water molecules. 12 of these datasets 
contained a ligand that was identified as a binding site ligand. These structures were fully 
refined as they were the key focus of this experiment. The refinement statistics for the final 







Figure 5.3: Screenshots from the PANDDA.inspect interface.  
Panel A shows a dataset in which a fragment was modelled into the electron density identified 
by PANDDA.analyse. Panel B is an example of electron density identified that did not represent 




Figure 5.4: PANDDA.inspect summary. 
Dark blue dots show the placement of a fragment on the SpGpsB structure, which has 4 GpsB 
molecules (2 dimers) in the asymmetric unit. The numbers indicate a binding area identified 
by PANDDA.inspect. Sites 5, 6 and 8 were target binding sites. The red arrows point to the 4 
PBP binding sites. 
5.7 Target binding site ligands 
The 12 binding site ligands were numbered 1-12 and details of each ligand can be found in 
Table 5.3. It is clear from the structures that these 12 ligands occupy a similar binding site in 
SpGpsB to SpPBP2a27-40, between helix 1 and helix 2 of a GpsB monomer (Figure 5.5) with 
some ligands making contacts with symmetry-related molecules. The specific site in each 
structure where the ligand was built into the electron density is shown in Figure 5.6. The main 
grouping of ‘hits’ either bound directly or are in close proximity to residues in GpsB that are 
essential for viability in vivo and peptide-binding in vitro, including Tyr23, Val28, Asp29, Leu32 




Figure 5.5: Ligands that occupy the PBP binding site of GpsB.  
Panel A shows a cartoon of N-SpGpsB bound to PBP2a. The GpsB dimer is coloured cyan and 
the PBP2a peptides are coloured green. Helix 1 (α1) and helix 2 (α2) of each GpsB dimer are 
labelled. Panel B shows the structure of N-SpGpsB with the 12 ligands that bind in the PBP2a 
binding site, superimposed in one of the binding sites of the GpsB dimer. The 12 ligands are 
shown in stick form with a distinct colour. Three of the essential SpGpsB residues required for 
PBP2a binding are shown in stick form and are labelled. Helix 1 (α1) and helix 2 (α2) of each 
GpsB dimer are labelled. 
Analysis of the binding sites of ligands 1 and 6 indicated there were no hydrogen bonds 
between the ligand and the SpGpsB monomer, but potential stacking interactions with Phe12 
(Figure 5.7). Stacking with Phe12 was also seen with ligands 8, 9, 10 and 12 (Figure 5.8). Ligand 
6 formed a hydrogen bond with the backbone carbonyl of Gln14 from a symmetry-related 
molecule and stacking with a symmetry related Phe12 was also observed. This might restrict 
the binding of this ligand to SpGpsB in the crystal form and not in solution. Ligands 2 and 11 
formed a salt bridge with their only nitrogen atom to Asp29 of SpGpsB (Figure 5.7 and Figure 
5.8). This interaction mimics the salt bridge that is formed between Arg31/33 of SpPBP2a and 
Asp29 (Figure 3.17). The nitrogen atom of ligand 2 was also coordinated by a symmetry-
related Glu40 (Figure 5.7). The second important SpGpsB aspartic acid for PBP binding, Asp33, 
formed a hydrogen bond to a nitrogen atom in ligands 5 and 9 (Figure 5.7 and Figure 5.8). A 
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second nitrogen atom from ligand 9 formed a hydrogen bond with the carbonyl oxygen of 
Phe12 (Figure 5.8). Hydrogen bonding of the carbonyl oxygen of Phe12 was also seen with 
nitrogens of ligands 5, 7 and 10 (Figure 5.7 and Figure 5.8) and this same nitrogen atom in 
ligand 5 and 7 formed a hydrogen bond with the carbonyl oxygen of Gln14 (Figure 5.7 and 
Figure 5.8). Ligand 7 was also coordinated by hydrogen bonding from the backbone amide of 
Lys9 and side chain of Glu40 from a symmetry-related molecule. A salt bridge was important 
in the binding of ligand 8 between one of the two nitrogen atoms and Glu40 (Figure 5.8). In 
binding site 1 of both the SpGpsB:SpPBP2a and SpGpsB:SpPBP2x structures this same 
glutamate formed an interaction with SpPPB2aArg31 (Figure 3.17 B) and SpPBP2xArg22 (Figure 
3.27 B). Ligand 8 also stacked with a symmetry-related Phe12. Ligands 3 and 12 involved a 
similar interaction between respective oxygen atoms and the side chain nitrogen of Lys9, and 
ligand 12 formed a sulphur H-bond with the backbone amide of Lys9 (Figure 5.7 and Figure 
5.8). The binding of ligand 3 is strengthened via hydrogen bonding with carbonyl oxygens of 
Gln14 and Phe12 from a symmetry-related molecule (Figure 5.7). Ligand 4 bound in a slightly 
different site to the other 11 ligands on the other side of helix 1, where it formed a hydrogen 
bond with the carbonyl oxygen of Glu15 and a sulphur H-bond with the carbonyl oxygen of a 
symmetry-related Ala44 (Figure 5.7). This site is still in close proximity to the essential binding 
site residues Asp29 and Asp33. Glu15 was also involved in the binding of ligand 10, forming 
hydrogen bonds with a nitrogen atom (Figure 5.8). The importance of Glu15 in PBP binding 
was shown in the SpGpsB:PBP2a structure where it formed a salt bridge with Arg36 in binding 




Figure 5.6: Structures of the 12 target binding site ligands bound to N-SpGpsB. 
Each numbered panel corresponds to a different ligand found in the first column of Table 5.3. 
N-SpGpsB is shown as a cartoon and coloured cyan in each panel. Each ligand is shown in sticks 
with the carbon atoms coloured in green. The electron density of each ligand is shown by grey 
mesh. The map shown is the final Refmac-weighted 2mFobs-DFcalc map contoured at 0.16 
electrons per Å3 with a carve of 1.6. In each panel chain A of GpsB in the SpGpsB4-63:SpPBP2a27-
40 structure is superimposed onto the GpsB chain with a bound ligand and SpPBP2a27-40 shown 
as a cartoon at 70 % transparency and coloured grey. A sketch of each ligand is displayed to 




Figure 5.7: Binding site interactions of ligands 1-6 with N-SpGpsB between helix one (α1) 
and helix two (α2) of a GpsB monomer.  
Each numbered panel corresponds to a different ligand listed in the first column of Table 5.3. 
The two subunits of the N-terminal GpsB dimer are coloured cyan in cartoon form and each 
ligand is coloured green as sticks. Nitrogens are blue, oxygens are red and sulphurs are yellow. 
GpsB residues important in binding are shown as sticks and are labelled. Symmetry related 
residues involved in coordinating the ligand are shown as sticks and coloured grey. Salt bridges 




Figure 5.8: Binding site interactions of ligands 7-12 with N-SpGpsB between helix one (α1) 
and helix two (α2) of a GpsB monomer.  
Each numbered panel corresponds to a different ligand listed in the first column of Table 5.3. 
The two subunits of the N-terminal GpsB dimer are coloured cyan in cartoon form and each 
ligand is coloured green as sticks. Nitrogens are blue, oxygens are red and sulphurs are yellow. 
GpsB residues important in binding are shown as sticks and are labelled. Symmetry related 
residues involved in coordinating the ligand are shown as sticks and coloured grey. Salt bridges 
and hydrogen bonds are represented by dashed black lines.  
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5.8 The ability of small ligand hits to compete with SpPBP2a binding to SpGpsB 
A competition assay was conducted to test if any of the 12 fragment hits were able to compete 
with SpPBP2a for the SpGpsB binding site. As the 12 fragments were dissolved in 100 % DMSO, 
the tolerance of the SpPBP:SpGpsB interaction was first tested in the presence of DMSO. The 
final concentration of DMSO in the crystal soaks was 20 % and the ability of TAMRA-labelled 
SpPBP2a23-45 to bind to SpGpsB1-63 monitored by fluorescence polarisation was not affected 
by DMSO up to 2% (Figure 5.9). The Kd of the interaction with no DMSO was 104 ± 19 µM and 
in the presence of 2% DMSO it was 93 ± 18 µM.  
 
Figure 5.9: DMSO tolerance testing of the PBP:GpsB interaction. 
The interaction of TAMRA-labelled SpPBP2a23-45 peptide with wild-type N-terminal domain of 
GpsB from S. pneumoniae (SpGpsB1-63) at varying DMSO concentrations. Binding data and the 
fit of the data produced in Sigma plot for each of the data sets are plotted on the graph. The 
key shows which data set is represented on the graph by colouring. 
It was determined that 100 µM of SpGpsB1-63 would be used in the competition assay as it 
slightly higher than the Kd of the interaction measured by FP between SpGpsB1-63 and 
SpPBP2a23-45 (Kd of ~70 µM) and gave a constant and detectable FP value of ~90 mP with 40 
nM of TAMRA-labelled SpPBP2a23-45. The concentrations of SpGpsB1-63 and TAMRA-labelled 
SpPBP2a23-45 remained consistent throughout the experiment and the concentration of each 
fragment was increased from 15.625 to 2000 µM. None of the 12 fragments were able to 
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displace TAMRA-SpPBP2a23-45 as the measured FP stayed at a constant level with increasing 
fragment concentration (Figure 5.10). If the fragment had been able to compete with TAMRA-
SpPBP2a23-45 it would bind in place of the fluorescent peptide and the FP would decrease as 
the fragments were not fluorescently labelled. With 100 µM of SpGpsB1-63 and 40 nM of 
TAMRA-SpPBP2a23-45 in the displacement assay, the fragments were competing for 100 µM 
worth of sites meaning the bottom of the assay was 100 µM. It is therefore safe to conclude 
that the individual fragments did not bind to SpGpsB1-63 with an affinity higher than 100 µM, 
causing no displacement of TAMRA-SpPBP2a23-45. To test if TAMRA-SpPBP2a23-45 bound to 
SpGpsB1-63 could be displaced, a control reaction was carried out with un-labelled SpPBP2a27-
40, again up to a 2 mM concentration. This showed that TAMRA-SpPBP2a23-45 was displaced by 
the un-labelled peptide as the FP value decreased from 89 to 44 mP (Figure 5.10). 
 
Figure 5.10: Competition assay monitored by fluorescence polarisation.  
A constant concentration of SpGpsB1-63 (100 µM) and TAMRA-labelled SpPBP2a23-45 (40 nM) 
were used in each measurement with increasing concentrations of ligands/un-labelled 
SpPBP2a27-40 up to 2 mM.  3 measurements were taken at each data point and the average is 
plotted on the graph as well as the standard error. The fluorescence polarisation with up to 2 
mM of any of the 12 ligands did not decrease (black symbols). Increasing the un-labelled 
SpPBP2a27-40 concentration up to 2 mM caused a decrease in FP (red curve).  
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5.9 Binding of ligands to N-terminal SpGpsB by ITC  
The ability of the ligand hits to bind to N-SpGpsB without the presence of PBP2a was tested 
using ITC. Ligands 8 and 12 were not suitable for this experiment as they precipitated at a 
concentration of 20 mM. For the remaining 10 ligands, 20 aliquots of each ligand at 20 mM 
were injected into 30 µM SpGpsB1-63. It was not possible to detect an interaction with a Kd 
tighter than 5 mM and no sigmoidal binding curves were produced. To conclude, no 
detectable binding of the 10 ligands were observed by ITC.  
5.10 Summary  
This chapter explores the first X-ray crystallography-based fragment screening experiment 
applied to GpsB. It has been demonstrated that N-SpGpsB crystals were a successful candidate 
for small fragment soaking, being able to withstand up to 20 % DMSO allowing the soaking at 
100 mM of fragments, without crystals cracking or dissolving. In total 14 % of the crystals 
soaked lead to a dataset with a bound ligand and 2 % of those ligands were identified as 
SpGpsB target binding site ligands. Analysis of the final 12 structures showed that the binding 
of 8 out of the 12 ligands involved the formation of van der Waals’ interactions, hydrogen 
bonds or salt bridges of ligand nitrogen atoms with SpGpsB residues (Phe12, Gln14, Glu15, 
Asp29, Asp33 and Glu40). The binding of SpPBP2a and SpPBP2x to SpGpsB is heavily centred 
on the formation of hydrogen bonds and salt-bridges between these GpsB residues with 
arginine residues from the PBP cytoplasmic mini-domains and mutation of these residues 
abrogated peptide binding in vitro and produced gpsB null phenotypes in vivo (Cleverley et 
al., 2019).  
None of the 12 binding site ligands identified by XChem bound to N-SpGpsB with a high 
affinity, and they were unable to compete with SpPBP2a for the binding site by biochemical 
interaction studies. The GpsB:PBP binding site is more of a binding surface than a binding cleft 
and the small fragments are only capable of making a few contacts to GpsB, inevitably giving 
them a low affinity. Half of the ligands made contacts with symmetry-related GpsB residues, 
providing more contacts for the ligand in the crystal to mimicking a binding cleft that is simply 
not present in solution.  
Putting together the data from XChem and ITC interactions studies it seems that ligand 9 could 
be the best candidate for follow up experiments. Ligand 9 made multiple contacts to N-SpGpsB 
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including the key Asp33 residue and ITC indicated weak binding in solution. This ligand could 
be used as a scaffold for the generation of a larger molecule capable of binding to SpGpsB 
with a higher affinity. The ligand could benefit from more nitrogen residues capable of forming 
salt-bridges with conserved aspartate and glutamate residues and an overall increase in 
hydrogen bonding capacity. The production of a successful chemical probe that blocks the 
GpsB:PBP interaction in S. pneumoniae, where GpsB is essential (Rued et al., 2017), could 
provide the building block for development of a novel antibiotic or combination therapy 
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No. of independent 
reflections 
 
54945 (1480) 60877 (194) 46693 (2295) 61086 (224) 57127 (630) 56085 (1659) 
Completeness (%) 
 
89.9 (49.4) 75.2 (4.9) 97.0 (96.1) 75.2 (5.6) 76.3 (17.1) 92.9 (54.9) 
Redundancy 
 
2.7 (1.2) 2.5 (1.0) 2.8 (1.9) 2.5 (1) 2.7 (1.1) 2.6 (1.1) 
CC1/2 (%) 
 
99.7 (31.8) 99.6 (0.0) 99.4 (34.0) 99.9 (71.7) 99.8 (82.6) 99.9 (59.2) 
<I>/<σ(I)> 12.9 (1.0) 12 (0.9) 8.7 (0.7) 17.1 (0.8) 13.5 (1.0) 16.7 (1.0) 
 
Refinement Statistics  
 
 















Rfree  0.226 0.221 0.268 0.217 0.211 0.217 
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*Values in parenthesis are for the highest resolution shell  
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Data Statistics  
 
     
















AutoPROC AutoPROC Xia2 3dii AutoPROC Xia2 3dii AutoPROC 
Wavelength (Å) 
 
0.9159 0.9159 0.9159 0.9159 0.9159 0.9159 















0.036 (0.520) 0.033 (0.723) 0.030 (0.598) 0.029 (0.370) 0.026 (0.359) 0.035 (0.952) 
Space group P 1 21 1 
 
P 1 21 1 
 
P 1 21 1 
 
P 1 21 1 
 
P 1 21 1 
 






































No. of measured 
reflections 
1540462 (1677) 139350 (3399) 103238 (4261) 154766 (231) 147046 (1914) 135268 (3615) 
 
 
No. of independent 
reflections 
56727 (1509) 47512 (1748) 32358 (1603) 54311 (187) 55199 (1512) 48897 (2091) 
 
 
Completeness (%) 90.9 (49.1) 92.8 (64.4) 99.4 (99.01) 66.9 (4.6) 91.9 (50.87) 95.7 (83.1) 
 
Redundancy 2.7 (1.1) 2.9 (1.9) 3.2 (2.7) 2.8 (1.2) 2.7 (1.3) 2.8 (1.7) 
 
CC1/2 (%) 99.7 (40.4) 99.9 (37.2) 99.8 (59.8) 99.7 (78.5) 99.8 (76.9) 99.9 (32.6) 
 
<I>/<σ(I)> 13.3 (1.5) 12.8 (0.7) 12.1 (1.2) 13.6 (0.8) 13.3 (1.1) 11.2 (0.5) 
 
Refinement Statistics  
 
 















Rfree  0.222 0.233 0.252 0.219 0.220 0.242 
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*Values in parenthesis are for the highest resolution shell  
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Chapter 6: How Does the Phosphoprotein ReoM Regulate Peptidoglycan 
Synthesis in Listeria monocytogenes? 
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6.1 Introduction  
Transient protein phosphorylation is an important cellular process utilized by all living cells 
(Ardito et al., 2017). Bacteria use phosphoprotein signalling to respond efficiently to many 
external stimuli, such as being challenged with antibiotics (Bugrysheva et al., 2011). Gram-
positive bacteria possess a conserved family of eukaryote-like serine/threonine protein 
kinases (eSTPKs) and partner phosphatases (eSTPs) that play a role in regulating many cellular 
processes, including virulence in Staphylococcus aureus (Zheng et al., 2018b). 
One of the most well characterised eSTPKs is PrkC from Bacillus subtilis, which consists of an 
intracellular N-terminal kinase domain and an extracellular sensing region linked by a short 
transmembrane helix (Pompeo et al., 2018). The external regulatory region is comprised of 
three PASTA (PBP and serine/threonine kinase associated) domains that bind to 
peptidoglycans and compounds containing beta-lactams (Pompeo et al., 2015; Yeats et al., 
2002). The principles of kinase autophosphorylation have been determined mostly in work in 
eukaryotes, and it has only recently been determined that this phenomenon also occurs in 
bacteria; the understanding of the activation mechanism in bacteria is, however, lacking 
(Manuse et al., 2015). In S. aureus the Kinase Domain (KD) of the eSTPK, Stk1, contains an 
activation loop that houses six phosphorylation sites to activate the kinase (Zheng et al., 
2018b). Stk1 detects cell wall stress responses via its PASTA domains, which results in kinase 
cis-autophosphorylation on Thr172. Molecular modelling of Stk1 suggests that the 
autophosphorylation reconfigures the activation loop from a closed conformation to an open 
and active one, revealing the substrate binding site to allow trans-phosphorylation of a second 
kinase (Zheng et al., 2018b). 
A number of eSTPK substrates are proteins involved in coordinating peptidoglycan synthesis 
within the division of Gram-positive bacteria (Manuse et al., 2015). Phospho-transfer profiling 
of the purified recombinant components has revealed that PknB, the eSTPK from 
Mycobacterium tuberculosis, phosphorylates the class A PBP PonA1 (Kieser et al., 2015) and 
GlmU (Parikh et al., 2009). GlmU is an important enzyme for the synthesis of UDP-GlcNAc and 
upon phosphorylation its activity is reduced (Parikh et al., 2009). The IreK eSTPK in 
Enterococcus faecalis phosphorylates a substrate, IreB, which has been implicated as a 
negative regulator of cephalosporin resistance (Hall et al., 2013). The phosphorylation status 
of orthologous eSTPK enzymes is influenced by the presence of the cell division regulator, 
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GpsB, in at least B. subtilis and Streptococcus pneumoniae (Pompeo et al., 2015, 2018). As 
shown in Chapter 3 and previously, GpsB binds to and co-ordinates the activities of 
peptidoglycan synthases in B. subtilis, L. monocytogenes and S. pneumoniae (Cleverley et al., 
2019). The Halbedel lab have identified numerous suppressor mutations in L. monocytogenes 
that restore the divisional phenotype observed with gpsB deletion. One of these mutations 
mapped to the ATPase subunit (clpC) of ClpCP, a heat stress protease that degrades MurA 
(Rismondo et al., 2017). MurA catalyses the first committed step of peptidoglycan synthesis 
via the transfer of enolpyruvyl from phosphoenolpyruvate to UDP-GlcNAc (Brown et al., 1995). 
Another gpsB suppressor mutation was mapped to the ribosomal binding site of the 
previously uncharacterised lmo1503 gene, a homologue of E. faecalis ireB (Wamp et al., 2020). 
This study will focus on the eSTPK/eSTP pair in L. monocytogenes, PrkA/PrpC and their 
relationship with a small phosphoprotein substrate, encoded by lmo1503, herein named 
ReoM. In this chapter, the phosphorylation profile of ReoM will be studied and the mechanism 
of activation of PrkA will be explored to identify the specific residues required for this 
activation. The crystal structure of full length ReoM is presented and a mechanism proposed 
to explain how protein:protein interactions of ReoM are affected by phosphorylation. 
6.2 ReoM and PrkA form a complex 
 Native-PAGE analysis 
The relationship between PrkA (encoded by lmo1820) and ReoM (lmo1503) was explored, 
initiated by the reported phosphorylation of the homologous IreB by IreK in E. faecalis (Hall et 
al., 2017). The kinase domain of PrkA (PrkA-KD) was first shown to interact with ReoM by 
native-PAGE gel electrophoresis. The isolated PrkA-KD and ReoM proteins each 
electrophoresed as a single species (lane 1 and lane 2, Figure 6.1). When ReoM was incubated 
with PrkA-KD, in the absence of ATP, a slower migrating species was observed and the 
individual band corresponding to PrkA-KD disappeared, indicating that the slower migrating 
species was a ReoM-PrkA-KD complex (lane 3 Figure 6.1). A faint band for ReoM remained, 
probably because the stoichiometry of the components applied to the gel did not quite match 




Figure 6.1: Native-PAGE analysis of the interaction between ReoM and PrkA-KD.  
Components of each lane are annotated above the image and the position and identity of 
relevant bands are marked to the side.  
Consequently, the stoichiometry of the ReoM:PrkA-KD complex was explored by incubating 
different ratios of the two proteins and running each of these on a native-PAGE gel (Figure 
6.2). Ratios of 10:1, 5:1, 2:1 and 1:1 were chosen and the gel indicated that the ratio was close 
to 5:1 as there was excess ReoM in the 10:1 (Lane 3, Figure 6.2) and excess PrkA-KD in 1:1 and 
2:1 (Lanes 4 and 5, Figure 6.2). The additional band beneath PrkA-KD in lanes 1, 4 and 5 
(indicated by a red asterisk) was likely to be PrkA-KD with multiple phosphoryl groups as it ran 
further on the gel, possibly due to the presence of additional negative charge. A second band 
was also seen, just below the band of the PrkA-KD:ReoM complex in lanes 3 and 6 (indicated 
by a blue asterisk), which might represent a complex of ReoM with PrkA-KD carrying additional 
phosphoryl groups; the phosphorylation profile of PrkA-KD is explored in Section 6.6.4. These 
additional bands are not observed in Figure 6.1 and this could be explained by varying levels 
of PrkA-KD phosphorylation across different protein preparations of recombinantly expressed 
PrkA-KD. An alternative explanation for the presence of the additional bands is that the PrkA-
KD run in Figure 6.2 was degrading, and the degradation product was still capable of binding 




Figure 6.2: Native-PAGE analysis of ReoM:PrkA-KD stoichiometry.  
Components of each lane are annotated above the image and the position and identity of 
relevant bands are marked to the side. The ratio of ReoM:PrkA-KD is shown in the bottom 
lane of the annotation. Additional bands are indicated by red and blue asterisks positioned on 
the left of the band, these bands are explained in the text. 
 Analytical size-exclusion chromatography 
The formation of a ReoM:PrkA-KD complex was confirmed by size exclusion chromatography 
(Figure 6.3 A). Isolated ReoM and PrkA-KD eluted from an S200 increase column at 16 mL and 
14 mL, respectively. The mixture of the two proteins with a 4-fold molar excess of ReoM (ratio 
determined from native-PAGE) eluted from the same column at 12 mL (Figure 6.3 B). SDS-
PAGE analysis confirmed the presence of both ReoM and PrkA-KD under this peak (Fractions 
17-19, Figure 6.3 C). The additional band observed in fractions 20-24 in Figure 6.3 C beneath 
the band for PrkA-KD was predicted to be a degradation product that is not observed when 




Figure 6.3: Analytical size-exclusion chromatography of ReoM and PrkA-KD.  
Panel A is a chromatogram of an S200 10/300 GL column run of ReoM:PrkA-KD. The blue arrow 
indicates the elution volume of the complex, the red and black arrows show where 
uncomplexed PrkA-KD and ReoM elute, respectively. Fractions 17-25 were collected, and 
these fractions are labelled on the chromatogram. Panel B shows overlaid chromatograms of 
S200 10/300 GL column runs of ReoM, PrkA-KD and ReoM:PrkA-KD. The key indicates the 
colour coding for each run and the arrows above each peak indicate the elution volume. The 
ReoM and PrkA-KD runs have both been normalised to that of the complex. Panel C is an SDS-
PAGE gel of the fractions collected from chromatogram shown in panel A and the number 
above each lane corresponds to the fraction collected. ReoM and PrkA-KD were loaded onto 
the final two lanes of the gel to aid identifying the proteins in each fraction. The additional 
band in fractions 20-24 is a predicted degradation product of PrkA-KD.  
 SEC-MALS 
The oligomeric state of ReoM and PrkA-KD as well as the complex were determined using size-
exclusion chromatography coupled to multi-angle light scattering (Figure 6.4). The 
experiments were performed and the data processed by Dr Owen Davies (Newcastle 
University). These data revealed ReoM had a predicted molecular mass of 25 kDa, which 
suggests the formation of a dimer in solution as a ReoM monomer has a mass of 10.6 kDa, a 
result that agrees with the oligomeric state of the homologue IreB (Hall et al., 2017). PrkA-KD 
had a molecular mass of 36 kDa, which is close to that expected of a monomer (37.4 kDa). The 
mass of the complex was determined as 82 kDa, which could account for 1:4 stoichiometry of 
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PrkA-KD:ReoM with 2 ReoM dimers (predicted mass 42.4 kDa) bound to a PrkA-KD monomer 
(37.4 kDa; total 79.8 kDa). This result also agrees with the predicted stoichiometry determined 
by native-PAGE analysis. The peak shapes are slightly asymmetrical, probably because the 
column used for the experiment had to be re-packed. The molecular masses, however, are 
reliable given their resemblance those predicted from sequences, the knowledge of the 
stoichiometry determined in an orthologous manner and that as BSA was run as a control and 
gave a mass of 67 kDa which is close to the known mass of 65 kDa. 
 
Figure 6.4: SEC-MALS analysis of ReoM, PrkA-KD and PrkA-KD:ReoM complex.  
The chromatograms are relatively scaled and represent the analysis of each protein injected 
at 10 mg/mL, including BSA as a control. The deconvoluted molecular mass of the eluting 
species (coloured dots) are plotted on the right-hand axis and are coloured the same colour 
as the species from which they were determined. The average molecular weights determined 
were 25 kDa for ReoM (blue), 36 kDa for PrkA-KD (red), 82 kDa for the PrkA-KD:ReoM complex 
(orange) and 67kDa for BSA. The corresponding theoretical masses are 10.6 kDa (ReoM), 37.4 
kDa (PrkA-KD) and 65 kDa (BSA), consistent with ReoM behaving as a dimer, PrkA-KD and BSA 
as monomers and the PrkA-KD:ReoM complex as a 1:2 trimer. 
 Analysis of ReoM and PrkA-KD binding by isothermal titration calorimetry 
Isothermal titration calorimetry (ITC) was used to assess the binding of PrkA-KD to ReoM, 
which revealed a Kd of 187 ± 41.1 nM for the interaction (Figure 6.5). The binding enthalpy 
(ΔH) was favourable at -13.1 kcal mol-1, which indicates the interaction is dominated by 
electrostatics. The entropic component (-TΔS) was unfavourable at 4.09 kcal mol-1, also 
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consistent with the requirement of some conformational changes that had to take place, 
alongside the hydrogen bonding, for the interaction to occur. The N value determined was 
0.256, which meant 4 molecules of ReoM bound to each PrkA-KD molecule, a result that 
agreed closely with the results from Native-PAGE and SEC-MALS. Buffer runs showed that 
ReoM and PrkA-KD produced negligible heat changes when injected into ITC buffer or when 
ITC buffer was injected into the cell containing either protein (Figure 6.5 B and C). This showed 
that the heat change for the interaction was not an artefact. 
 
Figure 6.5: Interaction of ReoM and PrkA-KD analysed by ITC.  
Panels A shows the ITC raw heat plot for 20 injections of PrkA-KD at 400 µM into 100 µM of 
ReoM in the cell. Panel B shows the ITC raw heats for 20 injections of PrkA-KD into buffer (10 
mM HEPES pH 8, 100 mM NaCl) and panel C shows raw heats of 20 injections of buffer into 
ReoM. Panel D shows the integrated binding heats (black circles) fit to a single set of sites 
model (black line) to determine N, Kd, DH, DG and -TDS. Integrated heats for the controls are 
also shown (B, blue; C, red). 
A comparable Kd of 372 ± 137 nM was produced with ReoM in the syringe injected into the 
cell containing PrkA-KD (Figure 6.6), with a stoichiometry parameter N of 3.2, not inconsistent 




Figure 6.6: Interaction of ReoM and PrkA-KD analysed by ITC.  
The top graph shows the ITC raw heat plot for 20 injections of ReoM at 1mM into 25 µM of 
PrkA-KD in the cell. Below are the integrated binding heats (black circles) fit to a single set of 
sites model (black line) to determine N, Kd, DH, DG and -TDS. 
6.3 Phosphorylation of ReoM by PrkA-KD 
Some passages in this section have been quoted verbatim from Wamp et al. (2020) in which I 
am the second author. Any passages used are my own work. 
 Native-PAGE analysis of the phosphorylation of ReoM by PrkA-KD 
Proteins with altered size, shape or charge can run differently on a native-PAGE gel therefore, 
phosphorylation of ReoM by PrkA-KD was first analysed by native-PAGE electrophoresis to see 
if the addition of a phosphoryl group caused the protein to run differently. When ReoM was 
incubated with PrkA-KD, Mg2+ (eSTPK enzymes are Mg2+ dependent (Pompeo et al., 2015)) 
and ATP, a band for free PrkA-KD was observed but there were no visible bands for ReoM and 
the ReoM:PrkA-KD complex. Instead a new species was present, migrating further in the gel 
than ReoM (lane 4, Figure 6.7), which is likely to be phosphorylated ReoM (P-ReoM). The 
additional negative charges on P-ReoM would cause the protein to visibly run further on the 
gel towards the cathode compared to ReoM. The absence of a ReoM:PrkA-KD complex with 





Figure 6.7: Native-PAGE analysis of the phosphorylation of ReoM by PrkA-KD. 
Components of each lane are annotated above the image and the position and identity of 
relevant bands are marked to the side. P-ReoM is the phosphorylated form of ReoM. 
 Isolation of P-ReoM 
The phosphorylation of ReoM was scaled up in order to isolate it from PrkA-KD and any 
unphosphorylated ReoM. P-ReoM was successfully purified by anion exchange (Figure 6.8 A) 
and confirmed by native-PAGE (Figure 6.8 B). Fraction 8 was chosen as P-ReoM for further 




Figure 6.8: Purification of P-ReoM. 
Panel A shows a MonoQ 5/50 GL chromatogram of a ReoM phosphorylation reaction. The 
blue trace is the measured mAU and the green trace is the concentration of NaCl (Conc % B). 
The fractions that were collected for analysis are labelled on the graph. Panel B shows a 
native-PAGE gel of the fractions collected in A. The corresponding fraction is labelled above 
each lane and the final lane contains ReoM as a control. 
 Mass spectrometry to identify the phosphorylated residue in ReoM 
Liquid chromatography-mass spectrometry (LC-MS) analysis* of ReoM isolated from PrkA-KD 
after phosphorylation revealed the addition of 79.9 Da in comparison to the mass of 
unmodified ReoM (10671.5 Da), which corresponds to the formation of a singly-
phosphorylated ReoM product of 10751.4 Da (Figure 6.9). MS/MS spectra obtained during 
peptide mass fingerprinting were also consistent with one phosphorylation event per protein 
chain; one ReoM peptide, spanning residues Asp5 to Lys22 with mass of 2151.89 Da, was 
increased by 79.96 Da after incubation with PrkA-KD and Mg/ATP. Analysis of the y- and b- 
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ions in the MS/MS fragmentation spectrum of this peptide was consistent only with Thr7 as 
the sole phosphosite in ReoM (Figure 6.10). This result is consistent with the observation from 
a phosphoproteomics study that identified Thr7 as a phosphorylation site in Lmo1503 (ReoM) 
(Misra et al., 2011). The importance of Thr7 in ReoM function is also highlighted by its high 
sequence conservation (96%) across all 2909 ReoM homologues present at NCBI. 
*All Mass spectrometry experiments in this chapter were performed by Dr Claire Jennings, 
Newcastle University. 
 
Figure 6.9: LC-MS analysis of ReoM and P-ReoM. 
Panel A and B show the ESI-QTOF raw data for non-phosphorylated ReoM and mono-
phosphorylated ReoM, respectively. Panel C is the deconvoluted mass spectrum for non-
phosphorylated ReoM (black) overlaid over the equivalent spectrum for mono-
phosphorylated ReoM, P-ReoM (red). The difference between the major peak of ReoM and P-




Figure 6.10: LC-MS/MS analysis of P-ReoM.  
LC-MS/MS was used to perform peptide mapping analysis on P-ReoM, revealing Thr7 is the 
sole phosphosite. The MS/MS fragmentation spectra of the phosphorylated peptide 
encompassing Asp5-Lys22 is presented with b-ion fragmentation in blue and y-ion 
fragmentation shown in red, whilst the precursor ion (m/z 1116.86, z=2+) is represented by a 
blue diamond. 
 Analysis of the interaction between P-ReoM and PrkA-KD by isothermal titration 
calorimetry 
The binding of P-ReoM to PrkA-KD was analysed by ITC to determine if there was a change in 
affinity after phosphorylation. No binding could be detected for the two proteins, which 
suggested that once ReoM is phosphorylated it can no longer bind to PrkA (Figure 6.11), 
consistent with the Native-PAGE analysis (Figure 6.7). 
 
Figure 6.11: Interaction of ReoM and P-ReoM with PrkA-KD monitored by ITC.  
Integrated ITC traces of ReoM and P-ReoM at 100 µM in the cell versus 400 µM of PrkA-KD in 
the syringe: the key indicates which variant is shown and their respective Kd.  
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 Analytical size-exclusion chromatography and circular dichroism of ReoM and P-ReoM 
Analysis of the oligomeric state of P-ReoM by size exclusion chromatography revealed that 
the protein behaved in solution the same as that of unphosphorylated ReoM; both variants 
eluted from the column at 14.6 mL (Figure 6.12) suggesting that the electrophoretic behaviour 
of P-ReoM on native-PAGE is not due to an altered oligomeric state. Circular dichroism of 
ReoM and P-ReoM also revealed that the two proteins had similar secondary structures and 
any structural changes due to phosphorylation did not grossly alter the structure, rather being 
limited to the movement of a loop or a flexible region (Figure 6.13).  
 
Figure 6.12: ReoM and P-ReoM have the same oligomeric state.  
Size exclusion chromatography analysis of ReoM and P-ReoM showed that phosphorylation 
of ReoM did not alter its oligomeric state. Both ReoM (solid) and P-ReoM (dashed) had an 




Figure 6.13: Secondary structure determination of ReoM and P-ReoM.  
A. Circular dichroism spectra of ReoM and P-ReoM were analysed using BeStsel (Micsonai et 
al., 2018); CD spectra were converted from millidegrees to delta epsilon. Shown here is the 
experimental data and the key indicates which data set is represented. B. Secondary structure 
prediction of ReoM and P-ReoM determined by BeStsel (Micsonai et al., 2018) from the CD 
spectra. The percentage of each element is displayed in a pie chart. There is negligible 
structural change on phosphorylation of ReoM. 
6.4 Crystallisation of ReoM 
Some passages in this section have been quoted verbatim from Wamp et al. (2020) in which I 
am the second author. Any passages used are my own work. 
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 Crystallisation trials 
ReoM at a concentration of 23 mg/mL in a buffer of 10 mM Na-HEPES pH 8, 100 mM NaCl was 
subjected to crystallisation using a number of sparse matrix crystallisation screens. Crystals of 
ReoM grew in 3 different conditions from the JCSG+ crystallisation screen: A3 (0.2 M di-
ammonium hydrogen citrate, 20 % PEG 3000), A6 (0.1 M phosphate/citrate pH 4.2, 0.2 M 
lithium sulfate, 20 % w/v PEG 1000) and C12 (10 % w/v PEG 1000/ 10 % w/v PEG 8000) (Figure 
6.14). In each drop the crystals grew in clusters and were either rod shaped or cuboidal-like. 
Crystallisation of P-ReoM and PrkA-KD:ReoM was attempted using a number of sparse matrix 
crystallisation screens but no crystals were obtained.  
 
Figure 6.14: Crystals of ReoM. 
Panel A is a drop from JCSG+ A6, panel B is a drop from JCSG+ A3 and panel C is a drop from 
JSCG+ C12 in which crystals grew with the addition of ReoM at 23 mg/mL. The scale bar above 
each image provide a visual indication of the size of each crystal. 
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 Data processing, molecular replacement and model building 
The diffraction data for a crystal harvested from JCSG+ A6 were collected at Diamond Light 
Source I03 beamline. Diffraction data were processed and the structure of ReoM was solved 
to 1.6 Å by molecular replacement using the NMR structure of IreB (PDB ID: 5US5) as described 
in 2.4.4. The resultant molecular model was refined to convergence and the data collection 
and refinement statistics for the final structure of ReoM can be found in Table 6.1. 
 Analysis of the ReoM structure 
Perhaps unsurprisingly ReoM shares the same overall fold as IreB (Hall et al., 2017), each 
containing a compact 5-helical bundle (4 standard α-helices and one single-turned 310-helix 
between residues 52 and 54) with short loops between the secondary structure elements. 
Other than IreB (Hall et al., 2017), there are no structural homologues of ReoM with functional 
significance in the PDB (Figure 6.15). 
 
Figure 6.15: A DALI search (Holm, 2020) with ReoM. 
The top 20 matches against the full PDB of ReoM. Matches are ordered based on Z-score and 
the top two matches shown in the red box are chain A and B of IreB (PDB ID: 5US5). 
The helical bundles in both ReoM and IreB associate into homodimers with α-helices two and 
four from each protomer forming the majority of the homodimer interface, and these residues 
are highlighted in Figure 6.16 A. In agreement with the IreB structural analysis, 1200 Å2 of 
surface area is buried in the ReoM dimer interface, representing 9% of the total solvent 




Figure 6.16: Crystal structure of ReoM.  
Panel A is the structure of ReoM depicted as a cartoon with each protomer in the dimer 
coloured separately (cyan and orange). The secondary structure elements are numbered 
according to their position in the amino acid sequence. Thr7 and some of the key amino acids 
in the dimer interface and the hydrophobic core are drawn as stick figures. Panel B shows the 
stabilisation of the N-terminus in chain B. Chain B is coloured orange and symmetry related 
residues are in grey. The aromatic residues involved in a network of hydrophobic interactions 
are drawn in stick form as well as Thr7.  
Other than the compact helical bundle of ReoM, there is a ~16 residue-long N-terminal tail, 
with B-factors 25% higher than the rest of the protein, prior to the start of α-helix 1 at residue 
Ile17. The equivalent N-terminal region is also disordered in the NMR structure of IreB (Hall 
et al., 2017). Despite the absence of secondary structure, the ReoM model covering this region 
could be built with confidence from Asp5 in chain A and Asp2 in chain B (Figure 6.17 A). The 
extended N-terminal regions are at least partially stabilised by crystal lattice interactions that, 
in chain B, include Phe9 and Tyr10 forming a network of hydrophobic interactions with other 
aromatic residues from symmetry equivalent molecules, including contributions from another 
copy of Phe9 and Tyr10 (Figure 6.16 B). 
Consequently, it is possible to visualise Thr7, the target for phosphorylation by PrkA, in the 
flexible N-terminal region in both chains. The side chain of Thr7 in both chains makes no 
intramolecular interactions and is thus amenable to phosphorylation by PrkA. The presence 
of a sulphate ion (a component of the crystallisation reagent) adjacent to the sidechain of Thr7 
could mimic what P-ReoM might look like (Figure 6.17). The sulphate ion is captured by a 
positively-charged micro-environment incorporating residues Lys35, Arg57, His58 and Arg62 




Figure 6.17: Microenvironment of the sulphate ion bound to Thr7.  
Panel A shows the final 2Fobs -Fcalc electron density map, contoured at a level of 0.42 electrons 
per Å3, at the N-terminus of chain A (cyan) in the immediate vicinity of Thr7 and of a sulphate 
ion. Symmetry related residues are coloured grey. Panel B highlights the positively charged 
residues from a symmetry related molecule (drawn in stick form) that form hydrogen bonds 
(yellow dashed lines) with the sulphate. 
6.5 Mutational analysis of ReoM 
Some passages in this section have been quoted verbatim from Wamp et al. (2020) in which I 
am the second author. Any passages used are my own work. 
 Native-PAGE to analyse the behaviour of ReoM when threonine 7 is mutated 
Since Thr7 had been identified as the phosphorylation site on ReoM, it was mutated to both 
an alanine and aspartic acid to explore the effect of ablating and mimicking phosphorylation, 
respectively. Both ReoMThr7Ala and ReoMThr7Asp appeared to interact with PrkA-KD, as a 
complex band was observed on native-PAGE when the mutants were mixed with the kinase 
(lanes 6 and 9, Figure 6.18). Unlike with wild-type ReoM (lane 3, Figure 6.18) this complex 
band remained after the addition of ATP with both mutants (lanes 7 and 10, Figure 6.18). As 
expected, this result indicates that a clear phosphorylation reaction did not occur, because 
after phosphorylation of wildtype ReoM it can no longer bind to PrkA-KD (Figure 6.11). In 
addition, only a slight shift was observed for ReoMThr7Ala, running further on the gel (lane 7, 
Figure 6.18) and no clear shift was seen with ReoMThr7Asp (lane 10, Figure 6.18) after incubation 
with ATP, compared to wildtype ReoM (lane 3). The shift seen for ReoMThr7Ala could point to a 
second, non-specific phosphorylation site. The band for ReoMThr7Asp (lane 8, Figure 6.18) ran 
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further in the gel than ReoM (lane 1, Figure 6.18), as expected due to the additional aspartate 
residue (phosphomimetic) in place of a threonine residue. 
 
Figure 6.18: Native-PAGE of ReoM Thr7 mutation phosphorylation reactions. 
Components of each lane are annotated above the image.  
 Analysis of the interaction between ReoM and ReoM variants with PrkA-KD using 
isothermal titration calorimetry 
The strength of the interactions of Thr7 mutants with PrkA-KD was measured using ITC. 
ReoMThr7Ala had a Kd of 654 ± 127 nM for PrkA-KD, which was a 3-fold decrease in affinity 
compared to wild-type, whereas ReoMThr7Asp had a Kd of 855 ± 189 nM which was a 4-fold 
decrease in affinity compared to WT (Figure 6.19). The binding enthalpy in both cases was 
more favourable with values of -19.8 kcal mol-1 (Thr7Ala) and -14.1 kcal mol-1 (Thr7Asp), 
however the entropy factor was more unfavourable at 11.5 kcal mol-1 and 5.96 kcal mol-1. An 
interaction could not be detected for P-ReoM with PrkA-KD, which is consistent with the 
results from native-PAGE with the complex band disappearing after phosphorylation. The 
slight reduction in affinity observed with ReoMThr7Ala could be explained by the loss of the 
hydroxyl group of Thr7 that weakly affected the interaction but not to a substantial degree. 
The retention of binding of PrkA-KD to ReoMThr7Asp, albeit with a 4-fold lower affinity than WT, 
indicates the mutation of threonine 7 to an aspartate is not an ideal phosphomimetic in this 
instance. Aspartate and glutamate residues are not complete chemical mimics of 
phosphothreonine and therefore phosphomimetic mutations do not work in every case 
(Dephoure et al., 2013). Aspartic and glutamic acid are smaller than phosphoserine/threonine 
and carry a net negative charge of -1 compared to -2 of the phospho-residue. Furthermore, 
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aspartic and glutamic acid have trigonal planar geometry which does not completely mimic 
the shape of a phosphoserine/threonine with tetrahedral geometry. 
 
Figure 6.19: Interaction of ReoM and ReoM variants with PrkA-KD monitored by ITC.  
ITC raw heat plots and integrated binding heats for 20 injections of PrkA-KD at 400 µM into 
100 µM of ReoMThr7Ala (A) and ReoMThr7Asp (B) in the cell. Integrated binding heats were fit to 
a single set of sites model to determine N, Kd, DH, DG and -TDS. C. Integrated ITC traces of 
ReoM variants at 100 µM in the cell versus 400 µM of PrkA-KD in the syringe. The key indicates 
which variant is shown and the respective Kd that was determined.  
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 Mass spectrometry analysis of ReoMThr7Ala 
The slight shift in ReoMThr7Ala on a native-PAGE gel after incubation with PrkA-KD prompted 
analysis of this mutant by intact LC-MS to see if there was a secondary phosphorylation site. 
Both ReoMThr7Ala and ReoMThr7Ala after incubation with ATP/Mg and PrkA-KD had an intact 
mass of 10641.9 (Figure 6.20). The predicted mass of ReoMThr7Ala by ProtParam 
(https://web.expasy.org/protparam/) was 10642.09 which meant neither variant of 
ReoMThr7Ala was phosphorylated and the shift observed on native-PAGE was not due to the 
addition of a phosphoryl group on a secondary ReoM site. The shift observed could be due to 
low level, non-specific phosphorylation that was not stable and/or did not accumulate 
sufficiently to be detected, even by modern MS methodologies. 
 
Figure 6.20: LC-MS analysis of intact ReoMThr7Ala mutant.  
Panel A and B show the ESI-QTOF raw data for ReoMThr7Ala and ReoMThr7Ala following 
incubation with PrkA-KD. Panel C is the overlaid deconvoluted mass spectrum demonstrating 
lack of phosphorylation of ReoMThr7Ala in the absence (black) and presence of PrkA-KD (red). 
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6.6 Activation mechanism of PrkA 
 Identification of PrkA residues to be mutated 
The activation mechanism of PrkA-KD was explored to determine if there was an equivalent 
residue to threonine 172 from S. aureus Stk1 that had to be phosphorylated in order for the 
kinase to become active (Zheng et al., 2018b). Appropriate alanine substitutions were made 
to 6 residues of PrkA-KD determined by the sequence alignment to be the equivalent of the 
activation loop residues in Stk1, as well as Ser169Ala as the equivalent residue in S. aureus 
Stk1 is histidine (Figure 6.21 A). The conservation of these activation loop residues in a range 
of Gram-positive bacteria is highlighted by the multiple sequence alignment in Figure 6.21 B. 
 
Figure 6.21: Sequence alignments of eSTPKs.  
Panel A shows a sequence alignment of the kinase domains of Stk1 (S. aureus) and PrkA (L. 
monocytogenes). The secondary structure of Stk1 (PDB ID: 4EQM) is shown above the 
sequence. Residues selected for mutational analysis in PrkA are indicated by black triangles. 
Panel B shows a multiple sequence alignment of the activation loop region of eSTPKs from a 
range of Gram-positive bacteria. Serine and threonine residues are highlighted yellow to 
shown their conservation. Ser163 and Ser173 of LmPrkA are conserved as either a Ser/Thr 
throughout the 8 species and Thr at the equivalent position of LmPrkAThr165 is highly 
conserved. Abbreviations: Lm, Listeria monocytogenes; Sa, Staphylococcus aureus; Bs, Bacillus 
subtilis; Sp, Streptococcus pneumoniae; Cd, Clostridioides difficile; Ef, Enterococcus faecalis; 
Mt, Mycobacterium tuberculosis; Sv, Streptomyces venezuelae. 
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 Native-PAGE to assess the ability of PrkA-KD mutants to bind and phosphorylate ReoM 
PrkA-KD mutants were analysed by native-PAGE to test their ability to both bind to and 
phosphorylate ReoM. Figure 6.22 shows the native gels of the phosphorylation reactions of 
ReoM with Serine 173, 169 and 167 mutants of PrkA-KD. As with wild-type PrkA-KD, PrkA-
KDSer173Ala formed a complex with ReoM (PrkA-KDSer173Ala lane 2), but this complex appeared 
weaker with a less intense band than with the wild-type proteins, indicating that this mutant 
had a lower affinity for ReoM. There was also a much more prominent ReoM band in this lane 
compared to the wild-type reaction (PrkA-KD lane 2). This free ReoM supported the conclusion 
that PrkA-KDSer173Ala cannot bind to wild-type ReoM as strongly. With the addition of ATP/Mg 
to PrkA-KDSer173Ala and ReoM there was no visible shift in ReoM which suggested that this 
mutant kinase is unable to phosphorylate ReoM (PrkA-KDSer173Ala lane 3). PrkA-KDSer173Asp had 
a similar pattern to PrkA-KDSer173Ala, with even less evidence of a complex formation with 
ReoM and no evidence of phosphorylation (PrkA-KDSer173Asp lanes 2 and 3) suggesting strongly 
that mutating Ser173 to an aspartate could not mimic the phosphorylated residue. Both PrkA-
KDSer173Ala and PrkA-KDSer173Asp ran higher on the gel than PrkA-KD, which could be explained 
by loss of negative charge because these mutants could not autophosphorylate. PrkA-
KDSer169Ala and PrkA-KDSer167Ala had a similar pattern to wild-type PrkA-KD indicating that 
mutating either of these residues had no discernible impact on the ability of the kinase to 
autophosphorylate, bind ReoM, or act as a kinase. 
The remaining activation loop residue mutants of PrkA-KD were analysed by native-PAGE and 
the results are shown in Figure 6.23. PrkA-KDSer160Ala ran as three distinct bands, which 
probably indicated the presence of multiple phosphorylation states (PrkA-KDSer160Ala, lane 1). 
Like wild-type PrkA-KD, this mutant was able to both bind to and to phosphorylate ReoM 
(PrkA-KDSer160Ala, lanes 2 and 3). PrkA-KDThr162Ala and PrkA-KDSer163Ala also behaved like wild-
type but PrkA-KDThr162Ala appeared to have a single phosphorylation state (PrkA-KDThr162Ala, 
lane 1) whereas PrkA-KDSer163Ala had three (PrkA-KDSer163Ala, lane 1). PrkA-KDThr165Ala was the 
only other mutant to act differently as it demonstrated no ability to phosphorylate ReoM 




Figure 6.22: A native gel comparing the phosphorylation activity of wild-type PrkA-KD with 
mutants. 
For each PrkA-KD variant lane 1 was the kinase on its own, lane 2 was the kinase plus ReoM 
and lane 3 was the kinase plus ReoM, ATP and MgCl2.  
 
Figure 6.23: A native gel comparing the activity of wild-type PrkA-KD with mutants.  
For each PrkA-KD variant lane 1 was the kinase on its own, lane 2 was the kinase plus ReoM 
and lane 3 was the kinase plus ReoM, ATP and MgCl2.  
Finally, Gly18 of PrkA is a part of a conserved glycine rich loop in the kinase domain that is 
thought to be important in binding ATP during phosphorylation (Rakette et al., 2012). During 
genetic constructions designed to delete prkA and prpC from the chromosome, the Halbedel 
lab made the observation that the only DprpC clone they could isolate contained a suppressor 
mutation in prkA, which removed the Gly18 codon of prkA. The effect of removing this glycine 
residue on the activity of PrkA-KD was therefore tested in vitro. Native-PAGE analysis showed 
that removing this glycine residue did not impact the ability of the kinase to both bind to and 
to phosphorylate ReoM (Figure 6.24), and therefore, the presence of three other glycine 
residues in close spatial and sequential proximity is likely to impart the necessary flexibility on 





Figure 6.24: A native gel comparing the activity of wild-type PrkA-KD with Gly18 deletion 
mutant.  
For each PrkA-KD variant lane 1 was the kinase on its own, lane 2 was the kinase plus ReoM 
and lane 3 was the kinase plus ReoM, ATP and MgCl2.  
 Analysis of the interaction between PrkA-KD mutants and ReoM by isothermal 
titration calorimetry 
ITC was used to assess the binding of all PrkA-KD variants to ReoM (Figure 6.25 and Figure 
6.26). Mutating Ser173 had the most visible hinderance on binding to and phosphorylating 
ReoM, as observed by native-PAGE. When the interaction of PrkA-KDSer173Ala with ReoM was 
probed with the same conditions used for WT, there was no observable binding (Figure 6.25 
B). The same result was observed for PrkA-KDSer173Asp (Figure 6.25 C). The concentration of 
ReoM in the cell was reduced to 25 µM and the concentration of PrkA-KDSer173Ala increased to 
650 µM in effort to detect lower affinity binding. A Kd of 2.2 ± 0.3 µM was observed, 10-fold 
lower affinity than WT but the heat change was so low that it cannot be considered a reliable 
result (Figure 6.27). The binding enthalpy also was more unfavourable than wild-type, with a 
value of -3.4 kcal/mol whereas the entropy factor was lower at -4.2 kcal/mol and together 
these values suggest that in this interaction there are fewer conformational changes and the 




Figure 6.25: Interaction of PrkA-KD WT and mutants to ReoM analysed by ITC. 
The ITC raw heats for 20 injections of PrkA-KD at 400 µM into 100 µM ReoM in the cell. A= 
WT, PrkA-KD, B= PrkA-KDSer173Ala, C= PrkA-KDSer173Asp, D= PrkA-KDSer169Ala, E= PrkA-KDSer167Ala, F= 
PrkA-KDThr165Ala, G= PrkA-KDSer163Ala, H= PrkA-KDThr162Ala, I= PrkA-KDSer160Ala and J= PrkA-KD△
Gly18. The Kd determined for each of the variants is shown. 
The rest of the activation loop Ser/Thr mutants were subjected to ITC runs under the same 
conditions as WT PrkA-KD (Figure 6.25 and Figure 6.26). A summary of the binding affinities 
and thermodynamic parameters determined can be found in Table 6.2. Each of the mutants 
had a reduction in affinity for ReoM compared to wild-type PrkA-KD, between 2- and 5-fold in 
all cases. The phosphorylated residues in the activation loop could be important in binding 
kinase substrates, such as ReoM, by participating in electrostatic interactions with the partner 
protein. Inhibiting the phosphorylation of these individual PrkA-KD residues could reduce the 
hydrogen bonding capacity of PrkA-KD for ReoM, thus reducing the affinity. Apart from PrkA-
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KDSer173Ala/Asp, the only other mutant unable to phosphorylate ReoM (determined by native-
PAGE) was PrkA-KDThr165Ala, and this had the second lowest affinity of the activation loop 
residue mutants for ReoM. A reduction of affinity of over 5-fold was observed compared to 
wild-type (Figure 6.25 F), suggesting that Thr165 may have a more specific role in the 
phosphorylation of substrates. This is supported by the observation from native-PAGE that 
PrkA-KDThr165Ala is unable to phosphorylate ReoM and this residue is highly conserved in the 
multiple sequence alignment generated in Figure 6.21 B. 
 
Figure 6.26: Affinity of PrkA-KD WT and mutants binding to ReoM determined by ITC.  
The integrated heats of binding of PrkA-KD WT and mutants vs ReoM overlaid. Where binding 
was observed the data were fit to a single set of sites binding model (solid line) to determine 
binding parameters that can be found in Table 6.2.  
PrkA-KD△Gly18 had the most impact on the affinity of the kinase for ReoM, other than mutating 
Ser173. A Kd of 1.7 ± 0.2 µM was measured which is an 8-fold decease in affinity compared to 
wild-type (Figure 6.25 J). The binding enthalpy was more unfavourable than wild-type with a 
value of -8.9 ± 0.3 kcal/mol and the entropy factor was more favourable at 1.2 kcal/mol. This 
could suggest that not as many conformational changes were involved in this interaction and 




Figure 6.27: Interaction of PrkA-KDSer173Ala with ReoM analysed by ITC. 
ITC raw heat plots and integrated binding heats for 20 injections of PrkA-KDSer173Ala at 650µM 
into 25 µM ReoM in the cell. Integrated binding heats (black dots) were fit to a single set of 
sites model (black line) to determine N, Kd, DH, DG and -TDS. 
All of the PrkA-KD mutants were analysed by circular dichroism. The data confirmed all 
mutants were correctly folded and had a comparable CD spectrum to wild-type that is 
consistent with a mixed α/β fold of structure expected of eSTPKs (Zheng et al., 2018b) (Figure 
6.28). As the overall secondary structure of the mutants was globally the same, it could be 
said that difference in binding to and phosphorylating ReoM was not due to the incorrect 
folding of the mutant and more likely it was more subtle structural changes behind the 




Figure 6.28: Circular Dichroism spectra of PrkA-KD WT and mutants.  
Circular dichroism spectra of PrkA-KD variants were analysed using BeStsel (Micsonai et al., 
2018); CD spectra were converted from millidegrees to delta epsilon. Shown here is the 
experimental data and the key indicates which data set is represented. Single mutations did 
not have a significant impact on the structure of PrkA-KD; all PrkA-KD mutants had a 
comparable CD spectrum to wild-type which is also consistent with the expected mixed α/β 
fold structure of eSTPks (Zheng et al., 2018b). 
 Mass spectrometry to assess the phosphorylation state of PrkA-KD mutants 
The impact of the mutations on the ability of PrkA-KD to autophosphorylate was explored by 
LC-MS. Intact LC-MS was performed to analyse how the mutation impacted the number of 
species present. Wild-type PrkA-KD spectra showed 5 major peaks (Figure 6.29) with each 
peak separated by 79-81 amu, typical of a phosphorylation profile as a phosphoryl group has 
a molecular mass of 80 Da. The 5 peaks corresponded to the expected mass of PrkA-KD 
(37414.91 Da) plus 4-8 phosphoryl groups. There was no observable peak for 
unphosphorylated PrkA-KD. The multiple phosphorylation states of PrkA-KD gives an 
explanation as to why multiple bands were observed by native-PAGE, the two main bands 




Figure 6.29: LC-MS analysis of WT PrkA-KD. 
The peaks have amu values labelled and each peak in the central zone of the spectrum has an 
encircled number representing the number of phosphoryl groups for that species.  
PrkA-KDSer173Ala showed four major peaks, again representative of a phosphorylation profile 
(Figure 6.30). The smallest major peak on the spectrum represented PrkA-KDSer173Ala without 
any phosphoryl groups with a molecular mass of 37399.9 Da. The largest major peak has a 
molecular mass of 37639.6 Da, an increase of 239.7 Da consistent with a phosphorylation 
profile of 0-3 phosphoryls. Abolishing phosphorylation of Ser173 severely hindered the ability 
of PrkA to autophosphorylate and the phosphorylation profile observed for PrkA-KDSer173Ala 
could in fact lie outside of the activation loop. PrkA-KDSer169Ala had six major peaks, each again 
separated by 79-80 amu, with a phosphorylation profile almost identical to wild-type (Figure 
6.31). This demonstrates unequivocally that Ser173 and not Ser169 is important for the 




Figure 6.30: LC-MS analysis of PrkA-KDSer173Ala. 
The peaks have amu values labelled and each peak in the central zone of the spectrum has an 
encircled number representing the number of phosphoryl groups for that species. 
 
Figure 6.31: LC-MS analysis of PrkA-KDSer169Ala.  
The peaks have amu values labelled and each peak in the central zone of the spectrum has an 
encircled number representing the number of phosphoryl groups for that species.  
Finally, lambda phosphatase treated PrkA-KD displayed one peak at 37416.1 Da, which 
indicates completely unphosphorylated protein, supporting the conclusion that the multiple 




Figure 6.32: LC-MS analysis of PrkA-KD treated with lamda phosphatase. 
The peaks have amu values labelled and the single large peak in the middle represents PrkA-
KD without any phosphoryl groups attached.  
6.7 PrpC dephosphorylates both P-ReoM and PrkA-KD 
Some passages in this section have been quoted verbatim from Wamp et al. (2020) in which I 
am the second author. Any passages used are my own work. 
 Native-PAGE analysis of the dephosphorylation reactions of PrkA-KD and P-ReoM by 
PrpC 
The ability of PrpC, the partner phosphatase to PrkA in L. monocytogenes, to interact with and 
remove phosphoryl groups from PrkA-KD and P-ReoM was also tested in vitro. PrkA and 
purified P-ReoM were each incubated with PrpC in the absence and presence of MnCl2, since 
divalent cations are essential co-factors for the PPM phosphatase family to which PrpC 
belongs (Kennelly, 2001), and the products were analysed by native-PAGE. Unlike with ReoM 
and PrkA-KD, no stable protein:protein complexes were formed either in the presence or 
absence of endogenous MnCl2 (Figure 6.33). The incubation of P-ReoM with PrpC and 
manganese resulted in the almost complete disappearance of the band corresponding to P-
ReoM (lane 6, Figure 6.33) in comparison to the same reaction conducted without the addition 
of MnCl2 (lane 5, Figure 6.33). The new band, corresponding to ReoM alone in lane 6, is 
masked by that for PrpC which migrates similarly to ReoM (lanes 1 and 4, Figure 6.33) under 
these electrophoresis conditions. When incubated with PrpC in the presence of manganese 
ions, the band for PrkA-KD electrophoresed more slowly than for PrkA-KD in isolation (lanes 3 
and 8, Figure 6.33), indicating that PrkA-KD had been dephosphorylated by PrpC and 




Figure 6.33: Native-PAGE analysis of PrkA-KD and P-ReoM dephosphorylation by PrpC. 
Components of each lane are annotated above the image and the position and identity of 
relevant bands are marked to the side. 
 Isolation of dephosphorylated PrkA-KD 
To determine the phosphorylation state and activity of PrkA-KD after the incubation with 
PrpC, it was isolated from the mixture by immobilised metal affinity chromatography. PrpC 
was purposely left with the His6-tag on after purification so that after the incubation with 
PrkA-KD and MnCl2 the two proteins could be separated by passing the mix over an Ni-NTA 
column. As PrkA-KD did not have a His6-tag it was collected in the flow through and PrpC 
bound to the column and was eluted with imidazole. Figure 6.34 is a native-PAGE gel with the 
results of the purification of dephosphorylated PrkA-KD and its activity. Lane 3 shows the 
dephosphorylation reaction and lane 4 shows the flow through (FT) from the Ni-NTA column. 
The band for PrkA-KD has shifted upwards indicating the loss of negative charge by the 
removal of phosphoryl groups. Lane 5 is the elution of PrpC, which runs the same as before 
the reaction. Lanes 6 and 7 show that dephosphorylated PrkA-KD is no longer able to bind to 
and phosphorylate ReoM under the reaction conditions used. There is no complex band for 
the incubation of dephosphorylated PrkA-KD (FT) with ReoM in Lane 6 and the band for ReoM 
in lane 7 does not run as P-ReoM does in lane 8. PrpC is therefore capable of completely 




Figure 6.34: Native-PAGE analysis of PrkA-KD activity. 
Components of each lane are annotated above the image and the position and identity of 
relevant bands are marked to the side. PrkA-KD was incubated with His6-PrpC and MnCl2 and 
passed over a Ni-NTA column. FT is the flow through from the Ni-NTA column and E is the 
elution from the column with 250 mM imidazole.  
 Mass spectrometry of P-ReoM and PrkA-KD after incubation with PrpC 
The presence of unphosphorylated ReoM and the absence of P-ReoM after incubation with 
PrpC was confirmed by LC-MS (Figure 6.35). There was a single peak at 10670.53 Da which is 
only a single Dalton different from the estimated unphosphorylated mass of 10671.5 Da. LC-
MS analysis of PrkA-KD that had been incubated with PrpC/MnCl2 yielded a single major 
species of 37,413.2 Da, consistent with the predicted mass of the expressed recombinant 
construct, and the absence of a peak corresponding to phosphorylated PrkA-KD, P-PrkA-KD 
(Figure 6.36). PrkA-KD is therefore capable of autophosphorylation when recombinantly 
expressed, a phenomenon that has been observed previously with the related eSTPKs, B. 
subtilis PrkC and E. faecalis IreK (Madec et al., 2003; Kristich et al., 2011). Autophosphorylation 
of PrkC and IreK is important for kinase activity which has been demonstrated through the 
phosphorylation of an exogenous substrate, MBP (myelin basic protein), a routinely used 
substrate of eSTPKs (Madec et al., 2003; Kristich et al., 2011). PrkC activity is important for 
biofilm formation and sporulation (Madec et al., 2002) and IreK along with its partner 
phosphatase IreP act in a signal transduction event to regulate the adaption E. faecalis to 




Figure 6.35: LC-MS analysis of ReoM after incubation with PrpC.  
Panel A is the ESI-QTOF raw data and B is the deconvoluted mass spectrum demonstrating the 




Figure 6.36: LC-MS analysis of PrkA-KD after incubation with PrpC.  
Panel A is the ESI-QTOF raw data and B is the deconvoluted mass spectrum demonstrating the 
presence of non-phosphorylated PrkA-KD. 
6.8 Small angle X-ray scattering of ReoM, PrkA-KD and PrkA-KD:ReoM complex 
SAXS data of ReoM, PrkA-KD and the PrkA-KD complex were collected and processed by Dr 
Owen Davies (Newcastle University). The SAXS molecular masses were estimated at 28 kDa 
for ReoM, 38 kDa for PrkA-KD and 77 kDa for the complex, in agreement with those 
determined by SEC-MALS (25 kDa, 36 kDa and 82 kDa). Dummy atom models (DAM) were 
generated with DAMMIF and the crystal structure of a ReoM dimer and a Phyre2 model (Kelley 
et al., 2015) of PrkA-KD were manually docked into the mesh of the DAM models. The average 
chi-squared values for the agreement of the SAXS data to the rapid ab initio bead models were 
1.28 (ReoM), 1.34 (PrkA-KD) and 1.22 (PrkA-KD:ReoM). The DAM models of ReoM and PrkA-
KD were globular with apparent flexible tails (Figure 6.37). The explanation for this with 
regards to ReoM is likely the presence of the ~16 residue N-terminal flexible tail observed in 
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the crystal structure but the elongated region of the PrkA-KD DAM model was unexpected 
from the structures of the isolated proteins/homologs. The structures of 2 ReoM dimers and 
one PrkA-KD monomer were manually modelled into the DAM model of the PrkA-KD:ReoM 
complex based on the stoichiometry determined from ITC, native-PAGE and SEC-MALS. The 
site/sites at which PrkA-KD interacts with ReoM are unknown but one theory could be that 
the flexible N-terminal regions of two separate ReoM dimers bind near the activation loop of 
PrkA-KD. 
 
Figure 6.37: SAXS analysis of ReoM, PrkA-KD and PrkA-KD:ReoM.  
SAXS-derived ab-initio dummy atom models (DAM) of ReoM (A), PrkA (B) and PrkA-KD:ReoM 
(C) calculated with DAMMIF from small-angle X-ray scattering profiles. The DAM models are 
shown in mesh and a top and side profile is displayed. The cartoon structure of ReoM (cyan) 
and Phyre2 model of PrkA-KD (magenta) (Kelley et al., 2015) have been manually docked into 
the mesh.  
6.9 The importance of ReoM in vivo 
This study was a collaboration with the Halbedel lab who performed a number of in vivo 
experiments alongside the in vitro work presented here. Described below are a number of key 
experiments reported in Wamp et al. (2020).  
The sole deletion of reoM did not cause a growth or divisional defect in L. monocytogenes, the 
cells grew at a comparable rate to wild-type and observation by scanning electron microscopy 
revealed the cells had a normal rod-shape. ∆reoM did however, affect the stability of MurA 
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and the deletion caused an accumulation of MurA by at least 8-fold compared to WT. The role 
of MurA is to transfer an enoylpyruvate moiety to UDP-GlcNAc in the first committed step of 
peptidoglycan synthesis (Brown et al., 1995). It had been shown previously that MurA 
accumulated in a ∆clpC mutant strain, a heat stress protease responsible for the degradation 
of MurA (Rismondo et al., 2017). The MurA levels were the same in a double ∆reoM ∆clpC 
mutant compared to a single ∆reoM mutant demonstrating that ReoM exerts its effect on 
MurA levels in a ClpC dependent manner. The degradation of MurA was analysed over time 
in cells with blocked protein synthesis induced by the treatment with chloramphenicol. No 
MurA degradation was observed in mutants lacking reoM or clpC, compared to wild-type, 
showing that the two proteins are just as important for MurA degradation. The MurA 
accumulation caused by a reoM deletion stimulated peptidoglycan biosynthesis as there were 
thicker PG layers at the cell poles of ∆reoM and cells had an increased resistance to ceftriaxone 
(a cephalosporin antibiotic). 
The importance of the phosphorylation of Thr7 on ReoM was explored using a Thr7Ala 
mutant. In a ∆reoM mutant, cells did not grow with reoM Thr7Ala under an IPTG inducible 
promoter, in the presence of IPTG and only a small amount of wild-type MurA levels could be 
detected in cells expressing reoM Thr7Ala. ReoMThr7Ala was completely incapable of being 
phosphorylated by PrkA-KD in vitro (Section 6.5.3), although the two proteins were still 
capable of interacting with a nanomolar affinity (Section 6.5.2). Together, this showed that 
the phosphorylation of ReoM is essential for the viability of L. monocytogenes. The inducible 
reoM Thr7Ala did grow, even with IPTG, when clpC was deleted suggesting that the 
phosphorylation of ReoM inhibits the ClpCP dependent degradation of MurA. There was an 
accumulation of MurA levels in a prpC depletion strain and no MurA could be detected in cells 
depleted of prkA, which supports the conclusion that phosphorylated ReoM caused an 
accumulation of MurA. 
6.10 Summary 
This chapter explored the relationship between the protein kinase/phosphatase pair 
PrkA/PrpC and a small phosphoprotein named ReoM (Regulator of MurA degradation) in L. 
monocytogenes in the context of cell signalling and the link to peptidoglycan synthesis. eSTPKs 
are important for the regulation of many cellular processes in Gram-positive bacteria (Madec 
et al., 2002) and the respective kinase from L. monocytogenes, PrkA, is essential (Wamp et al., 
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2020). ReoM has been identified as a substrate of PrkA-KD, the two proteins bound with 
nanomolar affinity and did not associate after phosphorylation of the former by the latter. 
The results from ITC, Native-PAGE and SEC-MALS were consistent with a 1:4 binding ratio of 
PrkA-KD:ReoM, however, the exact binding sites for ReoM on PrkA-KD are yet to be identified. 
ReoM is phosphorylated by PrkA-KD on a single site at Thr7 that is present in a flexible N-
terminal region. The phosphorylation of Thr7 is essential for the viability of L. monocytogenes 
and this phosphorylation inhibits the ClpCP dependent degradation of MurA (Wamp et al., 
2020).  
It was shown by mass spectrometry that PrkA-KD has multiple phosphorylation sites and by 
native-PAGE that the phosphorylation of Ser173 is essential for the activity of the kinase. 
When Ser173 was mutated, PrkA-KD was rendered inactive and it could not bind with optimal 
affinity to ReoM and was unable to phosphorylate it. The requirement of an activating Ser/Thr 
residue for kinase activity has also been identified in eSTPKs from range of Gram-positive 
species (Shakir et al., 2010; Ravala et al., 2015; Zheng et al., 2018b). The kinase activation 
model proposed by Zheng et al., as applied to PrkA, would suggest that PrkA-KD is in an 
inactive conformation when Ser173 is not phosphorylated, and the activation loop mimics a 
substrate thus preventing binding of either PrkA molecules or ReoM. The binding of ATP and 
cis autophosphorylation of Ser173 induces a conformational change in PrkA and the activation 
loop moves out of the substrate binding site into an active conformation (Figure 6.38). An 
activated kinase molecule can then interact with another and trans autophosphorylation of 
the other activation loop Ser/Thr residues can occur (Zheng et al., 2018b). 
The phosphorylation of PrkA-KD and ReoM can be reversed by the partner phosphatase PrpC. 
After an incubation with PrpC to remove phosphoryl groups, PrkA-KD was unable to bind to 
and phosphorylate ReoM and this inability to function as a kinase is supported by mutational 




Figure 6.38: Model of PrkA-KD activation. 
A prediction of the kinase domain structure of PrkA generated in Phyre2 (Kelley et al., 2015) 
modelled into an inactive and active conformation. The Phyre2 model was highly based on the 
structure of PknB from S. aureus (PDBID: 4EQM). The structure is represented in cartoon form 
with the N-lobe coloured magenta, C-lobe is green and the activation loop is cyan. Ser/Thr 
residues in the activation loop are shown in stick form and are labelled. The binding of ATP to 
the ATP binding loop (Gly18, shown in stick form) induces cis phosphorylation of Ser173 and 
a conformational change of the activation loop occurs.  
The structure of ReoM was used to propose a model of the conformational changes that might 
take place upon phosphorylation of Thr7. After phosphorylation a substantial movement of 
Thr7 is proposed such that it then interacts with a positively-charged surface on helix 3, which 
comprises 4 arginine residues at positions 57, 62, 66 and 70. These residues are highly 
conserved amongst all 2909 ReoM homologues in the NCBI sequence database at 57 %, 99 %, 
76 % and 98 % conserved, respectively. This approaching the level of conservation observed 
for the phosphorylation site (96 %). In order to assess the likely relevance of this model, the 
wild-type reoM allele was replaced by alanine substitutions at each of these positions and the 
viability of each corresponding L. monocytogenes strain assessed. Mutant strains harbouring 
ReoM substitutions Arg66Ala or Arg70Ala grew as wild-type and there was no discernible 
gross phenotypic change (Wamp et al., 2020). By contrast, L. monocytogenes strains carrying 
ReoM Arg57Ala and Arg62Ala mutations were unviable, a lethality reminiscent of the 
expression of ReoM Thr7Ala (Wamp et al., 2020). Thus, Arg57 and Arg62 are certainly 
important for ReoM structure/function; the possibility of their mutation Ala causing 
substantial disruption of the tertiary structure of ReoM is unlikely since they are both surface-
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exposed and make little intramolecular interactions. Therefore, the impact on viability is more 
likely to stem from an impact on ReoM function, perhaps because the co-ordination of P-Thr7 
is lost, and therefore the conformation and the position of the flexible N-terminal region is 
disrupted (Figure 6.39). Confirmation of the molecular consequences of ReoM 
phosphorylation, however, remains to be determined. 
 
Figure 6.39: A model of the predicted conformational change induced by the 
phosphorylation of ReoM.  
The grey cartoon represents the original positioning of the N-terminus of chain A in the crystal 
structure of ReoM. The N-terminus of chain A coloured in cyan represents where it could be 
positioned after a conformational change following phosphorylation of Thr7. The yellow 
dashed lines show the potential hydrogen bonds formed between P-Thr7 and Arg57/Arg62.  
In addition to ReoM, a second novel factor named ReoY, has been identified for the ClpCP-
dependent degradation of MurA (Wamp et al., 2020). Like reoM, reoY had no divisional defects 
when singly deleted and an accumulation of MurA was observed in a ∆reoY mutant (Wamp et 
al., 2020). It has also been shown previously that the deletion of murZ contributed to the 
accumulation of MurA (Rismondo et al., 2017). The separate deletions of clpC, reoY and murZ 
overcame the lethality of the inducible reoM Thr7Ala mutant which suggested that ClpCP, 
ReoY and MurZ all act down stream of ReoM (Wamp et al., 2020).  BACTH experiments showed 
that ReoM interacted with MurA, and ReoY interacted with ClpC, ClpP and ReoM, which 
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implies ReoM and ReoY are the connecting factors between MurA and ClpCP (Wamp et al., 
2020). Together these results have led to the suggestion that ReoM plays a key role in the 
phosphorylation signalling mechanism linking cell wall integrity sensing, by the PASTA 
domains of PrkA, to the control of peptidoglycan synthesis by MurA and this model is 
summarised in Figure 6.40. 
 
Figure 6.40: A model illustrating the role of ReoM as a substrate of PrkA and a regulator of 
ClpCP. 
The diagram shows how PrkA is activated by autophosphorylation after detecting an external 
muropeptide signal via its PASTA domains (inactive PrkA in red and activated PrkA in green). 
Active PrkA then phosphorylates ReoM. The phosphorylation of ReoM and PrkA is reversed 
by PrpC. Unphosphorylated ReoM along with ReoY and MurZ activate MurA degradation by 
ClpCP. MurA catalyses the first step of peptidoglycan synthesis. The phosphorylation of ReoM 
by PrkA prevents the ClpCP-dependent degradation of MurA so that MurA can accumulate 




Data Statistics*  Refinement Statistics*  
Beamline Diamond I03 Rwork  0.153 
Date 
 
20/05/18 Rfree 0.214 
Wavelength (Å)  0.976 No. of non-H atoms  


















R.m.s. deviation from ideal 
values 
 
Bond angle (°) 







Rpim 0.064 (0.533)   
Solvent content (%) 38 Average B factor (Å2) 
 
 
No. of measured 
reflections 






No. of independent 
reflections 
23059 (1129)   
Completeness (%) 99.8 (99.8)   
Redundancy 4.8 (4.9)   
CC1/2 (%) 98.6 (62.0)   
<I>/<σ(I)> 8.2 (2.2)   
*Values in parenthesis are for the highest resolution shell 
Table 6.1: Data statistics and refinement details of the ReoM structure 
 
Mutant  Kd N ∆H ∆G -T∆S 
WT 187 ± 41.0 nM 0.26 ± 0.003 -13.1 ± 0.251 -9.03 4.09 
Ser173Ala 2.2 ± 0.3 µM 0.28 ± 0.004 -3.4 ± 0.01 -7.61 -4.2 
Ser173Asp /     
Ser169Ala 909 ± 180 nM 0.30 ± 0.005 -16.6 ± 0.50 -8.11 8.46 
Thr167Ala 647 ± 94.0 nM 0.37 ± 0.004 -13.8 ± 0.27 -8.31 5.48 
Thr165Ala 1.05 ± 0.20 µM 0.29 ± 0.005 -16.1 ± 0.48 -8.02 8.03 
Ser163Ala 557 ± 110 nM 0.33 ± 0.004 -12.7 ± 0.31 -8.39 4.29 
Thr162Ala 879 ± 150 nM 0.29 ± 0.004 -16.3 ± 0.43 -8.12 8.2 
Ser160Ala 437 ± 110 nM 0.25 ± 0.004 -14.3 ± 0.41 -8.49 5.83 
△Gly18 1.67 ± 0.220 µM 0.62 ± 0.01 -8.91 ± 0.38 - 7.75 1.16 
Table 6.2: A summary of the binding affinities and thermodynamic parameters determined 
for the interaction of PrkA-KD mutants with ReoM, analysed by ITC.  
Results are from the injection of 400 μM PrkA-KD into 100 μM ReoM except for Ser173Ala 
(highlighted blue) which was from 650 μM PrkA-KD into 25 μM ReoM. 
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Bacterial cell division is a complex process that requires the coordination of DNA replication, 
chromosome segregation, membrane fission and cell wall remodelling. Protein interactions, 
signalling mechanisms and the formation of protein complexes involved in these cellular 
processes ensure their tight regulation. The molecular, genetic, biochemical and biophysical 
characterisation of proteins involved in bacterial cell division will help understand this 
fundamental biological process and aid in the design of novel antibiotics required due to the 
increasing and wide-spread resistance to existing drugs. In this thesis, the functions of two 
important proteins in the division of Gram-positive bacteria, GpsB and ReoM, were explored. 
A summary of the key findings from this thesis and how these results have aided in the 
characterisation of Gram-positive cell division are discussed below. 
7.2 Extension of the GpsB interactome  
In Chapter 3, the specific molecular interactions were identified between the N-terminal 
domain of GpsB and the cytoplasmic mini-domains of PBPs from two human pathogens L. 
monocytogenes and S. pneumoniae, to add to the known information of the interaction 
between GpsB and PBP1 in the Gram-positive division model organism, B. subtilis. Prior to this 
study, the N-terminal domain of GpsB had been shown by BACTH to interact with the major 
bi-functional class A PBP from L. monocytogenes (LmPBPA1), and it was implicated that GpsB 
acted as a negative regulator of this peptidoglycan synthase (Rismondo et al., 2016). In S. 
pneumoniae, GpsB and the class A PBP, PBP2a were pulled down by co-IP (Rued et al., 2017), 
however, no previous interaction had been determined between GpsB and the class B PBP, 
PBP2x and this work represents the first demonstration of a specific interaction between 
these proteins. 
The crystal structures of GpsB in complex with the cytoplasmic mini-domains of LmPBPA1, 
SpPBP2a and SpPBP2x, along with the previously solved BsGpsB5-64:BsPBP11-17 structure, 
revealed the positively charged PBPs bound to a negatively charged groove between helix 1 
and helix 2 of a GpsB monomer (Figure 7.1). A conserved feature of the GpsB:PBP interaction 
was discovered in the form of a single arginine that poked into the negatively charged groove 
of GpsB and was in the same orientation in each species, forming a similar set of interactions. 
This central arginine was required to be in an alpha helical conformation or in a beta-turn, 
which demonstrated that the binding of PBP peptides to GpsB is favoured by secondary 
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structural elements. The binding of BsPBP11-17 and SpPBP2a27-40 involved a second arginine 
residue Arg11 and Arg36, respectively, that made important contacts to GpsB. No such feature 
was seen in the structures of BsGpsB5-64Lys32Glu:LmPBPA11-15 and SpGpsB4-63:SpPBP2x13-28. FP 
analysis suggested that Arg12 of LmPBPA1 could fulfil the role of the second arginine residue, 
but this could not be confirmed by structural information due to the lack of ordered peptide 
in the crystal structure. FP studies suggested that the interaction between SpGpsB and 
SpPBP2x was more transient than the interactions with the class A PBPs, which may explain 
why the binding of this PBP is centred only on a single arginine residue. Two modes of binding 
were observed with SpPBP2a, either Arg31 or Arg33 could act as the central arginine residue 
and when one form of binding was inhibited, either by crystal contacts or by mutation, the 
peptide could compensate by binding in the other form.  
The importance of the identified PBP binding residues in GpsB were supported by a number 
of in vivo experiments. For instance, growth defects in L. monocytogenes and a lethal 
phenotype in S. pneumoniae were observed with mutations in the conserved GpsB aspartic 
acid pair and tyrosine residue required for PBP binding (Tyr27/Asp33/Asp37 in L. 
monocytogenes and Tyr23/Asp29/Asp33 in S. pneumoniae) (Cleverley et al., 2019). These 
phenotypes were similar to gpsB deletions, showing that these residues are essential for one 
of the main biological functions of GpsB (Rismondo et al., 2016; Rued et al., 2017). It was 
further shown in L. monocytogenes that the N-terminal domain of GpsB is required for the 
binding of both PBPA1 and MreC but that slightly different surfaces/residues are involved 
(Cleverley et al., 2019). The depletion of gpsB in S. pneumoniae and a gpsB deletion in L. 
monocytogenes led to a more severe phenotype than the mutation of the cytoplasmic mini-
domain of Sppbp2a or deletion of LmpbpA1, suggesting that the co-ordination of PBPs is not 
the sole function of GpsB and there are other GpsB-dependent interactions that cause the 




Figure 7.1: Comparison of the binding sites of all solved GpsB:PBP complexes.  
Panel A shows the binding site of BsGpsB5-64:BsPBP11-17, Panel B shows the binding site of 
BsGpsBLys32Glu5-64:LmPBPA11-15, Panels C and D are binding site 1 and 2 of SpGpsB4-
63:SpPBP2a27-40, respectively and Panels E and F are binding site 1 and 2 of SpGpsB4-
63:SpPBP2x13-28, respectively. Residues important in binding are shown as sticks coloured by 
atom. Salt bridges and hydrogen bonds are represented by dashed black lines, van der Waals’ 
interactions by dashed yellow lines and intra-molecular interactions by a dashed red line.  In 
each panel apart from Panel F (were the identity of the arginine could not be determined), a 
section of the binding sequence from the respective PBP is shown with the main coordinated 
arginine or arginine pairs coloured green.  
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Since a number of GpsB interacting partners with various division functions have been 
identified across Gram-positive bacteria, it is not surprising that the phenotype of a gpsB 
mutant is not solely caused by the loss of a single PBP binding partner. Current knowledge of 
the GpsB interactome shows conserved interactions across a range of Gram-positive bacteria 
with peptidoglycan synthases (Claessen et al., 2008; Rismondo et al., 2016; Cleverley et al., 
2016; Rued et al., 2017; Cleverley et al., 2019), the elongation factor MreC (Claessen et al., 
2008; Rued et al., 2017; Cleverley et al., 2019) and the FtsZ regulator EzrA (Claessen et al., 
2008; Steele et al., 2011; Fleurie et al., 2014a; Pompeo et al., 2015; Rued et al., 2017). An 
interaction between GpsB and the late division proteins DivIB and DivIC as well as the FtsZ 
tethering protein SepF have been identified in L. monocytogenes (Cleverley et al., 2019) but 
not B. subtilis (Claessen et al., 2008) and S. aureus is the only species were a direct interaction 
between FtsZ and GpsB has been shown thus far (Eswara et al., 2018). The hexameric structure 
of GpsB enables the binding of multiple interacting partners, whether that be clustering 
multiple PBP molecules to a specific area for peptidoglycan synthesis or the bringing together 
of different divisome components. GpsB has been shown to coordinate peptidoglycan 
synthesis during elongation, vegetative division and asymmetric division during sporulation, 
at least in B. subtilis (Claessen et al., 2008; Cleverley et al., 2019; Muchová et al., 2020). L. 
monocytogenes does not sporulate and GpsB is conserved in spherical bacteria that do not 
elongate, although they do need to remodel the peripheral cell wall during division (Rued et 
al., 2017). All told, these observations suggest that GpsB has varying functions across Gram-
positive bacteria.  
The conserved PBP1 motif in Bacillaceae (S/T/N)RxxR(R/K) has been used to identify the novel 
BsGpsB binding partners BsYrrS and BsYpbE that are predicted to be peptidoglycan 
remodelling proteins and an interaction network with the additional proteins BsYrrR, BsRodZ 
and BsPBP1 has been proposed (Cleverley et al., 2019). BsYrrS is in a bicistronic operon with 
BsYrrR (Wei et al., 2004) and the latter gene encodes PBP4b, a class B PBP the expression of 
which is regulated by sporulation sigma factors E (Wei et al., 2004) and F (Steil et al., 2005), 
which further supports a role for GpsB in sporulation. An extension of this approach could be 
used to identify the novel GpsB interacting proteins in Streptococcaceae, however, this may 
prove challenging: the RSxxxR motif identified in most streptococci class A PBPs is present in 
SpPBP2a with the first arginine of the motif corresponding to Arg31. Multiple binding modes 
were observed for SpPBP2a, binding with the exact contacts to GpsB varying between arginine 
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residues. Multiple binding modes, the requirement of local sequence structure as well as the 
requirement of the motif to be close to the membrane are some reasons why sequence-based 
searches alone are not sufficient to complete the GpsB interaction network.  
Future work on this area of research should involve characterising the GpsB interactome 
across various Gram-positive species, through different stages of the cell-cycle and during the 
stress response to different factors such as temperature or being challenged with antibiotics, 
where GpsB has an important function in L. monocytogenes (Rismondo et al., 2016). Solving 
the structures of GpsB in complex with other binding partners will identify the exact binding 
surfaces and show the molecular basis of the interactions. The structures of multi-protein 
complexes will provide information on how they assemble and what proteins are able to bind 
to GpsB simultaneously, and these molecular studies need to be complemented with 
functional assays so that the effect of GpsB interaction on the new proteins can be quantified. 
Identifying new PBP interacting partners would also extend the current knowledge of the 
GpsB:PBP interactome and it would be invaluable in determining if any other PBPs are capable 
of binding in multiple binding modes like SpPBP2a. To investigate the conserved and apparent 
species-specific roles of GpsB across Gram-positive bacteria, complementation experiments 
could be performed. ∆gpsB mutants in different species could be complemented with various 
gpsB homologues and the impact on localisation, co-localisation and interacting partners 
tested.  
7.3 Functional divergence between GpsB and DivIVA  
GpsB and DivIVA have slightly different roles in overlapping areas in cell division of Gram-
positive bacteria. In Chapter 4, the importance of the high structural homology between the 
N-terminal domains of BsGpsB and BsDivIVA with relation to protein function was analysed. 
The N-terminal domains of BsGpsB and BsDivIVA were closely compared and specific features 
were identified to suggest why BsGpsB can bind to BsPBP1 but BsDivIVA cannot. BsDivIVA is 
incapable of binding to BsPBP1 because the BsPBP1 binding site in BsGpsB between helix 1 
and 2 is blocked by a loop between the equivalent two helices in BsDivIVA. BsPBP1 binding 
capability was successfully introduced into BsDivIVA by protein engineering in the form of 6-
residue mutant (BsDivIVA1-62Asn6LysAsn10GluThr12GluAsn26AspAla30AspArg33Ile) that incorporated 
conserved PBP binding residues of GpsB and opened up the blocked binding site in BsDivIVA.  
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Conservation analysis of the N-terminal domains of GpsB and DivIVA revealed a higher level 
of conservation in GpsB than DivIVA at the identified PBP binding surface. In both proteins, 
the level of conservation at helix 1 and the adjacent region of helix 2 was higher than at the 
C-terminus suggesting that this is the region in both proteins that makes contacts with 
interacting partners. Different residues at slightly different positions with varying 
conservation levels might suggest why GpsB and DivIVA do not have the same N-terminal 
interacting partners.  
It is likely that GpsB arose from an initial gene duplication of divIVA and since this duplication 
sufficient time has elapsed for the sequences to diverge but not the gross structures of the N-
terminal domains. The shared unique N-terminal fold positions a conserved hydrophobic-
arginine pair important for lipid binding (Halbedel & Lewis, 2019), demonstrating an important 
requirement for the structure in both proteins. The divergence in sequence might suggest why 
the N-terminal domains of each protein have apparent different functions, for example, GpsB 
for binding and coordinating PBPs (Cleverley et al., 2019) and DivIVA for the recruitment of 
the division inhibitor MinCD to the cell poles via MinJ (Bramkamp et al., 2008; van Baarle et 
al., 2013). The C-terminal domains of GpsB and DivIVA appear to have diverged significantly 
in both sequence and structure, thus providing the main differences between the overall 
functions of GpsB and DivIVA. The small C-terminal domain of GpsB appears to only be 
important for oligomerisation (Rismondo et al., 2016), whereas the longer C-terminal domain 
of DivIVA is important for oligomerisation (Oliva et al., 2010), protein binding (Perry & 
Edwards, 2006; Donovan et al., 2012; Ginda et al., 2013; Lenarcic et al., 2009; Schumacher et 
al., 2016) and for acting as a bridge from one N-terminal dimer to another to enable DivIVA to 
sense membrane curvature (Halbedel & Lewis, 2019).  
A recent study demonstrated a relationship between GpsB and the essential sporulation 
protein SpoIIE in the early stages of sporulation in B. subtilis, confirmed by a direct interaction 
between GpsB and SpoIIE by BACTH and pull-down assays (Muchová et al., 2020). It had 
previously been shown that DivIVA and SpoIIE co-immunoprecipitated and that DivIVA 
localised and anchored SpoIIE to the cell poles during sporulation (Bradshaw & Losick, 2015). 
Since SpoIIE is a membrane protein with a cytosolic region and both GpsB and DivIVA interact 
with it, it could be suggested that this interaction mediated their N-terminal domains, serving 
a specific purpose for the maintained structural homology. This theory could be tested by 
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BACTH with specific domains of GpsB/DivIVA and SpoIIE, mutational analysis with in vitro 
interaction studies and by solving the co-crystal structures.  
7.4 The regulation of peptidoglycan synthesis in L. monocytogenes by the phosphoprotein 
ReoM 
In Chapter 6, the relationship between the essential L. monocytogenes protein kinase PrkA 
and its partner phosphatase PrpC with the small phosphoprotein ReoM was explored. The 
Halbedel lab provided a link between ReoM and the regulation of peptidoglycan synthesis 
through the control of MurA levels. ReoM was identified as a substrate of the PrkA/PrpC pair 
and was found to be solely phosphorylated on Thr7 in its flexible N-terminus. ReoM interacted 
with the kinase domain of PrkA (PrkA-KD) with a nanomolar Kd and a 1:4 binding ratio of PrkA-
KD to ReoM was determined by various techniques. In vitro phosphorylation and 
dephosphorylation of ReoM was determined by PrkA-KD and PrpC, respectively, and upon 
phosphorylation, ReoM no longer interacted with PrkA-KD.  
The role of MurA in the cell-cycle is to transfer an enoylpyruvate moiety to UDP-GlcNAc in the 
first committed step of peptidoglycan synthesis (Brown et al., 1995). MurA levels accumulated 
in a reoM mutant and it was shown that this accumulation was dependent on ClpCP (Wamp 
et al., 2020), a heat stress protease responsible for the degradation of MurA (Rismondo et al., 
2017). The phosphorylation of ReoM on Thr7 was shown to be essential for L. monocytogenes. 
With a reoMThr7Ala mutant, phosphorylation by PrkA was abolished meaning ClpCP inactivation 
by P-ReoM was abrogated, thus causing increased degradation of MurA to a level were the 
cells were no longer viable (Wamp et al., 2020).  
PrKA-KD was required to be autophosphorylated to be active and capable of phosphorylating 
ReoM. Autophosphorylation appears to be a characteristic trait of eSTPKs as it is also 
important for the kinase activity of BsPrkC, EfIreK and SaStk1 (Madec et al., 2003; Kristich et 
al., 2011; Zheng et al., 2018b). The requirement of an activating Ser/Thr residue for 
autophosphorylation and kinase activity has been identified in eSTPKs from range of Gram-
positive species (Shakir et al., 2010; Ravala et al., 2015; Zheng et al., 2018b). Ser173 was 
identified as the activating residue required for the autophosphorylation of the activation loop 
of PrkA-KD, the single mutation reduced the phosphorylation profile from 4-8 phosphoryls for 
wild-type to 0-3 for the PrkA-KDSer173Ala mutant. The inability to autophosphorylate due to the 
PrkA-KDSer173Ala mutation, or by complete removal of the phosphoryl groups by PrpC, not only 
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rendered the PrkA-KD inactive but also reduced its binding affinity for ReoM and consequently 
was no longer capable of phosphorylating ReoM. 
The crystal structure of ReoM was solved, revealing a 5-helical bundle that associated into a 
homodimer, consistent with the structure of its homologue IreB (Hall et al., 2017). A model 
was proposed for the conformational change that may occur upon phosphorylation of Thr7 in 
the flexible N-terminal tail. After phosphorylation, the P-Thr7 residue moves to interact with 
surface-exposed Arg57 and Arg62 in helix 3. This model was supported by the high 
conservation of Arg57 and Arg62 and in vivo mutational analysis showed they were critical for 
the function of ReoM (Wamp et al., 2020). The conformational change could impact the ability 
of ReoM to interact with its binding partners, which might explain why ReoM no longer 
interacts with PrkA after phosphorylation. 
Two other proteins that were found to affect the ClpCP-dependent degradation of MurA were 
ReoY and MurZ (Rismondo et al., 2017; Wamp et al., 2020). The separate deletions of clpC, 
reoY and murZ overcame the lethality of the inducible reoMThr7Ala mutant, which suggested 
that ClpCP, ReoY and MurZ all act down stream of ReoM (Wamp et al., 2020). ReoM 
homologues are present across Firmicutes, whereas ReoY homologues are restricted to bacilli. 
YrzL and YpiB are the B. subtilis homologues of ReoM and ReoY, respectively. MurAA levels in 
B. subtilis increased by at least 12-fold in ∆yrzL, ∆ypiB and ∆clpC strains, demonstrating that 
the functions of these proteins are conserved (Wamp et al., 2020). Taking together all of the 
results from in vitro and in vivo experiments, a novel cell division phosphorylation signalling 
mechanism was identified with ReoM playing an important role. Along with ReoY, MurZ and 
ClpCP, ReoM is the link between cell wall integrity sensing by the PASTA domains of PrkA and 
the control of peptidoglycan synthesis by MurA (Figure 6.40).  
There are areas for improvement and future work in various aspects of this chapter. MS/MS 
spectra and peptide analysis of PrkA-KD would confirm the exact activation loop residues that 
are phosphorylated in the active kinase. Peptide analysis of PrkA-KDSer173Ala in comparison to 
wild-type would be useful for identifying phosphorylation sites outside of the activation loop 
and the functional relevance of these sites could be tested. The importance of PrkA Thr165 
requires more exploration as it was the only activation loop Ser/Thr residue, other than 
Ser173, that was required to be phosphorylated for the activity of the kinase. A 
phosphorylation profile of PrkA-KDThr165Ala would show if this mutant had an impact on 
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autophosphorylation resulting in an inactive kinase, or whether phosphorylation of this 
residue is specifically required for substrate phosphorylation. Solving the crystal structure of 
PrkA-KD would provide more information for the function of Thr165 and other activation loop 
residues as their relative position to other functional components of the kinase would be 
determined. The multiple bands of PrkA-KD on native-PAGE should have been excised and 
examined by MS to determine if they were a degradation product or multiple phosphorylation 
states. 
The PrkA:ReoM complex requires more analysis to understand how this complex assembles. 
Ideally a co-crystal structure would be solved to provide the specific molecular basis of the 
interaction, however, this is easier said than done and there were multiple failed attempts to 
obtain this structure. Better quality SAXS data and more extensive analysis using multiphase 
ab initio modelling and modelling of complexes by multidomain proteins would provide more 
reliable information on the assembly of the PrkA:ReoM complex. The first 16 amino acids of 
ReoM that make up the flexible N-terminus could be deleted and the ability of this variant to 
bind to PrkA tested in vitro, to determine if it is solely this region that binds to PrkA or if there 
are other residues of ReoM involved. The ability of PrkA homologues to bind to and 
phosphorylate ReoM, and PrkA to phosphorylate ReoM homologues could be explored to gain 
further knowledge of the conserved features required for this mechanism.  
The molecular consequences of the phosphorylation of ReoM are yet to be determined and 
solving the structure of P-ReoM would ultimately shed light on the proposed conformational 
change theory. The effect of ReoM phosphorylation and how exactly ReoM controls the 
activity of ClpCP at the molecular level is an important question still to be addressed.  
Finally, the phosphorylation levels of ReoM could be measured in vivo at different stages of 
the cell-cycle and in response to various external stimuli using P-Thr antibodies. This could 
indicate at which stages of the cell-cycle ReoM is phosphorylated and inhibiting the 
degradation of MurA by ClpCP. It could also confirm if the phosphorylation of ReoM by PrkA 
changes in response to peptidoglycan fragments. It has been proposed in B. subtilis that PrkC 
is only activated by peptidoglycan fragments during the stationary phase and otherwise PrkC 
dispersed around the cell (Pompeo et al., 2018). Phosphorylation of ReoM by PrkA in response 
to muropeptides could restart peptidoglycan synthesis at this stage of the cell-cycle. Pompeo 
et al. also proposed that GpsB activates PrkC during cell division in the exponential phase of 
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growth. The impact of GpsB on the phosphorylation and activity of both PrkA and ReoM is an 
area for future work to test if this mechanism is maintained across species or if it is specific 
for B. subtilis and what reasons there might be for this.  
7.5 New potential antibiotic targets  
The importance of GpsB, PrkA and ReoM in the division of Gram-positive bacteria, specifically 
in the synthesis of peptidoglycan, has been demonstrated in this thesis, adding to the overall 
picture of cell division. GpsB is essential in S. pneumoniae (Rued et al., 2017), conditionally 
essential in L. monocytogenes (Rismondo et al., 2016) and PrkA and P-ReoM are required for 
the viability of L. monocytogenes (Wamp et al., 2020). L. monocytogenes infections can lead 
to human listeriosis which is coupled to a high mortality rate of 25-30 % (Lomonaco et al., 
2015) and S. pneumoniae diseases range from mild respiratory tract infections to 
pneumococcal pneumonia and meningitis (Henriques-Normark & Tuomanen, 2013). 
Listeriosis is particularly dangerous for pregnant women and can result in miscarriages and 
neonatal deaths (Segado-Arenas et al., 2018), whereas small children and the elderly are at 
highest risk with S. pneumoniae infections (Henriques-Normark & Tuomanen, 2013). The only 
feasible treatment for Listeria infections are antibiotics, predominantly a combination therapy 
of aminoglycosides and penicillins (Luque-Sastre et al., 2018) and for decades penicillin was 
the standard treatment for pneumococcal infections (Henriques-Normark & Tuomanen, 
2013). Like many forms of bacteria, Listeria and pneumococci are rapidly acquiring resistance 
to antimicrobial compounds (Henriques-Normark & Tuomanen, 2013; Luque-Sastre et al., 
2018). Since there is an absence of GpsB and ReoM homologues in humans, they offer the 
potential to be targets for novel antibiotics to treat infections caused by Gram-positive 
bacteria.  
In Chapter 5, an X-ray crystallography-based fragment screening experiment with the N-
terminal domain of SpGpsB was performed to identify small ligands that could be used as a 
scaffold to generate a chemical probe to block the GpsB:PBP interaction. Two of the ligands 
(3 and 9) bound with millimolar affinity to GpsB and ligand 9 was identified as the best scaffold 
candidate for the generation of a larger molecule capable of binding to SpGpsB with a higher 
affinity. Building the GpsB interactome and identifying the molecular basis of the interactions 
could lead to the discovery of new antibiotic targets. N-terminal GpsB ligands identified by 
XChem that bind in novel GpsB interaction sites could be used as starter molecules for the 
 
 196 
production of chemical probes. The development of probes that block essential bacterial 
division processes is only a small stepping-stone in the production of a novel antibiotics that 
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Figure Apx A.1: Plasmid map of pETM-11, image taken from SubtiWiki  http://subtiwiki.uni-
goettingen.de/wiki/index.php/PETM-11 
 





























Mutate Asn6 to Lys and Asn10 to 
Glu in BsDivIVA1-62N26DA30D 
N6KN10ER GCGAAAACTTTTTGTAAACGTCTTTTCGTGAATAT
CTTTTGGCGTTAATGGCATATGG 
Mutate Asn6 to Lys and Asn10 to 
Glu in BsDivIVA1-62N26DA30D 
R33IF GTAGATGAATTCCTAGACCAAGTCATAAAAGATT
ACGAAATTGTTCTCCG 

















Mutate Lys32 to Glu in BsGpsB1-68 
K32ER CCTTAATAATCATATCTAAAAATTCGTCAACGTCTT
CTTGCTTGTAGCCTC 
Mutate Lys32 to Glu in BsGpsB1-68 
D35AF GAAGACGTTGACAAATTTTTAGCTATGATTATTAA
GGATTATGAAACCTTCCATC  
Mutate Asp35 to Ala in BsGpsB1-68 
D35AR GATGGAAGGTTTCATAATCCTTAATAATCATAGCT
AAAAATTTGTCAACGTCTTC  




Mutate Ser19 to Cys and Lys21 to 
a stop codon in LmPBPA1 
S19CK21STOPR CCTCGTTTTTGGGATTTCTATTTACAACCACCACTT
TGTTTATTGCGATACTG 
Mutate Ser19 to Cys and Lys21 to 
a stop codon in LmPBPA1 
R8AF GGCAGATAAACCGCAGACAGCATCTCAGTATCGC
AATAAACAAAG 









































Mutate Gly43 to Cys and Arg46 to 
Stop codon in SpPBP2a 
G43CR46STOPR GATAACGACGCCAGAATTTTCAAATCGGACATAC
TTGGGCTAATTTTTTTCGATCAC 
Mutate Gly43 to Cys and Arg46 to 
Stop codon in SpPBP2a 
R30AF GACTCTGATTCTACTATCTTAGCTCGCTCTCGTAGT
GATCGAAAAAAATTAGCCC 


























Mutate Ser32 Ala in SpPBP2a23-45 
S32AR GGGCTAATTTTTTTCGATCACTACGAGCGCGACGT
AAGATAGTAGAATCAGAGTC 




























Mutate Arg31 to Lys and Arg33 to 
Lys in SpPBP2a23-45 
R31KR33KR CGATCACTTTTAGATTTACGTAAGATAGTAGAATC
AGAGTCCATGGAACCCTG  
Mutate Arg31 to Lys and Arg33 to 
Lys in SpPBP2a23-45 
R36AF CTTACGTCGCTCTCGTAGTGATGCAAAAAAATTAG
CCCAAGTATG 








Mutate Ile28 to Ala and Leu 29 to 
Ala in SpPBP2a23-45 
I28AL29AR CGATCACTACGAGAGCGACGTGCGGCAGTAGAA
TCAGAGTCCATGGAAC  
Mutate Ile28 to Ala and Leu29 to 




Mutate Ser30 to Cys, Leu31 to 




Mutate Ser30 to Cys, Leu31 to 
























Mutate Arg22 to Lys in 
SpBPB2x12-31N21A 
SpGpsB 
SPGPSBDELF CCA CTA CTG AGA ATC TTT ATT TTC AGG GCG 
CCA TTA TTT TTT CAG CG 
Deletion of residues 1-3 in 
SpGpsB1-63 
SPGPSBDELR CGC TGA AAA AAT AAT GGC GCC CTG AAA ATA 
AAG ATT CTC AGT AGT GG 




Mutate Asp33 to Ala in SpGpsB4-63 
D33AR CATAGTCCTTGATGACATCGGCTAAAAACTCGTCA
ACTTCTAC 




Mutate Thr7 to Ala in LmReoM 
T7AR GAATCATCGCCGAAGTTGTAAAACATTGCTTGATC
TTTTGAATCCATGGC 
Mutate Thr7 to Ala in LmReoM 
T7DF GGGCGCCATGGATTCAAAAGATCAAGACATGTTT
TACAACTTCGGCGATGATTC 
Mutate Thr7 to Asp in LmReoM 
T7DR GAATCATCGCCGAAGTTGTAAAACATGTCTTGATC
TTTTGAATCCATGGCGCCC 










































































Mutate Thr167 to Ala in LmPrkA-
KD 
G18DELF CAATAGGCGGCGGAATGGCCAATGTG Deletion of Gly18 in LmPrkA-KD 
G18DELR CACATTGGCCATTCCGCCGCCTATTG Deletion of Gly18 in LmPrkA-KD 
Table Apx B.1: Mutagenic primers used in this study  
Primer Sequence 5’ to 3’ Cloning 
SPGPSBF GCTATACCATGGCAAGTATTATTTTTTCAGCG Cloning SpGpsB residues 1-64 




Cloning SpGpsB residues 1-64 




Cloning ReoM (lmo1503) into 
pETM11 at NcoI and XhoI sites 
REOMR CGATATCTCGAGTCATTTCTCACCAATTTCGTTATT
TTTCAG 
Cloning ReoM (lmo1503) into 
pETM11 at NcoI and XhoI sites 
PRKAF GCTATACCATGGCAATGATGATTGGTAAGCGATT
AAGCG 
Cloning PrkA-KD (lmo1820) into 
pETM11 at NcoI and XhoI sites 
PRKAR CGATATCTCGAGTCATTTTTTCTTTTTCTTATCTTTT
TTCTCCTCAGG 
Cloning PrkA-KD (lmo1820) into 
pETM11 at NcoI and XhoI sites 
PRKPF GCTATACCATGGCAATGCATGCAGAATTTAGAAC
AGATAGAG 
Cloning PrkP (lmo1821) into 
pETM11 at NcoI and XhoI sites 
PRKPR CGATATCTCGAGTCATGAAGCATCCCTCCCTTTC Cloning PrkP (lmo1821) into 
pETM11 at NcoI and XhoI sites 
PBPA1F GATTTTCCATGGCAGATAAACCGCAGACAAG Cloning LmPBPA1 into pMAT11 




Cloning LmPBPA1 into pMAT11 
between NcoI and XhoI sites 
PBP2AF GCTGCGACTCTGGCAGGGATGCTCGAGGGGCCG
G 
Cloning SpPBP2a into pMAT11 
between NcoI and XhoI sites 
PBP2AR CCGGCCCCTCGAGCATCCCTGCCAGAGTCGCAGC Cloning SpPBP2a into pMAT11 
between NcoI and XhoI sites 
PBP2XF GACTTTTTCTCGAGGTTTTGCACACTCAAGTAACG Cloning SpPBP2x into pMAT11 
between NcoI and XhoI sites 
PBP2XR CAAAACCTCGAGAAAAAGTCATCATTCTGCC Cloning SpPBP2x into pMAT11 
between NcoI and XhoI sites 
Table Apx B.2: Primers for the construction of plasmids expressing recombinant proteins
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